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ROLE OF ENDOTHELIAL BKCa CHANNEL ACTIVITY IN DIMINISHED
VASOCONSTRICTOR REACTIVITY FOLLOWING CHRONIC HYPOXIA
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Melissa Anne Riddle
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PhD

ABSTRACT

Vasoconstrictor responsiveness of the systemic circulation are attenuated
following prolonged exposure to hypoxia. Previous work from our laboratory has
demonstrated vasoconstrictor reactivity is diminished due to hyperpolarization of the
vascular wall in systemic arterioles. The hyperpolarization of the vascular wall was found
to be dependent upon the endothelium, heme oxygenase (HO), and calcium-activated
large conductance potassium channel (BKCa) as removal of the endothelium or blockade
of HO or BKCa restored vasoreactivity. Interestingly, recent evidence for HO and BKCa
association has emerged in carotid body glomus cells where HO and BKCa form oxygen
sensing complexes. In these novel oxygen sensing complexes, HO-derived CO activate
BKCa channels in localized domains that regulate carotid body membrane potential. The
presence and function of HO and BKCa association has not been previously acessed in the
systemic endothelium. The following studies investigated a novel HO-BKCa functional
unit in systemic vascular endothelial cells. In whole cell patch clamp experiments it was
demonstrated that HO-dependent activation of BKCa
vi

significantly increased

transmembrane currents in ECs following CH. Additionally, HO-dependent BKCa activity
was unearthed following disruption of caveolin-1 function or potentially inhibited
following incubation with the caveolin-1 scaffolding domain, demonstrating the
inhibitory role of caveolin-1 on HO-BKCa complexes. Membrane potential recordings and
isolated arteriole experiments further demonstrated EC BKCa

regulates EC Em and

vasoconstrictor reactivity following CH through a loss in caveolin-1 inhibition. This
study is the first to characterize HO-dependent BKCa activation regulation by caveolin-1
and demonstrate a functional role for endothelial BKCa in vascular tone.
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CHAPTER 1
INTRODUCTION
Chronic hypoxia (CH) is associated with pathological conditions that impair
oxygenation or with prolonged residence at high altitude. Previous studies have
demonstrated that vasoconstrictor responsiveness of the systemic circulation is attenuated
following prolonged exposure to hypoxia (Auer & Ward, 1998;Doyle & Walker,
1991;Hu et al., 1996;Toporsian & Ward, 1997). Diminished vasoconstrictor reactivity
following CH is observed both systemically as a reduced total peripheral resistance
response to vasoconstrictor agonists (Doyle & Walker, 1991) and in several individual
vascular beds (O'Donaughy & Walker, 2000;Jernigan et al., 2001;Auer & Ward,
1998;Caudill et al., 1998) suggesting that it is a generalized response to this stimulus.
Further, since diminished vasoconstrictor activity is maintained following acute return to
normoxia (Doyle & Walker, 1991;Auer & Ward, 1998) and is largely unaffected by PO2
upon re-oxygenation (Doyle & Walker, 1991) this response to CH appears to be an
adaptation, distinct from acute responses to hypoxia.
This impairment of vasoconstriction is endothelium-dependent. For example,
reduced agonist-induced constriction following CH is reversed by endothelial disruption
in both aorta (Caudill et al., 1998;Doyle & Walker, 1991) and in resistance arteries
(Earley et al., 2002).

A similar endothelium-dependence is observed in attenuated

myogenic reactivity following CH in mesenteric arterioles (Earley & Walker, 2002).
Furthermore, CH-induced blunted vasoconstriction in the mesenteric vascular bed is
associated with an endothelium-dependent reduction in vascular smooth muscle (VSM)
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calcium as well as VSM hyperpolarization (Earley & Walker, 2002;Earley et al.,
2002;Earley & Walker, 2003). Further, removal of the endothelium, inhibition of heme
oxygenase (HO), (Earley et al., 2002;Naik & Walker, 2003), CYP P450 products (Earley
et al., 2003), or BKCa channels (Naik & Walker, 2003;Hughes et al., 2010) normalizes
membrane potential and restores vasoreactivity in arterioles from CH rats.
Although the mechanisms responsible for altered responsiveness in the
vasculature during CH are not fully defined, previous experiments suggest that
endothelial nitric oxide (NO) (Earley & Walker, 2003), carbon monoxide (CO) (Jernigan
et al., 2001;Naik et al., 2003;O'Donaughy & Walker, 2000;Gonzales & Walker,
2002;Caudill et al., 1998) and epoxyeicosatrienoic acids (EETs) (Earley et al., 2003) may
be involved.

In addition, VSM Em and vasoreactivity are restored in mesenteric

resistance arteries from CH rats following inhibition of large conductance calciumactivated K+ (BKCa) channels (Earley et al., 2003;Naik & Walker, 2003). Since NO, CO
and EETs are all endogenous activators of these channels, a primary role of BKCa in
altered vasoreactivity following CH is likely.
BKCa are important regulators of arterial tone via their hyperpolarizing influence
on vascular smooth muscle (VSM). VSM BKCa channels are regulated by localized
increases in calcium due to sparks from ryanodine-sensitive stores (Jaggar et al., 2000).
Although most studies concerning the role of BK channels in vascular control focus on
the VSM, there is increasing evidence that endothelial cells (EC) also express these
channels although both their expression and physiological significance in native cells
have been questioned (Gauthier et al., 2002). It has been suggested that although these
channels may be quiescent in some vascular beds, their activity is unmasked in various
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pathological conditions or in cell culture (Sandow & Grayson, 2009). The following
sections will outline the development of vascular dysfunction associated with chronic
hypoxia and chronic obstructive pulmonary disease, further discussing the role of the
endothelium in modulating vascular tone in pathological conditions associated with CH;
with a focus on the regulation and physiological role of BKCa channels in vascular
function/dysfunction.
Clinical Definition of Hypoxia:
Hypoxia can be defined as “a deficiency in the amount of oxygen that reaches the
tissues of body” ("Hypoxia" Merriam-Webster, 2011). This deficiency in oxygenation of
the tissues may result from a variety of mechanisms, such as inadequate oxygenation of
the arterial blood due to decreased atmospheric pressures for oxygen (PO2) as
experienced with increased altitude. Decreased oxygenation of tissues may also result
from low hemoglobin concentrations, decreased cardiac output, or impaired unloading of
oxygen from hemoglobin resulting in inadequate systemic oxygen delivery. Inadequate
peripheral oxygen delivery, as in the case of right-to-left shunting in the lung, and
diffusion impairment also result in hypoxemia (Pierson D.J., 2000). Thus, recognizing the
mechanism(s) of hypoxemia is important for proper diagnosis and treatment of patients.
The role of the efficiency of gas exchange on hypoxemia clinically is determined by
calculating the alveolar-to-arterial PO2 difference (P(A-a)O2). Arterial blood is first
obtained from patients to measure the partial pressures of oxygen and carbon dioxide in
the arterial blood, PaO2 and PaCO2 respectively.

Alveolar PO2 (PAO2) can then be

calculated using the alveolar gas equation:
PAO2 = PIO2 – PaCO2/R
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PaCO2 is the arterial carbon dioxide tension, R is the respiratory quotient, and PIO2 is
calculated from barometric pressure (PB), the partial pressure of water vapor (PH2O) at
body temperature, and the FIO2
PIO2 = (PB – PH2O) X FIO2

When breathing air at sea level, PIO2 is: (760-47mmHg) X 0.21, or approximately 150
mmHg. The respiratory quotient (R), the overall ratio of CO2 produced to O2 consumed
by the body, is about 0.8 (for most North American diets). Thus if the patient’s PaCO2 is
40mmHg:
PAO2 = 150 mmHg – 40 mmHg/ 0.8 = 100 mmHg
Calculated differences of P(A- a)O2 less than 20 mmHg are considered normal, while values
greater than 30 are abnormal (Pierson D.J., 2000). Administration of supplemental
oxygen and determined P(A-a)O2 values further aide in determining the patient’s cause for
hypoxemia. For example: normal values for P(A-a)O2 with increased PaCO2 (hypercapnia)
would suggest decreased alveolar ventilation, while abnormal values for P(A-a)O2,
decreased PaCO2 with positive responses from the patient to supplemental oxygen would
suggest ventilation-perfusion mismatching as seen in COPD patients. Understanding the
root of the patient’s hypoxemia enables appropriate measures to be taken to restore PaO2.
Acute hypoxia stemming from the use of barbiturates (respiratory depressants), or
decreased hemoglobin content in the blood require different courses of treatments; and
are not caused by impairment of lung function. In conditions that result in chronic
hypoxia, PaO2 is not readily restored and may not be restored to normal ranges as long-
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term exposure to the hypoxemia has resulted in chronic maladaptations that limit oxygen
diffusion across tissues. Fick’s law of diffusion states that the rate of gas transfer (Vgas)
through a sheet of tissue is proportional to: the tissue area (A), the difference in gas
partial pressure (P1-P2) between the two sides and inversely proportional to the tissue
thickness (T). The rate of diffusion is proportional to the diffusion constant (D) which is
defined as the quotient of the solubility and the square root of the molecular weight of the
gas.

Diseases such as COPD, where inflammation and occlusion of the airways occurs, result
in defective tissue diffusion. Further discussion on COPD and the mal-adaptations to
sustained hypoxia are discussed below.

Chronic Obstructive Pulmonary Disease
An estimated 6.9 billion people will inhabit the earth this year. Of the estimated
57 million annual deaths, 17 million will perish from cardiovascular disease ("COPD:
World Mortality/ Morbidity Rates", Central Intelligence Agency Factbook, 2009).
Worldwide, heart disease and stroke account for close to 13 million of the deaths from
cardiovascular disease and remain the top 2 causes of death globally. Another emerging
disease is COPD, which is currently the fourth leading cause of death worldwide ("COPD
Facts" World Health Organization, 2004) and the third leading cause of death in the
United States (Minino A.M. et al., 2008). The World Health Organization reported in
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2004 over 64 million people worldwide had been diagnosed and were living with COPD;
of those 64 million over 3 million lost their lives ("COPD Facts" World Health
Organization, 2004). The number of people with moderate to severe COPD continues to
rise as current numbers indicate well over 80 million people now are diagnosed with the
disease ("COPD Facts" World Health Organization, 2004). It is projected that by the
year 2020 COPD will be the third leading cause of death in the world (Rabe K.F. et al.,
2007). This largely preventable disease continues to plague the some of the world’s
poorest countries as close to 90% of COPD deaths occur in low to middle income nations
("COPD: World Mortality/ Morbidity Rates", Central Intelligence Agency Factbook,
2009). Cigarette smoking and occupational and environmental exposure to toxic airborne
pollutants include the main risk factors for developing COPD, with cigarette smoking as
the leading risk factor.
It is interesting that relatively few risk factors connect the world’s largest killers:
the “chronic diseases” COPD, heart disease, and stroke. Smoking remains the number
one risk factor for all three with dietary and lifestyle choices also aiding the development
and progression of these diseases. Even though cigarette smoking rates have dropped in
developed nations the past decade the projected number of deaths due to tobacco use
continues to rise with an estimated 3 million deaths annually by 2025. In developing
countries the use of tobacco and smoking is rising and an estimated 7 million deaths
annually by 2025 is projected ("COPD Facts" World Health Organization, 2004).
Epidemiologic evidence linking COPD to cardiovascular morbidity and mortality
continues to increase. Patients with COPD have a two to three fold increase in the risk of
cardiovascular events including death (Sin D.D. & Man S.F., 2005). Interestingly, COPD
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is the only major chronic disease with an increasing death rate in sharp contrast to the
recent dramatic decline in deaths from heart disease, stroke, and other cardiovascular
disorders (Mannino D.M., 2003).
An Inflammatory Disease:
COPD is characterized by chronic airflow limitation that is associated with
abnormal inflammatory responses of the lung (Rabe K.F. et al., 2007). Patients may
exhibit airway inflammation and mucus plugging as found in chronic bronchitis; or have
remodeling and/or parenchymal destruction with losses of the elastic properties of the
lung as found in emphysema. The severe inflammation and remodeling lead to airflow
limitation and tissue specific adaptations to the decreased tissue oxygenation (Rabe K.F.
et al., 2007) and increased tissue hypercapnia. Airway inflammation develops in the early
stages of COPD; inhaled irritants trigger abnormal inflammatory responses leading to
recruitment and infiltration of inflammatory cells to the lung, resulting in airway
inflammation and thickening (Devor & Crawford, 1984;Redline et al., 1989). The
recruitment of inflammatory cells and factors contributes to mucociliary dysfunction
plugging conducting airways (Sethi S & Murphy T.F., 2001;Kardos P & Keenan J.,
2006). Structural changes usually occur as a result of the chronic inflammation and
include airway wall fibrosis, increases in bronchiolar smooth muscle, epithelial
metaplasia, and destruction of lung parenchyma, and remodeling of the pulmonary
vasculature (Jeffery P.K., 2001;Kardos P & Keenan J., 2006).
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Secondary Pulmonary Arterial Hypertension (PAH):
The normally low resistance, low pressure pulmonary vasculature develops
heightened tone and vasoconstriction resulting in increased pulmonary vascular
resistance and pulmonary arterial pressure following long term exposure to hypoxia. The
increased pulmonary vascular resistance in COPD patients can additionally lead to the
development of secondary pulmonary arterial hypertension (PAH) (Burrows B et al.,
1972;Cermona G & Higenbottam, 2002). PAH is characterized by pulmonary arterial
obstruction by vascular proliferation and remodeling, endothelial dysfunction, and an
imbalance of vasoconstrictors to vasodilators promoting increased vascular tone and
vasoconstriction. The hypothesized mechanisms behind the development of higher
pulmonary arterial pressures will be presented in more detail below in “Cardiovascular
Responses to Chronic Hypoxia”, as chronic hypoxemia is the driving force behind the
development of these mal-adaptations in a variety of lung diseases (Humbert et al., 2004)
or long term residence at high altitude, and are therefore not unique to secondary PAH.
Extrapulmonary Manifestations of COPD:
COPD extrapulmonary manifestations (systemic effects) stem from dyspnea and
increased whole body inflammation. The increased inflammation, oxidative stress, and
hypoxia contribute to the development of PAH, cor pulmonale, edema formation, muscle
wasting, muscle fatigue, severe weight loss and malnutrition (Smith, 2009). Inflammatory
mediators, such as TNF-α and interleukin-1β may aide in altering leptin metabolism,
leading to a hypermetabolic state in patients with severe COPD (Smith, 2009). Muscle
wasting and muscle fatigue are common in COPD patients (Eisner M.D et al., 2008).
Additionally, endothelial dysfunction from the excessive systemic inflammation places
8

patients at a greater risk for developing co-morbidities (Eisner M.D et al., 2008) (Smith,
2009).
Cor pulmonale:
Increased pulmonary arterial pressure in PAH leads to the development of cor
pulmonale (Lee-Chiong T.L. & Matthay R.A, 2002). Cor pulmonale is characterized by
hypertrophy and dilation of the right ventricle and can range clinically from mild changes
in right ventricle function to right heart failure (Lee-Chiong T.L. & Matthay R.A, 2002)
(de Leeuw P.W. & Dess A, 2003). Cardiac output is initially maintained at normal in cor
pulmonale, suggesting the disease is not just a cardiac disorder. It is postulated that
volume overload stimulated from underfilling of the arterial system secondary to a fall in
total peripheral resistance results in the development of pressure-induced hypertrophy of
the right ventricle and eventual failure of the right heart (de Leeuw P.W. & Dess A,
2003). Patients with severe edema formation and cor pulmonale indeed exhibit normal
cardiac outputs with low systemic blood pressure and vascular resistance (de Leeuw P.W.
& Dess A, 2003;Anand I.S. et al., 1992).
Systemic Edema:
Fluid accumulation and swelling in the legs and feet is common in patients with
severe COPD and PAH. Edema formation can develop as stated above in cor pulmonale,
however recent evidence indicates the development of cor pulmonale is not the only
factor leading to the development of systemic edema in COPD. Hypoxemia can impair
renal function by promoting renal arteriolar vasoconstriction and causing fluid to shift
from intravascular to extravascular spaces. In addition to hypoxia, patient retention of
CO2 also provides a potent stimulus for edema formation with increased bicarbonate
9

reabsorption by the kidneys (Lee-Chiong T.L. & Matthay R.A, 2002;MacNee W, 1994).
Atrial natriuretic peptide (ANP) levels may also contribute to COPD patient edema
development. ANP, a 28-amino acid peptide is released in response to atrial stretch and
sympathetic stimulation to decrease sodium reabsorption, blood volume, and blood
pressure. A failure of ANP release is believed to contribute to salt and water retention
and edema in patients with COPD/PAH cor pulmonale (Winter et al., 1989). Normal and
slightly elevated plasma levels of ANP have been recorded in patients (Lee-Chiong T.L.
& Matthay R.A, 2002;Lee-Chiong T.L. & Matthay R.A, 2002;Winter et al., 1989),
suggesting that ANP insufficiency may contribute to the progression of edema. The
increased pooling of blood in the veins of the lower extremeties and fluid leak from the
increased vascular pressure results in patient discomfort and contributes to patient
exercise intolerance.
Skeletal Muscle Function:
Systemic inflammation and hypoxia contribute to the development of skeletal
muscle dysfunction in COPD patients. Systemic inflammation and increased reactive
oxygen species has been demonstrated to lead to increased muscle protein damage and
skeletal muscle catabolism (American Thoracic Society and European Respiratory
Society, 1999). Chronic hypoxia, itself has an adverse effect on skeletal muscle by
limiting muscle energy utilization and ATP production (American Thoracic Society and
European Respiratory Society, 1999). In the exercising muscle, oxidative muscle
metabolism is abnormal in patients with COPD. Working muscles depleted energy with
higher free phosphates to phosphorylated creatine phosphate ratios (Payen et al.,
1993;Kutsuzawa et al., 1995;Wuyam et al., 1992) while oxidative phosphorylation was
10

found to be reduced in COPD patients (Mannix et al., 1995) (American Thoracic Society
and European Respiratory Society, 1999). Thus, with decreased ability for energy
production and increased damage the health of and function of skeletal muscle in COPD
patients is limited.
The debilitating disease is not strictly a pulmonary disorder, as more systemic
effects of the disease are being recognized. For those who have known or currently are
diagnosed with COPD, it is often the non pulmonary effects that are the most destructive
to the patient’s quality of life. Even with supplemental oxygen to aid the hypoxemia,
patient mobility and ability to conduct everyday tasks are limited. Therefore, it is of vital
importance to understand the underlying mechanisms in the development and progression
of COPD as the disease climbs its way to being the world’s third greatest killer by 2020.
Current investigations utilizing animal and cellular models of COPD use a variety of
stimuli to induce tissue/cellular adaptations similar to those seen in humans with COPD.
One such model is long term exposure to chronic hypoxia. Many of the cardiovascular
derangements found in COPD are observed in response to the chronic hypoxemia and are
further discussed below.

Cardiovascular Responses to Hypoxia:
Acute Hypoxia:
Acute exposure to hypoxia results in increased heart rate, cardiac output, ventilation,
catecholamine secretion, and blood pressure (“Hypoxia, polycythemia and cyanosis”
Harrison's Principles of Internal Medicine. Braunwald et. al., 1998). Stimulation of
peripheral arterial chemoreceptors from the decreased PaO2 leads to depolarization and
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release of catecholamines from type I glomus cells. Afferent fibers of the
glossopharyngeal and vagus nerve are activated and the action potential is propagated to
cardiorespiratory centers of the brain, which relay action potentials to efferent fibers of
the vagus nerve decreasing parasympathetic stimulation of the heart leading to increased
heart rate and sympathetic stimulation of the heart increasing stroke volume and heart
rate to increase cardiac output (“Hypoxia, polycythemia and cyanosis”

Harrison's

Principles of Internal Medicine. Braunwald et. al., 1998). Decreases in PO2 are also
sensed within the vasculature, as acute hypoxia causes hypoxic pulmonary
vasoconstriction and systemic vasodilation.

Systemic Vasodilation:
In the systemic vasculature, exposure to acute hypoxia results in vasodilation. The
innate response of the systemic vasculature to dilate to decreased PO2 is important in
maintaining constant blood flow and thus nutrient and oxygen delivery to delicate tissues.
This especially is important in the cerebral circulation which consumes close to 20% of
resting total-body oxygen and receives 14% of the body’s cardiac output (Kandel et al.,
2000). Hypoxia-induced relaxation may occur directly from cellular sensing of the
reduced PO2 and/or from increased production of vasodilator metabolites from systemic
tissues. Reductions in ATP production and increases in adenosine, lactic acid, and
circulating potassium and hydrogen ions can increase vasodilation (Furchgot, R.F.,
1966;Waypa & Schumacker, 2010;Taggart & Wray, 1998). The role of the endothelium
in this response is varied, as many groups have demonstrated vessel dilation and smooth
muscle relaxation in the absence of the endothelium (Smani et al., 2002;Quayle et al.,
2006;Pinder et al., 2009;Jackson, 2000). However in coronary arterioles hypoxic dilation
12

appears dependent on the endothelium (Lynch et al., 2006;Jimenez et al., 1996a;Liu &
Flavahan, 1997) and endothelial production of nitric oxide (NO) (Jimenez et al.,
1996;Parent et al., 1992;Liu & Flavahan, 1997;Lynch et al., 2006). Direct responses to
hypoxia within vascular smooth muscle may include the activation of K+ channels
(Quayle et al., 2006) or result in decreased intracellular calcium and contraction through:
1. inhibition of calcium entry, 2. inhibition of intracellular calcium release, 3. accelerated
uptake by the Sarco(endo)plasmic reticulum calcium-ATPase (SERCA) pump (Gupte &
Wolin, 2006) (Waypa & Schumacker, 2010). The mechanisms responsible for decreased
intracellular calcium following acute hypoxic exposure are still currently under
investigation. Current hypotheses support a role for increased cellular reactive oxygen
species (ROS), as it has been demonstrated that decreasing ROS and/or increasing the
reduced status of smooth muscle cells attenuated hypoxic vasodilation (Waypa &
Schumacker, 2010;Gupte & Wolin, 2006).

Hypoxic Pulmonary Vasoconstriction Response:
In contrast to vasodilation to hypoxia found in systemic arteries, the pulmonary
circulation constricts in response to this stimulus. This unique response in the pulmonary
circulation is biphasic with an acute phase followed by a slow sustained constriction. The
acute phase occurs within seconds, does not require the endothelium (Zhang et al.,
1997;Waypa & Schumacker, 2010), is associated with increased release of intracellular
calcium stores, closure of KV channels, and an opening of voltage dependent calcium
channels and non-selective cation channels (Archer et al., 1998;Morio & McMurtry,
2002;Lu et al., 2009;Waypa & Schumacker, 2010). The sustained or chronic phase
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results in activation of myosin light chain kinase increasing actin-myosin cross-bridging
and contraction (Waypa & Schumacker, 2010). Thus, acute hypoxia results in
constriction of pulmonary arteries in areas of poor ventilation. Constriction of these
arteries diverts blood flow to better ventilated areas, thereby matching ventilation to
perfusion enabling more efficient oxygenation. Return to normoxic conditions rapidly
reverses the cardiorespiratory changes to acute hypoxia. However in long term exposure
to hypoxia, restoration to normoxic conditions does not readily reverse chronic
adaptations of the cardiovascular system as discussed further below.

Chronic Hypoxia:
Long term exposure to hypoxia leads to chronic hyperventilation and
compensatory metabolic acidosis produced by increased renal bicarbonate loss (Wyatt F,
2011). The sustained tissue hypoxia additionally increases red blood cell production,
hemoglobin, and 2,3-bisphosphoglyceric acid production to increase the body’s oxygen
carrying capacity and thereby increase O2 delivery to the peripheral tissues. The increase
in red blood cells and decrease in plasma volume with chronic hypoxia lead to the
development of polycythemia. Cardiac output, the product of stroke volume and heart
rate, is normal at resting conditions as heart rate normalizes after long term exposure to
hypoxia and only a slight decrease in stroke volume is observed in humans (Wyatt F,
2011). Additionally, hypoxic pulmonary vasoconstriction persists resulting in the
development of increased pulmonary arterial pressure (Morrell et al., 2009). This
increase in pulmonary arterial resistance is associated with an increase in pulmonary
arterial pressure.
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Increases in Pulmonary Vascular Resistance:
Chronic hypoxia causes persistent hypoxic pulmonary vasoconstriction and an
increase in the muscularization of pulmonary arteries resulting in the development of
increased pulmonary arterial pressure and the development of pulmonary arterial
hypertension (PAH) (Morrell et al., 2009;Tuder et al., 2009).

The increased

muscularization of the pulmonary arteries and the persistent vasoconstriction reduce
arterial lumen diameter, resulting in an increase in vascular resistance as defined by
Poiseuille’s Law, which describes laminar flow of an incompressible uniform viscous
liquid (Newtonian fluid) through cylindrical tubes. Through the assumption of laminar
blood flow through cylindrical blood vessels we can estimate vascular resistance through
the following equation:
R = 8ƞl / πr4
Where resistance R = is proportional to changes in viscosity (ƞ) and length (l), and
inversely proportional to changes in vessel radius (r). This estimate of vascular resistance
illustrates the importance of blood viscosity, and especially vessel radius (diameter
changes) on vascular resistance. Thus, increased pulmonary resistance following chronic
hypoxia can be attributed to changes in arteriole diameter through enhanced
vasoconstrictive properties or vascular remodeling of pulmonary arteries; and from
increased viscosity of the blood through polycythemia.

15

Enhanced Vasoconstriction:
Chronic hypoxia has been demonstrated to increase vasoconstrictor reactivity of
pulmonary arteries. The mechanisms responsible for the enhanced constrictor properties
include increased smooth muscle sensitivity to calcium through RhoA signaling (Barman
S.A., 2007;Hyvelin et al., 2005;Jernigan et al., 2004), increased smooth muscle calcium
through cellular depolarization (Sweeney & Yuan, 2000;Naik et al., 2005), and decreases
in endothelial products that promote vasodilation (Fike et al., 1998;Giaid & Saleh,
1995;Girgis et al., 2005).
The small GTPase RhoA and its downstream effector Rho kinase (ROK) play an
important role in the regulation of the contractile state of vascular smooth muscle by
regulating phosphorylation of the myosin light chain by inhibiting myosin light chain
phosphatase activity (Jernigan & Resta, 2004). Filament cross-bridge cycling and smooth
muscle contraction are dependent upon the balance of the calcium dependent myosin
light chain kinase and the calcium independent myosin light chain phosphatase. Thus,
increased stimulation of RhoA results in enhanced calcium sensitivity of the contractile
apparatus and inhibition of its downstream effector ROK would decrease calcium
sensitivity. Following chronic hypoxia in models of PAH RhoA/ROK signaling is
upregulated (Barman S.A., 2007;Hyvelin et al., 2005;Jernigan & Resta, 2002) and
inhibition of ROK acutely reverses the effects of chronic hypoxia induced PAH (Hyvelin
et al., 2001;Nagaoka et al., 2004;Oka et al., 2007), demonstrating that ROK-mediated
vasoconstriction contributes greatly to increased pulmonary vascular resistance.
In addition to increased calcium sensitivity of the contractile apparatus, chronic
hypoxia results in smooth muscle cell depolarization from decreased expression of
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several isoforms of KV channels (Platoshyn et al., 2001). Smooth muscle depolarization
following chronic hypoxia has been observed in cultured smooth muscle cells and small
pulmonary arteries (Sweeney & Yuan, 2000;Naik et al., 2005), in which the decreased
expression of KV channels increases calcium entry into smooth muscle cells from voltage
dependent calcium channels and enhances constriction. The degree of tone or
vasoconstriction is highly dependent upon smooth muscle membrane potential and
intracellular calcium, however smooth muscle contraction and thus arteriole constriction
can be influenced by the vascular endothelium. The vascular endothelium produces many
important vasodilators that modulate vascular tone. Therefore, endothelial dysfunction
and a loss in production of vasodilatory substances can also lead to an increase in
vasoconstriction and vascular tone.
Pulmonary endothelial function following chronic hypoxia creates an improper
balance between endothelium-derived vasoconstrictive and vasodilatory substances. For
example, there is decreased synthesis of the potent vasodilators and anti-mitogens, NO
and prostacyclin (Moro et al., 2008). Furthermore, hypoxia enhances endothelial
synthesis and release of the endothelin-1 (ET-1) and thromboxane A2 (TXA2), two
vasoconstrictive factors that promote vasoconstriction and VSM proliferation (Moro et
al., 2008), leading to an imbalance of factors that influence vasoconstriction. To
summarize, there are many contributing factors leading to the enhanced constrictor
profile of pulmonary smooth muscle following prolonged exposure to hypoxia; all
leading to the development of increased pulmonary vascular resistance and increased
pulmonary arterial pressure.
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Vascular Remodeling:
The loss of anti-proliferative factors such as NO and increased production of
mitogenic factors such as ET-1 in chronic hypoxia induce vascular remodeling. ET-1
stimulation of ETA receptors on the smooth muscle increases intracellular calcium and
can activate calcium-sensitive transcription factors (Moro et al., 2008). Decreased KV
channel expression also promotes cellular proliferation by increasing cytosolic calcium.
A rapid increase in nuclear calcium occurs with the rise in cytosolic calcium; this
increase in nuclear calcium accelerates cell proliferation by modulating the cell cycle
(Park W.S. et al., 2010). The decreased potassium efflux out of KV channels also permits
increased activity of caspases and nucleases, further facilitating vascular remodeling
(Mandegar M & Yuan, 2011;Park W.S. et al., 2010) and smooth muscle proliferation.
There is also evidence for endothelial proliferation in the lumen of pulmonary arteries in
patients with mild COPD (Barbera J.A. et al., 1994). Together, enhanced vasoconstrictive
properties and hyperproliferation of vascular smooth muscle and endothelial cells,
promote increased vascular pressure in chronically hypoxemic patients through
decreasing the arterial lumen and increasing vascular resistance. In addition to the effects
of vascular remodeling and vasoconstriction, chronic hypoxia induced polycythemia may
also promote increased vascular resistance.

Polycythemia:
Polycythemia is an increase in systemic hematocrit (Hct) above normal values.
Congenital erythrocytoses from instrinsic genetic defects within bone marrow produce
primary polycythemia (Messinezy M & Pearson TC, 1999). Secondary polycythemia has
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two main etiologies; 1) acquired erythrocytoses associated with renal hypoxia, which is
the consequence of low blood oxygen saturation, which triggers the production and
release of ertythropoietin from the kidneys (Messinezy M & Pearson TC, 1999) and 2)
myeloid cancers resulting in unexpected erythropoietin production. Patients with lung
diseases, such as COPD and PAH, and in individuals who have resided at high altitude
for extended periods may develop secondary polycythemia (Braunwald E et al.,
1998;Ersley AJ, 1995;Saldivar et al., 2003). The increased Hct is believed to be an
adaptation to increase the oxygen-carrying capacity. However the increased Hct may
additionally have deleterious effects on hypoxic patients by increasing vascular resistance
by increasing blood viscosity. Interestingly, in patients with myeloproliferative diseases
the incidence of pulmonary hypertension appears to be common (Gupta R et al., 2006),
suggesting increased Hct and blood viscosity may be significant contributors to the
development of increased vascular resistance and the development of PAH. However,
exogenous application of erythropoietin and the development of polycythaemia in rats
did not result in the development of PAH (Petit R.D. et al., 1993; Walker et al., 2000). In
mouse and rat models of PAH the role of erythropoietin appears to be important in
protecting the pulmonary vasculature from pulmonary vascular remodeling associated
with PAH (Petit R.D. et al., 1993;Satoh K et al., 2006;Weissmann et al., 2005) and
development of the disease (Weissmann et al., 2005). Thus the role of erythropoietin and
polycythemia in increased vascular resistance in chronically hypoxic patients may result
in an increased tendency to develop PAH, with increased Hct and erythryopoietin having
beneficial as well as possible deleterious effects on the vasculature.
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Systemic Vascular Reactivity in Chronic Hypoxia:
Acute hypoxia results in systemic vasodilation and chronic hypoxia decreases
vascular tone. Chronic hypoxia significantly decreases vasoconstrictor responsiveness of
the systemic circulation (Auer & Ward, 1998;Toporsian & Ward, 1997;Hu et al.,
1996;Doyle & Walker, 1991). For example, acute activation of the cardiopulmonary and
arterial baroreceptors normally increases sympathetic responses resulting in increased
peripheral vascular resistance and maintenance of blood pressure. Following CH, the
effect of unloading cardiopulmonary and arterial baroreceptors fails to increase vascular
resistance and the ability to maintain blood pressure is compromised (Wolfel E.E &
Levine B.D., 2002). This has been observed systemically as a reduced total peripheral
resistance response to vasoconstrictor agonists and in several individual vascular beds
(O'Donaughy & Walker, 2000;Jernigan et al., 2001;Auer & Ward, 1998;Caudill et al.,
1998) suggesting that it is a generalized response to this stimulus. Interesting, diminished
vasoconstrictor reactivity of systemic arteries following CH can be restored by removal
of the endothelium (Earley et al., 2002;Naik & Walker, 2003), suggesting endothelial
modulation of vascular tone is decreasing arteriolar tone and vasoconstriction.

Endothelial Modulation of Vascular Tone
The Endothelium:
In 1628, William Harvey described the role of blood vessels in the circulatory
system and how they functioned in separating circulating blood and tissue. These “blood
vessels” were later found to be lined with cells by von Reckingausen in the 1800s. As the
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19th century came to an end, the endothelium was recognized as an inert cellophane like
membrane that lined the vessels and functioned in maintaining vessel wall permeability.
Starling’s experiments and his law of capillary exchange in 1896 overshadowed early
views by Heidenhahn (1891) which described the endothelium as an active secretory
system. It was not until half way through the 20th century and the development of
electronmicroscopes that it was recognized that the endothelium was more than a mere
physical barrier (Fishman, 1982;Cines et al., 1998). The vascular endothelium, is critical
for survival as is modulates vascular permeability, maintains anticoagulant properties,
and contributes to the

physiological control of vasoregulation (Davies, 2009). The

endothelial surface area in an adult human is composed of approximately 6 trillion cells,
weighs 1kg, and covers a surface area of 7m2 (Cines et al., 1998). Endothelial cells (ECs)
line all vessels in every organ system and regulate the flow of blood, biologically active
molecules, and nutrients. Blood flow is regulated in part by the antithrombotic surface of
the endothelium, where increases in shear stress and inflammation trigger ECs to create
prothrombotic and antifibrinolytic microenvironments which lead to the formation of
clots, limiting blood flow. Blood flow is also regulated by endothelial uptake or release
of vasoactive substances acting in a paracrine manner to constrict or dilate vessels (Cines
et al., 1998).
Adaptation to local environment:
The endothelium adapts to local hemodynamics acutely by release of vasoactive
substances modulating local vasoconstriction/vasodilation l responses, and to sustained
changes by altering gene and protein expression to promote adaptive structural
remodeling of the artery (Davies, 2009). Acute changes in hemodynamics, such as
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exercise, increase shear force upon endothelial cells resulting in a local increase in nitric
oxide (NO), prostacyclin and cytochrome P450 products to induce vasodilation and
increase blood flow to the working tissue. These short-term responses subside after the
termination of exercise and hemodynamic conditions return. Long term alterations of
hemodynamics may lead to phenotypic changes of the endothelium. For example in a
porcine model of atherosclerosis, in areas of disturbed blood flow multidirectional forces
in the aorta resulted in increased expression of coagulation factors such as plasminogen,
von-Willebrand factor, and t-PA. Additionally, NFκB, interleukin-6, and macrophage
chemoattractant proteins were upregulated resulting in a pro-artherosclerotic phenotype
of the endothelium (Passerini A.G. et al., 2004).
Flow-dependent Dilation:
Increased local blood flow sensed by the endothelium moderates local
vasodilation. This response requires functional endothelium and is termed “flow-induced
dilation”. Flow-induced (or dependent) dilation was first observed in 1933
(Schretzenmayr A Uber kreislaufregulatorische Vorgange an den groBen Arterien bei der
Musckelarbeit,1933). From early studies in isolated arteries and in vivo studies, it was
demonstrated to be dependent upon activation of the endothelium as physical removal of
endothelial cells eliminated dilation to increased flow (Pohl et al., 1986;Holtz et al.,
1984;Lie et al., 1970). Endothelial products hypothesized to be responsible for the
dilation include NO, PGI2, eicosatetraeonic acids (EETs), CO, and endothelium-derived
hyperpolarizing factors (EDHFs). In addition to release of endothelial-derived relaxation
factors from flow, acetylcholine and other intracellular calcium mobilizing agents, such
as adenosine triphosphate, all result in endothelium-dependent relaxations and are used as
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indicators of endothelial function within the vasculature. Thus, a lack or dampened
response to infused acetylcholine as well as flow-dependent dilation would be indicative
of impaired endothelial function.
Endothelial-dependent Dilation in COPD and Chronic Hypoxia:
Clinically, flow-induced dilation is often used to assess endothelial health and
function. Flow-induced dilation reflects conduit artery function, whereas intrabrachial
infusion of endothelium-dependent dilators, such as acetylcholine, reflects endothelial
function in resistance arteries (Burghuber & Valipour, 2009;Maclay et al., 2011;Lind et
al., 2009). COPD patients have been reported to be chronically vasodilated (Casiglia et
al., 1998); the chronic dilatory state may be due to augmented dilatory responses or
decreased tone and vascular remodeling. Further investigations have demonstrated that
endothelium-dependent dilation as assessed by acetylcholine infusion in systemic
resistance arteries from COPD patients is decreased (Maclay et al., 2011) as is flowinduced dilation (Moro et al., 2008;Lind et al., 2009). Increased arterial stiffening and
derangements in vascular tone from arterial remodeling in larger conduit arteries may
additionally contribute to the chronic vasodilated status of COPD patients (Maclay et al.,
2011). Endothelial dysfunction in these patients has been hypothesized to be largely due
to exaggerated inflammatory responses and cigarette toxicity, which have been shown
independently of COPD to decrease endothelial function (Edirisinge & Rahman,
2010;Heitzer & et.al, 1996).
Long term residence at high altitude has not been associated with a decrease in
flow-dependent dilation (Gupta A.K. et al., 1997); (Jansen et al., 2007). Additionally,
endothelium dependent dilation to hypoxia is maintained at high altitude (Gupta A.K. et
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al., 1997;Jansen et al., 2007). In laboratory models there are conflicting accounts on the
effects of hypoxemia on endothelium-dependent dilation. Decreased endotheliumdependent dilation in aorta rings of chronically hypoxic rats has been reported (Toporsian
& Ward, 1997). In contrast, multiple studies have demonstrated increased endotheliumdependent dilation. In isolated hearts from chronically hypoxic fetal guinea pigs
endothelium-dependent dilation was increased (Thompson et al., 2000). In Wistar rats
exposed to 24 hours to 7 days of chronic hypoxia NO-dependent dilation or dilator
responses to an acute hypoxic challenge were accentuated. The greatest increase in
skeletal muscle arterioles endothelium-dependent dilator response occurred during the
first 72 hours of hypoxic exposure and was greatly attenuated by the 7th day. Even with
the decreases in dilator responsiveness, endothelium-dependent relaxation was still
significantly greater in CH treated rats than normoxic controls (Walsh & Marshall, 2006).
Thus, depending on the length of exposure to hypoxia, the animal species, and the
vascular bed under study, endothelium-dependent dilation may be enhanced following
CH.
Endothelial dependent dilation to agonists such as acetylcholine increases
endothelial intracellular calcium levels and production of endothelial-derived vasodilators
such as NO, PGI2, CO, and epoxyeicosatrienoic acids (EETs). Each of these factors can
directly or indirectly act upon smooth muscle K+ channels and result in smooth muscle
cell hyperpolarization and relaxation. One K+ channel thought to largely contribute to
membrane potential regulation and modulation of vascular tone, the large conductance
calcium-activated K+ channel (BKCa), can be activated by a large array of endothelial-
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derived vasodilators. The roles of endothelial-derived NO, CO, EETs and EDHFs will be
further discussed below in the context of BKCa regulation of vascular tone.

The Role of BKCa Channels in Vasoregulation
As previously mentioned, vascular smooth muscle (VSM) contractility is
dependent upon intracellular Ca2+ and membrane potential (Em). The

balance of

endothelial vasodilators to vasoconstrictors affects VSM Em and/or Ca2+ and contractility.
Many of the vasoactive substances produced by the endothelium work directly or
indirectly on the actions of smooth muscle K+ channels, which are primarily responsible
for maintaining membrane potential (Em) and intracellular Ca2+ levels. Since both
intracellular Ca2+ and membrane voltage are determinants of BKCa activity, it is no
surprise the channel acts as a regulator of Em in smooth muscle cells. By fine tuning Em
and intracellular concentrations VSM BKCa channels regulate vascular tone (Tanaka Y et
al., ;Nelson & Quayle, 1995;Waldron & Cole, 1999).

VSM Em:
VSM BKCa channels are thought to contribute to the maintenance of Em in small
myogenic vessels. The large efflux of K+ that results from BKCa activation counteracts
pressure or chemical/agonist-induced depolarization and vasoconstriction (Tanaka Y et
al., ;Waldron & Cole, 1999;Brayden & Nelson, 1992). VSM BKCa channels are localized
to cellular caveolae. Caveolae are cellular invaginations that contain the structural
proteins caveolins and are thought to be important signaling domains (Jaggar et al.,
2000). VSM BKCa channels activated by local increases in intracellular Ca2+ from
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clusters of ryanodine receptors on the sacroplasmic reticulum (calcium sparks) (Nelson et
al., 1995). These calcium sparks increase channel activity and result in an efflux of K+
that is sufficient to hyperpolarize the sarcolemma by 10-20mV (Jaggar et al.,
2000;Nelson et al., 1995). Blockade of BKCa channels or ryanodine receptors causes
membrane depolarization, elevations in smooth muscle intracellular Ca2+, and results in
vasoconstriction. In addition to agonists or vascular responses that increase VSM calcium
sparks, endogenous endothelial derived vasodilators, such as NO, EETs, and CO
additionally increase the activity of VSM BKCa, while endothelial derived products such
as 20-hydroxyeicosatetraenoic acid (20 HETE) decrease BKCa activity.

Endogenous Products of the Endothelium That Stimulate VSM BKCa
Endothelial produced gaseo-transmitters such as NO (Bolotina et al., 1994) , CO
(Jaggar et al., 2002), and hydrogen-sulfide (H2S) (Jackson-Weaver et al., 2010) may
activate VSM BKCa channels within the systemic vasculature. The gaseo-transmitters NO
and CO may directly act upon the channel to increase activity, Alternatively, indirect
actions via the actions of cyclic guanosine-monophosphate (cGMP) and protein kinase G
(PKG) or protein kinase A (PKA) phosphorylation of the channel may increase activity
(Toro et al., 1998). Additionally, the cytochrome P450 epoxygenase metabolites
epoxyeicosatrienoic acids (EETs) activate VSM BKCa channels and dilate coronary
arterioles (Zhang et al., 2001). 11,12 EET increases BKCa activity in cell-attached and
inside-out patches (Zhang et al., 2001). Prostacyclin (PGI2) is another endothelial derived
relaxation factor that can increase BKCa activity indirectly through cyclic adenosinemonophosphate (cAMP) and PKA/PKG phosphorylation of the channel (Burnette &
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White, 2006;Tanaka Y et al., 2004). Channel modification by gaseotransmitters or
phosphorylation increases channel open probability through a variety of structural and
biochemical modifications that result in enhanced voltage or calcium sensitivity (Hou et
al., 2009). CO may act as a calcium surrogate (Hou et al., 2008), and archidonic acid
metabolites such as EETs may bind to the channel and alter channel structure to increase
opening of the channel or to decrease channel inactivation, deactivation, or removal from
the plasma membrane (Hou et al., 2009). In addition to endothelial influence, BKCa
channel activity has also been found to be sensitive to changes in the cellular
environment. Increased cellular stretch and decreased PO2 may increase and decrease
BKCa activity respectively, and are further discussed below.

VSM BKCa Activation by Stretch; The Myogenic Response:
Stretch of the vascular wall by increases in vascular pressure is sensed by
mechanosensitive ion channels that are able to produce intracellular signals in response to
mechanical stimuli. BKCa channels have been demonstrated to be “stretch” sensitive ion
channels and the mechanical sensitivity is hypothesized to be located in the channel’s
alpha subunit stress-axis regulated exon (STREX) a 59 amino acid insert in the C
terminus (Naruse et al., 2004;Naruse et al., 2009;Tang Q.Y. et al., 2005). In VSM cells
from pulmonary (Kirber et al., 2011), mesenteric (Dopico et al., 1994), and coronary
arteries (Wu & Davis, 2001) mechanical stretch increases BKCa channel opening.
Activation of the channels is hypothesized to act as a “brake”, thereby fine tuning stretchinduced depolarization of multiple stretch sensitive cation channels and thus limiting the
magnitude of vasoconstriction (Wu & Davis, 2001;Hill et al., 2010). Evidence also exists

27

for indirect activation of VSM BKCa channels from cell membrane extracellular matrix
proteins, such as α5β1 integrin and fibronectin which activate the channels through a cSrc dependent mechanism (Hill et al., 2010;Martinez-Lemus et al., 2005;Wu et al.,
2008;Yang & et.al, 2009). Thus, voltage, Ca2+ and cellular stretch can activate BKCa
channels to oppose vasoconstriction and promote vasodilation in arterioles.

BKCa as Oxygen Sensor:
BKCa channels have been demonstrated to be oxygen sensitive and act as oxygen
sensors in carotid body glomus cells (Williams et al., 2004) , pulmonary smooth muscle
cells, chromaffin cells, central neurons (Haddad & Liu, 2000) and alveolar epithelial cells
(Jovnovic et al., 2003). Severe hypoxia has been shown to inhibit channel activity in a
membrane-delimited manner in HEK-293 cells (Lewis et al., 2002), whereas in neurons
cytosolic factors are required for hypoxia to inhibit channel activity (Liu et al., 1999).
Current investigation into the mechanism responsible for oxygen sensing by BKCa
channels has uncovered a role for heme and heme oxygenase (HO). BKCa channels are
hemoproteins, and upon binding of heme are potentially inhibited (Yi et al., 2010). In
conditions in which free heme is degraded by HO, the channel remains active and can be
stimulated by the HO product CO (Yi et al., 2010). Recent co-immunoprecipitation
experiments in HEK293 (Williams et al., 2004) and Glomus type I cells have found BKCa
and HO-2 can form “oxygen sensitive” complexes. Interestingly, knockdown of HO-2
significantly decreases channel activity (Williams et al., 2004). The authors hypothesized
that hypoxia inhibits HO production of CO and thus limits channel activity, suggesting
that HO-2 was the “oxygen sensor” and CO levels regulated channel activity. However,
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experiments that characterized the heme binding domain (HBD) of BKCa channels found
that decreased oxygen and a reduced state of the HBD significantly increase the
channels’ affinity for heme and result in potent inhibition of the channel (Yi et al., 2010).
In contrast, in normoxic conditions channel affinity appears much higher for CO than
heme and permits channel activity (Yi et al., 2010). Thus, HO function and heme/CO
binding appear to be very important regulators of BKCa activity and associate with the
channel to form “oxygen sensitive” complexes. Whether these “oxygen sensitive”
complexes exist in the vasculature is under current debate.

HO dependent hyperpolarization following CH: HO has two predominate isoforms found
within the vasculature, HO-1 and HO-2. Following CH, whole artery HO-1 expression is
significantly increased with no change in HO-2 (Jernigan et al., 2001). Additionally, HO
activity is significantly increased following CH (Jernigan et al., 2001). Previously, we
identified HO and BKCa channel dependent regulation of smooth muscle cell membrane
potential and intracellular calcium concentration following CH in the rat (Earley et al.,
2002;Naik & Walker, 2003). Interestingly, the HO and BKCa dependent hyperpolarization
is dependent upon the presence of the endothelium and is independent of ryanodine
receptor stimulation (Earley et al., 2002;Naik & Walker, 2003) suggesting the
hyperpolarizing influence of BKCa activity may be localized to the endothelium.

Evidence for the Physiological Role of Endothelial BKCa Channels
BKCa channels are ubiquitously expressed throughout the body, and function in
modulating Em, intracellular Ca2+, and intracellular K+ to control neuronal excitability,
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vascular tone, neurotransmitter release, cell volume regulation, and fluid secretion. Their
presence in the endothelium has been recognized (Dong et al., 2007;Wang et al.,
2005;Wrzosek, 2009;Sandow & Grayson, 2009). From cultured cell studies, endothelial
BKCa channels were demonstrated to be inhibited by the scaffolding domain of caveolin1 (Wang et al., 2005) and localized to EC caveolae. Unitary conductance from EC BKCa
channels are similar to reported values of BKCa in other cell types (Sandow & Grayson,
2009;Rusko et al., 1992;Ling & O'Neill, 1992) and unlike VSM cellss, beta subunits do
not appear to play a role in the channels calcium sensitivity and the channels are activated
at more positive potentials (Eichhorn & Dobrev, 2007;Nimigean & Magleby,
1999;McManus et al., 2011).

Defining the Physiological Role for Endothelial BKCa:
Similar to their functions in VSM cells BKCa activity has been hypothesized to
regulate endothelial Em; however recent studies conducted by Ledoux et. al suggest small
and intermediate conductance calcium-activated potassium channels have a predominant
role regulating endothelial Em with no evidence for endothelial BKCa channels (Ledoux
et al., 2008). Defining the role for endothelial BKCa channels may prove to be a difficult
task, as expression and activity vary widely throughout the vasculature and may
additionally be altered by disease (Jovnovic et al., 2003;Wrzosek, 2009;Sandow &
Grayson, 2009). For example, in normoxic conditions, we have not found a role for
endothelial BKCa activity. However, following CH exposure BKCa activity emerges and is
the driving force behind vascular wall hyperpolarization following CH (Earley et al.,
2002;Naik & Walker, 2003). Thus, endothelial
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BKCa channels may contribute to

endothelial Emfollowing CH. In addition to contributing to endothelial Em, endothelial
BKCa channels have also been hypothesized contribute to flow-dependent dilation.
Flow Dependent Dilation
A role for endothelial BKCa channels in flow-dependent dilation was first
characterized in rat skeletal muscle arterioles and mesenteric arterioles, where luminal
administration of the BKCa selective inhibitor iberiotoxin (IBTX) eliminated dilation to
flow (Sun et al., 2001). Abluminal administration of IBTX was unable to block flowinduced dilation, demonstrating endothelial BKCa channels and not VSM BKCa were
likely responsible for flow-induced dilation. Increases in shear stress from increases in
hematocrit could potentially increase the role of these channels following disease,
demonstrating an important physiological role for endothelial BKCa channels in signal
transduction and dilation in health and disease. Thus endothelial BKCa channels are
activated by calcium, voltage, and “mechanical stress” from shear stress of the vascular
endothelium, but do they also function as an oxygen sensor?

Endothelial BKCa in Regulation of Vasoconstrictor Reactivity Following CH
With recent evidence indicating HO-BKCa complexes may function to regulate
membrane potential and act as “oxygen sensors”, the search to discover if HO-BKCa
signaling complexes exist in the vasculature began. In pulmonary arterial smooth muscle
cells, a weak association between HO and BKCa was found (Roth et al., 2009). Studies of
HO and BKCa complexes in the vascular endothelium have not been conducted. As
previously mentioned, CH exposure results in persistent diminished vasoconstrictor
reactivity that is dependent upon an intact endothelium, HO activity, and BKCa
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hyperpolarization of the vascular wall (Earley et al., 2002;Naik & Walker, 2003). Studies
further delineating the pathway responsible for BKCa dependent hyperpolarization found
that endogenous HO dependent BKCa activity occurred independently of ryanodine
receptors, which are required for VSM BKCa activation, suggesting that BKCa channels
responsible for the HO-dependent hyperpolarization may be localized to the endothelium.
Therefore we focused our research to investigate a role for the endothelium in the HOBKCa dependent loss of vasoconstrictor reactivity following CH. Endothelial BKCa
channel activity is hypothesized to be negatively regulated by caveolin-1 (Cav-1) through
its scaffolding domain. The activity of HO is additionally regulated by the scaffolding
domain of Cav-1 (Kim et al., 2004). Thus, decreases in Cav-1 function and/or expression
following CH may enable increases in both channel and enzyme activity. Indeed, in
pulmonary hypertension, Cav-1 expression in the pulmonary vasculature decreases
(Achcar et al., 2006;Cohen et al., 2004;Jasmin et al., 2004), thus it is possible
derangements in Cav-1 may occur within the systemic circulation as well.
In the current study, we examined the role of Cav-1 and HO dependent activation of EC
BKCa in freshly dispersed endothelial cells and gracilis arterioles from normoxic control
and CH rats. We conducted isolated arteriole, electrophysiology, and fluorescence
localization studies to test the hypothesis that CH exposure results in a loss in Cav-1
mediated inhibition of EC BKCa channels enabling increased channel activity by the
endogenous activator CO resulting in endothelial hyperpolarization and a loss in
vasoconstrictor reactivity.

32

Proposed Mechanism for Diminished Vasoconstrictor Reactivity Following CH

CHRONIC HYPOXIA
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HYPERPOLARIZATION OF EC EM

DIMINSHED VASOCONSTRICTOR REACTIVITY

Figure 1: Schematic diagram representing the hypothesis that CH exposure results in a loss of caveolin-1
mediated inhibition of EC BKCa channels enabling increased channel activity by the endogenous activator
CO resulting in endothelial hyperpolarization and a loss of vasoconstrictor reactivity.

Rationale and Specific Aims:
The systemic circulation following chronic exposure to hypoxia has a sustained
decrease in vasoconstrictor reactivity that is dependent upon the presence of the
endothelium (Doyle & Walker, 1991;Earley & Walker, 2002;Gonzales & Walker, 2002).
Blockade of heme oxygenase or BKCa channels restores vascular reactivity of arteries
from CH treated rats through restoration of vascular wall Em (Earley et al., 2002;Naik &
Walker, 2003;Naik et al., 2003;Naik & Walker, 2006). Moreover, recent studies suggest
33

that BKCa channels and HO in carotid body glomus cells function as regulators of
membrane potential and as “oxygen-sensors” (Williams et al., 2004). HO-BKCa
regulation of cellular membrane potential and “oxygen sensing” in the vasculature are
currently being explored, however their presence and function in the vascular
endothelium have not been defined.
HO and BKCa channels are inhibited by the scaffolding domain of Cav-1.
Derangements in Cav-1 localization, expression, and function and therefore

likely

mechanisms to influence the activity of BKCa. Interestingly, the role of endothelial BKCa
channels has not been defined and is largely unknown. Their presence in normoxic
conditions has been questioned, and channel activity may only emerge in the hypoxic
setting. Therefore we studied gracilis resistance arterioles and freshly dispersed
endothelial cells (ECs) from the aorta of control and CH rats to examine the role of
endothelial BKCa in both conditions. Interestingly, initial studies demonstrated no role for
endothelial BKCa activity in controls, but immunofluorescence localization studies
provided evidence for the presence of the channel in both CH and control conditions.
Because endothelial BKCa channels are inhibited by Cav-1, we additionally studied the
effects of altering Cav-1 function through manipulation of cellular cholesterol and the
addition of cell permeant peptides of the Cav-1 scaffolding domain in ECs from controls
and CH animals to determine the role of Cav-1 in regulating BKCa activity following
CH.
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Aim 1: Determine the expression and activity of endothelial BKCa following CH
Hypothesis: Loss of vasoconstrictor reactivity following CH exposure results from
increased endothelial BKCa channel activity and resultant membrane hyperpolarization.
Rationale: BKCa channels are likely involved in diminished vasoconstrictor reactivity
following CH, however prior experiments show that ryanodine-sensitive stores are not
involved in their regulation, suggesting VSM BKCa channels are not responsible for the
diminished vasoconstrictor response. This observation lead us to believe the BKCa
channels involved in the diminished vasoconstriction were localized to the endothelium.
EC BKCa channels have been not been previously characterized in native tissues,
therefore, experiments in this aim will isolate and characterize endothelial BKCa channels.

OBJECTIVES
1. Investigate EC BKCa activity following CH through whole cell patch clamp
2. Characterize EC BKCa channels through single channel records
3. Localize EC BKCa channel subunits through immunofluorescence
4. Characterize EC BKCa channels in cultured rat aortic endothelial cells (RAECs)

Specific Aim 1.1 – Investigate EC BKCa activity following CH through whole cell
patch clamp.
The presence and activity of endothelial BKCa channels is controversial.The
present study examined transmembrane currents using whole cell patch clamp to identify
and characterize BKCa activity in freshly dispersed endothelial cells. These experiments
measured and characterized outward K+ currents in freshly dispersed endothelial cells
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from control and CH exposed rats and assessed current sensitivity to BKCa specific
channel inhibitors and activators.

Specific Aim 1.2 – Characterize endothelial BKCa channels through single channel
records.
BKCa channels are classically identified by their unitary conductance, voltage and
calcium sensitivity, and inhibition by the channel specific inhibitor, iberiotoxin (IBTX);
thus we designed experiments to determine the unitary conductance, voltage and calcium
sensitivity of endothelial BKCa. Endothelial BKCa unitary conductance was determined
and compared to VSM BKCa unitary conductance to verify channel identity in whole cellcell attached and inside-out patch clamp single channel recordings. Calcium and voltage
sensitivity of endothelial BKCa were performed in inside-out patches and contrasted to
VSM BKCa calcium and voltage sensitivity to determine if endothelial BKCa exhibited
unique channel characteristics. Channel inhibition by IBTX was additionally verified.

Specific Aim 1.3 – Endothelial BKCa channel subunit localization through
immunofluorescent localization.
Determining the presence of EC BKCa channels has proven to be difficult as many
previous studies have identified protein and/ or mRNA of the channel (Sandow &
Grayson, 2010; Gauthier, K.M. et al., 2002), we designed these experiments to
investigate BKCa subunit immunofluorescence in intact arteries and isolated endothelial
cells.

Endothelial expression of BKCa α and β1 subunits was confirmed in resistance

artery sections

and in freshly isolated aortic endothelial cells using confocal

immunoflourescence microscopy.
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Specific Aim 1.4 – Characterization of EC BKCa in Cultured Rat Aortic Endothelial
Cells (RAECs).
Due to the limitations of sample purity and size in freshly dispersed ECs for
western blot detection of BKCa protein, we utilized a cultured EC line from rat aorta
(RAECs) and characterized the presence of BKCa in RAECs using immunofluorescence
and western blot.

RAEC expression of BKCa α was confirmed using confocal

immunoflourescence microscopy. For western blot detection, RAECs were collected and
lysed for protein and separated by SDS-PAGE and blotted for BKCa α.
Aim 2: Assess the role of the Cav-1 scaffolding domain in regulating endothelial
BKCa channels following CH.
Hypothesis: CH exposure results in a loss of Cav-1 inhibition of EC BKCa enabling
increased channel activity and a loss in vasoconstrictor reactivity.
Rationale: BKCa channels within ECs are hypothesized to be localized within caveolae
and inhibited by the scaffolding domain of Cav-1. Loss of caveolar structure, Cav-1
presence, or the ability of Cav-1 to directly regulate the channel through its scaffolding
domain following CH would result in increased channel activity and subsequent
diminished vasoconstrictor reactivity. Experiments in this aim will address alterations to
caveolae, Cav-1, and channel interaction with Cav-1 following CH exposure.
OBJECTIVES
1. Electrophysiological investigation of Cav-1 regulation of EC BKCa
2. Investigating the role of Cav-1 in EC hyperpolarization through membrane
potential studies
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3. Investigating the role of Cav-1 in diminished vasoconstrictor reactivity to agonists
and intraluminal pressure (myogenic tone).
4. Investigate EC caveolar structure following CH
5. Immunolocalization of Cav-1 and BKCa in native tissue
6. Co-immunoprecipitation of EC BKCa and Cav-1 in cultured RAECs.

Specific Aim 2.1– Patch clamp investigation of Cav-1 regulation of endothelial
BKCa
Since BKCa channels in cultured ECs are inhibited by association with Cav-1 and
its scaffolding domain (Wang et al., 2005) and are tightly regulated by lipid content of
cellular membranes (Thompson & Begenisich, 2006;Weaver et al., 2007), we examined
the effect of cholesterol depletion, cholesterol repletion, and the administration of a cell
permeant peptide of the scaffolding domain of Cav-1 on BKCa currents in freshly
dispersed cells from control and CH rats. For cholesterol depletion experiments the drug
methyl-β-cylcodextrin (MBCD) was administered and MBCD elicited currents were
tested for sensitivity to IBTX or NS-1619 to test for the presence of EC BKCa currents.
For cholesterol repletion experiments, MBCD and cholesterol (MBCD + ChL 8:1),
shown to replete membrane cholesterol and restore caveolar function (Levitan et al.,
2000;Romanenko et al., 2004), was administered and transmembrane currents were
examined. To determine channel inhibition by the scaffolding domain of Cav-1, a
synthesized cell permeant peptide of the scaffolding domain of Cav-1 (AP-CAV) or a
scrambled control peptide administered via patch pipette and transmembrane currents
were analyzed.
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Specific Aim 2.2 – Investigating the role of Cav-1 in EC hyperpolarization through
membrane potential (Em) studies.
Previous studies in our laboratory have demonstrated the vascular wall is
hyperpolarized following CH and this hyperpolarization is sensitive to IBTX and the
removal of the endothelium. Therefore we designed these experiments to measure
endothelial cell Em in gracilis arteries from control and CH rats to test whether CHinduced changes in Em could be inhibited by IBTX, AP-CAV, or mimicked by caveolar
disruption with MBCD, supporting a role for EC BKCa in mediating the vascular wall
hyperpolarization following CH.

Specific Aim 2.3 – Investigating the role of Cav-1 in diminished vasoconstrictor
reactivity to agonists and intraluminal pressure (myogenic tone).
Previous studies have demonstrated that following CH exposure systemic
arterioles display diminished vasoconstrictor reactivity, in which myogenic tone and
agonist-induced constriction are decreased compared to arterioles from normoxic control
animals. Interestingly, removal of the endothelium or application of IBTX restored
vasoconstrictor reactivity; thus we designed experiments in isolated gracilis arterioles to
assess the role of endothelial BKCa channels in mediating the decreased vasoconstrictor
reactivity following CH. Experiments were performed using cannulated, pressurized
gracilis arterioles in which active and passive (Ca2+-free) pressure–diameter relationships
in the presence of AP-CAV or scrambled were determined to assess myogenic tone.
Vasoconstrictor reactivity to the agonist, phenyelphrine (PE) was assessed over a
concentration range of 10-9 µmol/L to 10-5 µmol/L in the presence of intraluminal APCAV or scrambled control peptide. Reversal of constriction with 10 µM ACh at the
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termination of the PE concentration-response curve was used to verify endothelial
integrity.

Specific Aim 2.4 - Investigate EC Caveolar Structure in Control, CH, and MBCD
treatments.
Differences in caveolar structure have not been assessed in vascular endothelial
cells following CH. Additionally, the mild MBCD treatments that arterioles are subjected
to during our experimental procedures have not been assessed for alteration in caveolar
structure. To address these questions, we designed experiments to investigate caveolar
structure through electron microscopy. Gracilis arterioles and aorta from CH and control
rats were fixed and processed, dehydrated with ethanol, and imbedded in Lowicryl K4M.
Sections were observed using a Hitachi H7500 electron microscope and analyzed for
changes in caveolar gross structure or number.
Specific Aim 2.5 - Immunolocalization of Cav-1 and BKCa.
EC BKCa channels are hypothesized to be localized to caveolar domains and
associate with Cav-1 (Wang et al., 2005). To determine if EC BKCa channels co-localize
with Cav-1 in our model, we designed immunofluorescence experiments in cross sections
from gracilis arteries staining for BK α and Cav-1. Cross sections from gracilis arteries
from control and CH rats treated with primary antibodies for BK α and Cav-1 were
analyzed for co-localization. Individual channel masks and the EC mask were combined
to examine endothelial specific co-localization as defined by Manders correlation
coefficient values (Manders et al., 1992).
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Specific Aim 2.6 - Co-immunoprecipitation of EC BKCa and Cav-1 in cultured
RAECs.
To determine if there is an association of BKCa and Cav-1 and support
immunofluorescent co-localization findings, we conduced co-immunoprecipitations of
cultured RAECs. Cultured cells were utilized to reduce animal usage as current
techniques to separate endothelial cells from rat arteries do not provide samples void of
arterial smooth muscle cells (which also contain BKCa and Cav-1) and do not provide
large enough collections of cells for co-immunoprecipitations without pooling of cells
from several animals. RAECs were collected and gently lysed for protein. BKCa or Cav-1
antibodies were immobilized to coupling resin or to control non-amine reactive resin for
4 hours at 4°C. Columns containing either the antibody linked resins or control nonamine reactive resins were washed and incubated with the lysates. Sample elutions were
collected and analyzed by western blotting using antibodies for BKCa and Cav-1.

Aim 3: Investigate caveolin-1 regulation of heme oxygenase and HO-dependent
BKCa activity following CH.
Hypothesis: CH treatment results in a loss of Cav-1 inhibition of both HO and BKCa
resulting in EC hyperpolarization and diminished vasoconstriction.
Rationale: Whole cell patch clamp experiments and single channel records from Aim 1
will establish the effect of the HO product CO on EC BKCa channel activity. However,
the question of whether BKCa activity is dependent upon HO activity has not been
addressed. This aim will investigate the hypothesis that CH treatment results in a loss of
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Cav-1 inhibition of both HO and BKCa resulting in EC hyperpolarization and diminished
vasoconstriction.

OBJECTIVES
1. Patch clamp investigation of HO-dependent BKCa channel activity
2. Immunolocalization of HO-1, HO-2, Cav-1 and BKCa
3. Co-immunoprecipitation of HO-1, HO-2, BKCa, and Cav-1

Specific Aim 3.1 - Patch clamp investigation of HO-dependent BKCa channel
activity.
Previous experiments in our laboratory have demonstrated the vascular wall
hyperpolarization and diminished vasoreactivity is not only dependent upon the
endothelium and BKCa, but also the activity of HO. The HO product, CO can activate
VSM BKCa channels (Jaggar et al., 2002) and HO-dependent activation of BKCa channels
have been additionally found in carotid body glomus cells and act as an oxygen sensor
(Williams et al., 2004), thus we designed experiments to address if there was HOdependent activation of EC BKCa channels in our model through patch clamp
electrophysiology. HO-dependent activity of EC BKCa was assessed in freshly dispersed
ECs through measurement of transmembrane currents in the presence and absence of
HO-inhibitors and substrates. To corroborate findings in freshly dispersed cells we
additionally performed experiments investigating HO-dependent BKCa activity in
cultured RAECs.
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Specific Aim 3.2 - Immunolocalization of HO-1, HO-2, Cav-1 and BKCa.
EC BKCa (Wang et al., 2005), HO-1, and HO-2 (Kim et al., 2004a) have been
previously demonstrated to co-localize and be regulated by Cav-1. Additionally, HO-2
and BKCa (Williams et al., 2004) have been shown to associate, thus we designed
immunolocalization experiments in freshly dispersed ECs for CH and control rats to
analyze the possible associations amongst HO-1, HO-2, Cav-1, and BKCa. Colocalization was determined and analyzed for differences in the degree of association
following CH treatments.

Specific Aim 3.3 - Co-immunoprecipitation of HO-1, HO-2, BKCa, and Cav-1.
To corroborate findings of association amongst HO-1, HO-2, BKCa, and Cav-1 in
freshly dispersed ECs we designed co-immunoprecipitation experiments in cultured
RAECs to investigate physical associations amongst HO-1 and BKCa, HO-2 and BKCa,
HO-1 and Cav-1, and HO-2 and Cav-1. RAECs were collected and gently lysed for
protein. HO-1, HO-2, BKCa or Cav-1 antibodies were immobilized to coupling resin or to
control non-amine reactive resin for 4 hours at 4°C. Columns containing either the
antibody linked resins or control non-amine reactive resins were washed and incubated
with the lysates. Sample elutions were collected and analyzed by western blotting using
antibodies for HO-1, HO-2, BKCa and Cav-1.
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Chapter 2: General Methods for Dissertation

Experimental Groups
All protocols employed in this study were reviewed and approved by the Institutional
Animal Care and Use Committee of the University of New Mexico Health Science Center
(Albuquerque, NM). Experiments were performed on male Sprague-Dawley rats (Harlan). Rats
exposed to CH were placed in a hypobaric chamber maintained at a barometric pressure of
380 mmHg for 48 hours. Normoxic control rats were housed in identical cages at ambient
pressure (~630 mmHg).
Study of Isolated Resistance Arteries. Following exposure, rats were deeply anesthetized with
sodium pentobarbital (50 mg ip). Hindlimbs were removed and placed in ice-cold physiological
saline solution [PSS: 119 mmol/l NaCl, 4.7 mmol/l KCl, 25 mmol/l NaHCO3, 1.18 mmol/l
KH2PO4, 1.17 mmol/l MgSO4, 0.026 mmol/l K2-EDTA, 5.5 mmol/l glucose and 2.5 mmol/l
CaCl2]. Gracilis arterioles (third-order branches from the femoral artery; passive inner diameter
at 60 mmHg, 150-200 µm) were dissected free, cannulated on glass pipettes and mounted in an
arteriograph. Arteries were slowly pressurized to 60 mmHg with PSS using a servo-controlled
peristaltic pump (Living Systems) and superfused (10 ml/min) with warmed (37°C) PSS aerated
with a normoxic gas mixture (21% O2-6% CO2-73% N2). All experiments were performed under
normoxic conditions to examine sustained alterations in vascular control rather than acute
vasodilatory responses to hypoxia (Caudill et al., 1998;Naik & Walker, 2003). Previous
experiments have demonstrated that long term adaptations following CH exposure appear by 48
hours and are indistinguishable from effects of 4 week exposure (Jernigan et al.,
2001;O'Donaughy & Walker, 2000). The effects may be partially or fully reversed following 96
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hours of normoxic exposure (Jackson, 2005). Arteriole exposure to normoxic conditions for 2.53 hours throughout the course of the experiment do not reverse sustained alterations elicited by
CH exposure. Vessels were prepared for measurement of inner diameter (Earley & Walker,
2002;Earley et al., 2002;Earley & Walker, 2003;Earley et al., 2003), intracellular calcium
(Earley & Walker, 2003) or endothelial cell Em (Earley et al., 2002;Paffett et al., 2007)
depending upon the protocol.
Measurement of Vascular Smooth Muscle Cell Calcium Concentration. Pressurized arteries
were loaded abluminally with the cell-permeant, ratiometric, Ca2+-sensitive fluorescent indicator
fura-2 AM (Molecular Probes) as detailed previously (Earley & Walker, 2002). Immediately
prior to loading, fura-2 AM (1 mM in anhydrous DMSO) was mixed 2:1 with a 20% solution of
pluronic acid in DMSO, and this mixture diluted in PSS to yield a final concentration of 2 μM
fura-2 AM and 0.05% pluronic acid. Arteries were incubated in this solution for 45 min at room
temperature in the dark. The diluted fura-2 AM solution was equilibrated with the 21% O2 gas
mixture during this loading period. Vessels were rinsed for 20 min with aerated PSS (Dora et
al., 1997) following the loading period to wash out excess dye and to allow for hydrolysis of AM
groups by intracellular esterases. Fura-2-loaded vessels were alternately excited at 340 and 380
nm at a frequency of 1 Hz with an IonOptix Hyperswitch dual excitation light source and the
respective 510 nm emissions collected with a photomultiplier tube. Background-subtracted
340/380 emission ratios were calculated with IonOptix Ion Wizard software and recorded
continuously throughout the experiment, with simultaneous measurement of inner diameter (i.d.)
from red wavelength bright-field images as described above. VSM [Ca2+]i is expressed as the
mean F340/F380 ratio from the background-subtracted 510 nm signal.
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Measurement of Endothelial Cell Em: Endothelial cell Em was recorded from gracilis resistance
arteries using sharp electrodes as detailed previously (Earley et al., 2002;Naik & Walker, 2006).
Endothelial Em was measured in artery strips with the luminal surface exposed. Arteries were
superfused (2 ml/min) with a HEPES buffered saline solution warmed to 37oC. Sharp electrodes
(30-60 MΩ) were initially backfilled with Lucifer yellow (16.6 mg/ml in 1M LiCl) followed by
1M KCl, permitting post hoc epi-fluorescence dye identification of endothelial vs. VSM cells by
the distinct cellular morphological and dye transfer characteristics of each cell type as previously
described (Emerson & Segal, 2000).
Patch Clamp Studies of Isolated Endothelial Cells: Endothelial cells were freshly dispersed
from the aorta for electrophysiological study. The aorta was chosen as the source of cells based
on our earlier results showing parallel endothelium-dependent attenuation of vasoconstrictor
reactivity following CH in aortic rings and resistance vessels that is similarly reversed by HO
inhibition but not affected by NOS and COX blockade (Gonzales & Walker, 2002;Caudill et al.,
1998).

Aortae were removed and placed in ice-cold HEPES buffered physiological saline

solution (HBSS): mmol/l 150 NaCl, 6 mmol/l KCl, 1 mmol/l MgCl2, 1.5 mmol/l CaCl2, 10
mmol/l HEPES, and 10 mmol/l glucose and adjusted to pH 7.4 with NaOH. Thoracic aortae
were cut longitudinally and subsequently incubated for 2 hours in basal endothelial growth
medium with 4% bovine serum albumin and 10 μg/ml of the endothelial specific probe, 1,1’dioctadecyl-3,3,3’,3’-tetramethyl-indocarbocyanine

percholorate

(Ac-LDL-Dil)

at

37°C.

Immediately following the endothelial labeling procedure previously described (Hogg et al.,
2002;Paffett et al., 2007) aortae were cut into 2 mm strips and exposed to mild digestion solution
containing 0.2 mg/ml dithiothreitol and 0.2 mg/ml papain in HBSS for 45 min at 37°C. Vessel
strips were removed from the digestion solution and placed in 1 ml of HBSS containing 2 mg/ml
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BSA. Single endothelial cells were released by gentle trituration with a small bore Pasteur
pipette and stored at 4°C between experiments for up 5 hrs. One to two drops of the cell
suspension were seeded on a glass coverslip mounted on an inverted fluorescence microscope
(Olympus IX71) for 30 min prior to superfusion. Single endothelial cells were identified by the
selective uptake of the fluorescently labeled acylated low density lipoprotein Ac-LDL-Dil with a
rhodamine filter prior to each electrophysiological experiment. Freshly dispersed endothelial
cells were superfused under constant flow (2 ml/min) at room temperature (22-23°C) in an
extracellular solution (ECS: 141 mmol/l NaCl, 4.0 mM KCl, 1 mmol/l MgCl2, 1 mmol/l CaCl2,
10 mmol/l HEPES, 10 mmol/l glucose and buffered to pH 7.4 with NaOH). Whole cell current
data were generated with an Axopatch 200B amplifier (Axon Instruments) following a 5 min
dialysis period with 4-6 MΩ patch electrodes filled with an intracellular solution (ICS: 140
mmol/l KCl, 0.5 mmol/l MgCl2, 5 mmol/l Mg2ATP, 10 mmol/l HEPES, 1 mmol/l EGTA and
adjusted to pH 7.2 with KOH]. CaCl2 added to yield a free-Ca2+ concentration of 1 μM, as
calculated using WinMAXC chelator software. Upon attainment of whole cell patch clamp
configuration only ECs with series resistances < 15MΩ that maintained 1GΩ or greater seal
resistances throughout the course of the experiment were kept for analysis. Whole cell currents
were measured in response to voltage steps applied from

-60 mV to +150 mV in 10 mV

increments from a holding potential of -60 mV. For experiments utilizing the perforated patch
technique, 4-6 MΩ patch electrodes were backfilled with amphotericin B. After gigaseals were
obtained, the series resistance fell over a 10- to 15-min period to 15–20 M and remained stable
for up to 1 h. ECs with stable series resistances under 25 MΩ were used for experiments. Cell
capacitance was monitored and transmembrane currents were expressed in terms of current
density (pA/pF). There were no differences in cell capacitance between groups.
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Single Channel Recordings. For single channel experiments, cell attached and inside-out patch
clamp configurations were used. Patch pipettes had resistances ranging from 6 to 8 MΩ.
Extracellular solutions (ECS) contained: 130 NaCl, 5 KCl, 1.2 MgCl2, 10 HEPES, 10 Glucose,
1.2 CaCl2 (pH 7.30 with NaOH). Intracellular solutions (ICS) contained (in mM): 130KCl, 2
Na2ATP, 3 MgCl2, 10 HEPES, 1 EGTA, (pH 7.30 with KOH). For inside-out patch experiments
ECS contained: 140 KCl, 10 HEPES, 1 CaCl2, 1 MgCl2 (pH 7.3 with KOH). For experiments
investigating the effect of Ca2+ concentration on single channel opening probability (Npo) on
inside out patches EGTA and free Ca2+ (CaCl2 ) were varied to provide 10 nM, 50 nM, 100 nM,
1 μM, and 10 μM free Ca2+ solutions. Patches were held at -60, 0, and 40 mV test potentials to
for voltage sensitivity experiments. Single channel unitary conductance was determined from the
slope of currents measured in response to voltage steps applied from -100 mV to 150 mV in 10
mV increments from a holding potential of -60 mV. EC BKCa unitary conductance in
symmetrical K+ and assymetrical K+ were determined. All data were filtered at 5 kHz (-3dB)
and digitized at 10 kHz.
Single Channel Recordings from VSM Cells. For single channel experiments on freshly isolated
VSM cells, aortae were digested as stated above. Following gentle trituration freshly isolated
VSM cells were placed on Sylgard coated cover slips. VSM cells were identified by spindle
shape and an absence of DiI-Ac-LDL labeling. All experimental conditions were identical to EC
recordings (methods stated above) and calcium sensitivity of VSM BKCa channels were
compared to EC BKCa channels.
Immunofluorescence localization of BK α and BK β1 in artery sectionss: Arteries from control
and CH rats were collected following transcardial perfusion with PSS containing 10 mg
papaverin. The gracilis muscle was removed and frozen in OCT compound in liquid N2 and
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isopentane. 10 μm sections and thaw mounted to superfrost slides (Fisher) and fixed in 4%
formaldehyde PBS at room temperature for 10 min. After fixation cells were permeabilized in
0.01% Triton-X PBS for 10 min and blocked in 4% donkey serum in PBS for 1 hr at room
temperature. Cross sections were incubated with primary antibodies for BK α or BK β1
(Alamone). Some sections were additionally probed for with the endothelial marker, PECAM-1
(Santa Cruz) and BK α for endothelial specific localization. Primary antibodies for BK α or BK
β1 were detected with Cy5-conjugated donkey, anti-rabbit secondary antibodies. PECAM-1 was
detected with a Cy3-conjugated donkey, anti-mouse secondary antibody (all secondaries 1:500
dilution; Jackson Labs). The nuclear stain, Sytox (1:10,000 dilution; Molecular Probes) was then
applied. Sections were visualized with a confocal laser microscope (LSM 510 Zeiss; 63x oil
immersion lens).
Immunofluorescence localization of Caveolin-1 and BK α in Sectioned Arteries: Gracilis arteries
from control and CH rats were collected following transcardial perfusion with PSS containing 10
mg papaverin. The gracilis muscle was removed and frozen in OCT compound in liquid N2 and
isopentane. 10 µm sections were adhered to superfrost slides (Fisher) and fixed in ice cold
methanol (100%) for 10 min. After fixation cross sections were blocked in 4% donkey serum in
PBS for 1 hr at room temperature. Cross sections were incubated with primary antibodies for BK
α (Alamone 1:100) and Cav-1 (BD Biosciences 1:50). Primary antibodies for BK α were
detected with Cy5-conjugated donkey, anti-rabbit secondary antibodies. Cav-1 was detected with
a Cy3-conjugated donkey, anti-mouse secondary antibody (all secondaries 1:500 dilution;
Jackson Labs). The nuclear stain, Sytox (1:10,000 dilution; Molecular Probes) was then applied.
Confocal microscope images were obtained using a 63x oil immersion DIC objective (NA =1.4)
at a resolution of 524 X 524 and an optical slice of 0.7 µm.
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Immunofluorescence of Isolated Endothelial cells: Endothelial cells were freshly dispersed from
the aorta (see detailed methods above) and used for immunofluorescent detection of BK α and
ΒΚ β1 (Alamone 1:100), Caveolin-1 (BD Biosciences 1:50), Heme Oxyganse (HO-1)
(Stressgen 1:100) or Heme Oxygenase (HO-2) (Stressgen 1:100). One to two drops of the cell
suspension were seeded on a glass coverslip for 30 min prior to fixation in 4% formaldehyde
PBS at room temperature for 15 min. After fixation cells were permeabilized in 0.01% Triton-X
PBS for 10 min and blocked in 4% donkey serum in PBS for 1 hr. Cells were incubated with
primary antibodies for BK α / β1 , Cav-1, HO-1, or HO-2 and detected with fluorescent protein
conjugated secondary antibodies. Isolated cells were visualized with a confocal laser microscopy
(LSM 510 Zeiss; 63x oil immersion lens).
Electron Microscopy of Endothelial Caveolae: Gracilis arterioles and aorta from CH and control
rats (n = 4-6) were perfusion fixed, removed, and fixed in the same solution for an additional 15
min. Fixed samples were dehydrated with ethanol and imbedded in Lowicryl K4M. Sections
were observed using a Hitachi H7500 electron microscope.
Culture of rat aortic endothelial cells: Frozen rat aortic endothelial cells (Cell Appllications)
were thawed and seeded as directed by the manufacturer. Cells were grown on attachment factor
coated plates in rat endothelial cell growth medium (Cell Applications) at 37°C at 5% CO2 in a
humidified incubator to confluency for western blot and co-immunoprecipitation experiments.
Western blot of cultured rat aortic endothelial cells: ECs passages 6-7 were washed twice in
PBS then lysed in radio-immunoprecipitation assay buffer (RIPA) (Thermo Scientific)
containing protease and phosphatase inhibitors (Thermo Scientific). Lysates were collected,
centrifuged at 10,000 x g at 4°C for 5 minutes, and analyzed for protein content (Thermo Scientific Pierce BCA Protein kit). Cell lysates (10 μg) were separated in 10% sodium dodecyl
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sulfate polyacrylamide gels by electrophoresis and transferred to a nitrocellulose membrane.
Blots were blocked in odyssey blocking buffer (LI-COR) 1 h at room temperature then incubated
with primary antibodies for Cav-1 (1:500), BKCa (1:250), HO-1 (1:500), or HO-2 (1:200) in
0.01% Tween PBS overnight at 4°C (BKCa: Alamone, Cav-1: Santa Cruz, HO-1: Stressgen, HO2: Stressgen). After washing (3× 10 min in 0.01% Tween PBS), blots were incubated 1 h at room
temperature with dye conjugated secondary antibodies (LI-COR). Images were collected on an
infrared imaging system (LI-COR).
Co-immunoprecipitation of BKCa, Cav-1, HO-1, and HO-2 in rat aortic endothelial cells: Rat
aortic endothelial cells passages 6-7 were collected and lysed as described above. Coimmunoprecipitation (co-IP) was completed using Thermo Scientific Pierce co-IP kit as directed
by the manufacturer. Briefly, the BKCa, caveolin-1, HO-1, or HO-2 antibodies were immobilized
to the AminoLink Plus coupling resin or to control non-amine reactive resin for 4 hours at 4°C.
Columns containing either the antibody linked resins or control non-amine reactive resins were
washed and then loaded with arterial lysates and incubated overnight at 4°C. The next day
columns were washed and protein eluted using the kit’s provided elution buffer. Using the
Thermo Scientific Pierce Micro BCA Protein Assay kit, washes were tested for protein content
to verify successful washing before elution. Eluted samples were analyzed by Western blotting
using antibodies for BKCa, Cav-1, HO-1, or HO-2 with infrared dye-conjugated secondary
antibodies (LI-COR).
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ABSTRACT
The systemic vasculature exhibits attenuated vasoconstriction following hypobaric
chronic hypoxia (CH) that is associated with endothelium-dependent vascular smooth
muscle (VSM) cell hyperpolarization. We hypothesized that increased activity of
endothelial cell (EC) large conductance-calcium activated potassium channels (BKCa)
contributes to this response. Gracilis resistance arteries from hypobaric CH (PB = 380
mmHg for 48 hr) rats demonstrated reduced myogenic reactivity and hyperpolarized
VSM membrane potential (Em) compared to controls under normoxic ex vivo conditions.
These differences were eliminated by endothelial disruption. In the presence of
cyclooxygenase

and

nitric

oxide

synthase

inhibition,

combined

intraluminal

administration of the intermediate and small conductance calcium-activated K+ channel
blockers TRAM 34 and apamin was without effect on myogenic responsiveness and
VSM Em in both groups, however these variables were normalized in CH arteries by
intraluminal administration of the BKCa inhibitor iberiotoxin (IBTX). Basal EC Em was
hyperpolarized in arteries from CH rats compared to controls and was restored by IBTX,
but not by TRAM 34/apamin. K+ channel blockers were without effect on EC basal Em in
controls. Similarly, IBTX blocked acetylcholine (ACh)-induced dilation in arteries from
CH rats, but was without effect in controls, whereas TRAM 34/apamin eliminated
dilation in controls. ACh-induced EC hyperpolarization and calcium responses were
inhibited by IBTX in CH arteries and by TRAM 34/apamin in controls.

Patch clamp

experiments on freshly isolated ECs demonstrated greater K+ current in cells from CH
rats that was normalized by IBTX. IBTX was without effect on K+ current in controls.
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We conclude that hypobaric CH induces increased endothelial BKCa channel activity that
contributes to reduced myogenic responsiveness and EC and VSM cell hyperpolarization.

Key Words:

large conductance calcium-activated potassium channel; myogenic

response; endothelium-dependent vasodilation; membrane potential; patch clamp

74

INTRODUCTION
Chronic hypoxia (CH) results from pathological conditions that impair
oxygenation as well as from prolonged residence at high altitude. Previous studies have
demonstrated that vasoconstrictor responsiveness of the systemic circulation is attenuated
following prolonged exposure to hypoxia (Auer & Ward, 1998;Toporsian & Ward,
1997;Hu et al., 1996;Doyle & Walker, 1991). Diminished vasoconstrictor reactivity
following CH is observed both systemically as a reduced total peripheral resistance
response to vasoconstrictor agonists (Doyle & Walker, 1991) and in several individual
vascular beds (O'Donaughy & Walker, 2000;Jernigan et al., 2001;Auer & Ward,
1998;Caudill et al., 1998) suggesting that it is a generalized response to this stimulus.
Further, since diminished vasoconstrictor activity is maintained following acute return to
normoxia (Doyle & Walker, 1991;Auer & Ward, 1998) and is largely unaffected by PO2
(Doyle & Walker, 1991) this response to CH appears to be an adaptation, distinct from
acute responses to hypoxia.
Blunting of both agonist-induced and myogenic vasoconstriction following CH
appear to be endothelium-dependent.

For example, reduced agonist-induced

vasorelaxation is reversed following endothelial disruption in both aorta (Caudill et al.,
1998;Doyle & Walker, 1991) and resistance arteries (Earley et al., 2002) from CH rats.
A similar endothelium-dependence is observed in attenuated myogenic reactivity
following CH in mesenteric arterioles (Doyle & Walker, 1991).

Furthermore, CH-

induced blunted vasoconstriction in the mesenteric vascular bed is associated with an
endothelium-dependent reduction in vascular smooth muscle (VSM) calcium as well as
VSM hyperpolarization (Earley & Walker, 2002;Earley et al., 2002;Earley & Walker,
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2003). Thus, the endothelium appears to play a central role in altered vasoreactivity
following CH.
Although the mechanisms responsible for altered responsiveness in the
vasculature during CH are not fully defined,, previous experiments suggest that
endothelial nitric oxide (NO) (Earley & Walker, 2003), carbon monoxide (CO) (Jernigan
et al., 2001;Naik et al., 2003;O'Donaughy & Walker, 2000;Gonzales & Walker,
2002;Caudill et al., 1998) and epoxyeicosatrienoic acids (EETs) (Earley et al., 2003) may
be involved.

In addition, VSM Em and vasoreactivity are restored in mesenteric

resistance arteries from CH rats following inhibition of large conductance calciumactivated K+ (BKCa) channels (Earley et al., 2003;Naik & Walker, 2003). Since NO, CO
and EETs are all endogenous activators of these channels, a primary role of BKCa in
altered vasoreactivity following CH is likely.
Calcium-activated potassium (KCa) channels are widely distributed in vascular
tissue. They are classified into large (BKCa), intermediate (IKCa) and small (SKCa)
conductance channels. KCa channels exert a powerful effect on Em of both VSM and
endothelial cells in resistance arteries and the level of KCa channel expression and activity
is a fundamental determinant of vascular tone and blood pressure in both health and
disease (Sobey, 2001). Activity of VSM BKCa channels is regulated by calcium sparks
from ryanodine-sensitive stores and acts to promote VSM hyperpolarization and reduced
calcium influx through voltage gated calcium channels (Jaggar et al., 2000). Endothelial
SKCa and IKCa channels appear to play a prominent role in agonist-induced endothelial
hyperpolarization and consequent vasodilation (Gluais et al., 2005;Eichler et al.,
2003;Hilgers et al., 2006;Crane et al., 2003;Hinton & Langton, 2003). However, the
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physiological significance of endothelial BKCa channels has been questioned. Whereas
several studies have demonstrated that BKCa channels are present in both freshly isolated
and cultured endothelial cells (Brakemeier et al., 2003;Wang et al., 2005), a role for these
channels in control of vascular tone is controversial (Jackson, 2005;Wang et al.,
2005;Gauthier et al., 2002;Brakemeier et al., 2003).
The present study was designed to test the hypothesis that enhanced activity of
endothelial BKCa channels is responsible for blunted myogenic vasoconstrictor reactivity
following CH. This hypothesis was based on several key observations, notably: 1) CHinduced attenuated vasoconstrictor reactivity is endothelium-dependent and can be
reversed by blockade of endogenous activators of BKCa channels (NO,CO, EETs); 2) the
response to CH is BKCa-dependent, however dilation in response to endogenously
produced CO in CH arteries is not affected by ryanodine (Naik & Walker, 2003) which
inhibits VSM calcium sparks; and 3) endothelial cell [Ca2+]i is elevated following CH
(Earley & Walker, 2003) suggestive of endothelial cell hyperpolarization. Together,
these data suggest that endothelial BKCa channels may be involved in diminished
vasoreactivity following CH. Although much of our previous work was performed in
mesenteric arteries, we chose to examine gracilis resistance arteries in the present study
to not only extend our observations to another vascular bed, but also due to the reported
lack of myoendothelial electrical coupling in the hindlimb circulation (Sandow et al.,
2002). This characteristic enables unambiguous assessment of the effects of CH on
endothelial vs. VSM Em.
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METHODS
Animals. Experiments were performed on male Sprague-Dawley rats (Harlan). All
procedures were approved by the Institutional Animal Care and Use Committee of the
University of New Mexico Health Sciences Center.
Hypoxic Exposure. CH rats were exposed to hypobaric hypoxia at a barometric pressure
of 380 mmHg for 48 hours. Normoxic control rats were housed in identical cages at
ambient pressure (~630 mmHg).
Study of Isolated Resistance Arteries. Following exposure, rats were deeply anesthetized
with sodium pentobarbital (50 mg ip). Hindlimbs were removed and placed in ice-cold
physiological saline solution [PSS: 119 mmol/l NaCl, 4.7 mmol/l KCl, 25 mmol/l
NaHCO3, 1.18 mmol/l KH2PO4, 1.17 mmol/l MgSO4, 0.026 mmol/l K2-EDTA, 5.5
mmol/l glucose and 2.5 mmol/l CaCl2]. Caudal femoral artery branches (third-order
branches from the femoral artery; passive inner diameter at 100 mmHg, 150-200 µm)
were dissected free, cannulated on glass pipettes and mounted in an arteriograph. Arteries
were slowly pressurized to 100 mmHg with PSS using a servo-controlled peristaltic
pump (Living Systems) and superfused (10 ml/min) with warmed (37°C) PSS aerated
with a normoxic gas mixture (21% O2-6% CO2-73% N2). All experiments were
performed under normoxic conditions to examine sustained alterations in vascular control
rather than acute vasodilatory responses to hypoxia (Caudill et al., 1998;Naik & Walker,
2003). Previous experiments have demonstrated that long term adaptations following CH
exposure appear by 48 hours and are indistinguishable from effects of 4 week exposure
(Jernigan et al., 2001;O'Donaughy & Walker, 2000). The effects may be partially or
fully reversed following 96 hours of normoxic exposure (Jackson, 2005). Arteriole
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exposure to normoxic conditions for 2.5-3 hours throughout the course of the experiment
do not reverse sustained alterations elicited by CH exposure. For experiments involving
endothelium disrupted arteries, a 1-ml air bubble was passed through the vessel lumen
after cannulation. Endothelium-disruption was confirmed by the absence of a
vasodilatory response to 10 µM acetylcholine (ACh). Vessels were prepared for
measurement of inner diameter (Earley & Walker, 2002;Earley et al., 2002;Earley &
Walker, 2003;Earley et al., 2003), [Ca2+]i (Earley & Walker, 2003) or VSM or
endothelial cell Em (Earley et al., 2002;Paffett et al., 2007) depending upon the protocol.
Measurement of Vascular Smooth Muscle and Endothelial Cell Em: Vascular smooth
muscle (VSM) and endothelial cell Em was recorded from gracilis resistance arteries
using sharp electrodes as detailed previously (Earley et al., 2002;Naik & Walker, 2006).
VSM Em recordings were performed on pressurized arteries prepared as above, whereas
endothelial Em was measured in artery strips with the luminal surface exposed. Arteries
were superfused (2 ml/min) with a HEPES buffered saline solution warmed to 37oC.
Sharp electrodes (30-60 MΩ) were initially backfilled with Lucifer yellow (16.6 mg/ml in
1M LiCl) followed by 1M KCl, permitting post hoc epi-fluorescence dye identification of
endothelial vs VSM cells by the distinct cellular morphological and dye transfer
characteristics of each cell type as previously described (Emerson & Segal, 2000).
Measurement of Endothelial cell [Ca2+]i. Endothelial cell [Ca2+]i was measured as
described previously (Knot et al., 1999;Earley & Walker, 2003). Briefly, fura solution
(0.05 µM fura 2-AM and 0.05% pluronic in PSS) was administered to the lumen of
pressurized caudal femoral arteries using a servo-controlled peristaltic pump (Living
Systems) in the dark. Administration of fura 2-AM to the luminal surface for a short time
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has been previously shown to preferentially load endothelial cells (Kamouchi et al.,
1999). After a 1-min loading period, the lumen was perfused with PSS for 15 min to
wash out excess fura solution and allow hydrolysis of AM groups by intracellular
esterases. The vessel preparation was constantly superfused with warmed, aerated PSS.
Fura-loaded vessels were alternatively excited at 340 and 380 nm at a frequency of 10 Hz
and the respective 510 nm emissions were quantified using a photomultiplier tube and
recorded with the use of IonWizard software (IonOptix, version 4.4). Photometric data
were collected from the entire arterial segment under study. EC [Ca2+]i was expressed as
the mean F340/F380 ratio from the background-subtracted 510 nm signal. Ratiometric
images of unstimulated vessels were collected for ~10 min, then phenylephrine (PE;
1 µM) was administered followed by 10 µM ACh. Lack of a change in EC calcium levels
in response to PE demonstrated selective endothelial loading. ACh consistently induced
an increase in endothelial cell [Ca2+], when administered to endothelium-intact vessels as
shown by elevated F340/F380 ratio. To further demonstrate selective endothelial loading,
arteries were denuded with an air bubble at the end of the protocol, allowed 10 minute
recovery time, and PE and ACh tests were repeated. The lack of a change in F340/F380
in response to ACh after denudation was further evidence of selective endothelial
loading.
Patch Clamp Studies of Isolated Endothelial Cells:

Endothelial cells were freshly

dispersed from the aorta for electrophysiological study. The aorta was chosen as the
source of cells based on our earlier results showing parallel endothelium-dependent
attenuation of vasoconstrictor reactivity following CH in aortic rings and resistance
vessels that is similarly reversed by heme oxygenase inhibition but not affected by NOS

80

and COX blockade (Gonzales & Walker, 2002;Caudill et al., 1998).

Aortae were

removed and placed in ice-cold HEPES buffered physiological saline solution (HBSS):
mmol/l 150 NaCl, 6 mmol/l KCl, 1 mmol/l MgCl2, 1.5 mmol/l CaCl2, 10 mmol/l HEPES,
and 10 mmol/l glucose and adjusted to pH 7.4 with NaOH. Thoracic aortae were cut
longitudinally and subsequently incubated for 2 hours in basal endothelial growth
medium with 4% bovine serum albumin and 10 μg/ml of the endothelial specific probe,
1,1’-dioctadecyl-3,3,3’,3’-tetramethyl-indocarbocyanine percholorate (Ac-LDL-Dil) at
37°C. Immediately following the endothelial labeling procedure previously described
(Hogg et al., 2002;Paffett et al., 2007) aortae were cut into 2 mm strips and exposed to
mild digestion solution containing 0.2 mg/ml dithiothreitol and 0.2 mg/ml papain in
HBSS for 45 min at 37°C. Vessel strips were removed from the digestion solution and
placed in 1 ml of HBSS containing 2 mg/ml BSA. Single endothelial cells were released
by gentle trituration with a small bore Pasteur pipette and were stored at 4°C between
experiments for up 5 hrs. One to two drops of the cell suspension were seeded on a glass
coverslip mounted on an inverted fluorescence microscope (Olympus IX71) for 30 min
prior to superfusion. Single endothelial cells were identified by the selective uptake of
the fluorescently labeled acylated low density lipoprotein Ac-LDL-Dil with a rhodamine
filter prior to each electrophysiological experiment. Freshly dispersed endothelial cells
were superfused under constant flow (2 ml/min) at room temperature (22-23°C) in an
extracellular solution (ECS: 141 mmol/l NaCl, 4.0 mM KCl, 1 mmol/l MgCl2, 1 mmol/l
CaCl2, 10 mmol/l HEPES, 10 mmol/l glucose and buffered to pH 7.4 with NaOH).
Whole cell current data were generated with an Axopatch 200B amplifier (Axon
Instruments) following a 5 min dialysis period with 4-6 MΩ patch electrodes filled with
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an intracellular solution (ICS: 140 mmol/l KCl, 0.5 mmol/l MgCl2, 5 mmol/l Mg2ATP,
10 mmol/l HEPES, 1 mmol/l EGTA and adjusted to pH 7.2 with KOH]. CaCl2 added to
yield a free-Ca2+ concentration of 1 μM, as calculated using WinMAXC chelator
software. Upon attainment of whole cell patch clamp configuration only ECs with series
resistances < 15MΩ that maintained 1GΩ or greater seal resistances throughout the
course of the experiment were kept for analysis. Whole cell currents were measured in
response to voltage steps applied from -60 mV to +150 mV in 10 mV increments from a
holding potential of -60 mV.

Cell capacitance was monitored and transmembrane

currents were expressed in terms of current density (pA/pF). There were no differences
in cell capacitance between groups.
Immunofluorescence in Sectioned Arteries: Arteries from control and CH rats were
collected following transcardial perfusion with PSS containing 10 mg papaverin. The
gracilis muscle was removed and frozen in OCT compound in liquid N2 and isopentane.
10 μm sections were adhered to superfrost slides (Fisher) and fixed in 4% formaldehyde
PBS at room temperature for 10 min. After fixation cells were permeabilized in 0.01%
Triton-X PBS for 10 min and blocked in 4% donkey serum in PBS for 1 hr at room
temperature. Cross sections were incubated with primary antibodies for BK α or BK β1
(Alamone). Some sections were additionally treated with the endothelial marker,
PECAM-1 (Santa Cruz) and BK α for endothelial specific localization. Primary
antibodies for BK α or BK β1 were detected with Cy5-conjugated donkey, anti-rabbit
secondary antibodies. PECAM-1 was detected with a Cy3-conjugated donkey, antimouse secondary antibody (all secondaries 1:500 dilution; Jackson Labs). The nuclear
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stain, Sytox (1:10,000 dilution; Molecular Probes) was then applied. Sections were
visualized with a confocal laser microscope (LSM 510 Zeiss; 63x oil immersion lens).
Immunofluorescence of Isolated Endothelial cells: Endothelial cells were freshly
dispersed from the aorta (see detailed methods above) and used for immunofluorescent
detection of BK α and ΒΚ β1. One to two drops of the cell suspension were seeded on a
glass coverslip for 30 min prior to fixation in 4% formaldehyde PBS at room temperature
for 15 min. After fixation cells were permeabilized in 0.01% Triton-X PBS for 10 min
and blocked in 4% donkey serum in PBS for 1 hr. Cells were incubated with primary
antibodies for BK α / β1 (Alamone) and detected with Cy5-conjugated donkey, antirabbit secondary antibodies. Isolated cells were visualized with a confocal laser
microscopy (LSM 510 Zeiss; 63x oil immersion lens).
Experimental Protocols:
Myogenic Responses. Experiments in this and subsequent protocols were performed
under normoxic conditions to examine sustained alterations in vascular control rather
than acute vasodilatory responses to hypoxia. Active and passive (Ca2+-free) pressure–
diameter relationships were determined, as described previously (Doyle & Walker, 1991)
over intraluminal pressure steps between 40 and 140 mmHg. Vessel inner diameter was
monitored using video microscopy and edge-detection software (IonOptix Sarclen).
Initial diameters assessed in Ca2+-replete superfusate at a pressure below the
autoregulatory range (20 mmHg) did not differ between groups and ranged from 105 + 3
to 115+ 3 μm.

Endothelial integrity was assessed by constriction with 1 µM

phenylephrine (PE) and dilation with 10 µM acetylcholine (ACh) prior to Ca2+-free
superfusion.

Pressure-induced

vasoconstrictor
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responses

were

determined

for

endothelium-intact and endothelium-disrupted arteries as well as endothelium-intact
arteries in the presence of combined NOS inhibition (L-NNA; 100 µM) and COX
inhibition (indomethacin: 10 µM).

In addition, VSM Em was measured by sharp

electrode at 40, 100 and 140 mmHg. Myogenic responsiveness was also determined
during exposure to the following combinations of K+ channel inhibitors: 1)
charybdotoxin (CBTX – combined IKCa and BKCa blocker; 100 nM) plus apamin (SKCa
blocker; 100 nM); 2) TRAM 34 (selective IKCa blocker; 1 µM) plus apamin (100 nM);
and 3) IBTX (specific BKCa blocker; 100 nM) alone. All K+ channel inhibitors were
administered intraluminally in an effort to specifically target endothelial K+ channels.
VSM Em was examined in separate experiments at 120 mmHg in the presence of all of
the combinations of inhibitors except CBTX + apamin.
Effect of K+ Channel Blockers on Endothelium-Dependent Vasodilatory Responses to
ACh. Cumulative concentration-response curves to ACh (0.001-100 µM) were obtained
in arteries pressurized at 100 mmHg. Vessels were pre-constricted to 30% of equilibrated
lumen diameter with PE prior to ACh administration. Vasodilatory responses were
determined in arteries treated with the various inhibitors outlined above.

Parallel

experiments were performed in fura 2 loaded vessels to examine the endothelial calcium
response to ACh. Finally, endothelial Em responses to 10 μM ACh were measured with
sharp electrodes.
Effect of K+ Channel Blockers on Basal Endothelial Em.

Endothelial cell Em was

measured using sharp electrodes in arteries treated with the various inhibitors or
respective vehicles.
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Effect of K+ Channel Blockers on Isolated Endothelial Cell Transmembrane Currents.
Transmembrane currents were measured in aortic ECs freshly dispersed from control and
CH rats. After 5 min dialysis, whole cell currents were measured in response to voltage
steps outlined above. After the initial recording, cells were superfused with the K+
channel inhibitors tetraethylammonium (TEA; 10 mmol) and 4-aminopyridine (4-AP; 10
mM) to confirm measurement of K+ currents. Voltage steps were applied and recorded
after 5 min of superfusion with these inhibitors.
Effect of BKCa Channel Inhibition and Activation on Isolated Endothelial Cell
Transmembrane Currents. After cell dialysis, recordings were taken before and 5 min
after superfusion with the BKCa specific inhibitor IBTX (100 nM), or the BKCa activator
NS1619 (1,3 dihydro-1-[2-hydroxy-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-2Hbenzimidazol-2-one) (10 μM).
Effect of Cholesterol Depletion on Isolated Endothelial Cell Transmembrane Currents.
Since BKCa channels in cultured endothelial cells are inhibited by association with
caveolin-1 (Wang et al., 2005), we examined the effect of cholesterol chelation on
transmembrane currents in freshly dispersed cells from each group. After cell dialysis,
the cholesterol depletion drug, methyl-β-cylcodextrin (MBCD) (100 μM) was superfused
for 15 minutes before washout. Voltage step recordings were taken before and
superfusion with MBCD. Following MBCD treatments cells were superfused with IBTX
(100 nM) to test for the presence of EC BKCa currents. Electron microscopy of MBCD
treated arteries demonstrated that this low concentration of the agent did not deplete the
endothelia of caveolae (see Data Supplement Figure 4).
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BKCa Subunit Immunofluorescence in Intact Arteries and Isolated Endothelial Cells.
Endothelial expression of BKCa α and β1 subunits was confirmed in sectioned resistance
arteries

and

in

freshly

isolated

aortic

endothelial

cells

using

confocal

immunoflourescence microscopy.
Calculations and Statistics. Data are expressed as means ± SE. Values of n refer to the
number of animals in each group except for patch clamp studies where n represents the
number of cells. Myogenic tone was calculated as the percent difference in inner diameter
at each pressure when arteries were superfused with Ca2+-containing vs. Ca2+-replete
physiological salt solution. Vasodilation was expressed as % reversal of PE-induced preconstriction. Data were analyzed by repeated measures analysis of variance
(RMANOVA) and by a Bonferroni modified unpaired Student's t-test for multiple
comparisons when differences were indicated. Unpaired t-tests were used for single
comparisons between groups. P < 0.05 was accepted as statistically significant.
RESULTS
Myogenic responsiveness and VSM cell Em in pressurized arteries. Myogenic
vasoconstriction of gracilis resistance arteries from control and CH rats were assessed in
normoxic conditions to study persistent vascular adaptations following CH exposure and
not acute mechanisms involved in responses to hypoxia. Myogenic vasoconstriction
from CH rats was attenuated compared to normoxic controls (Fig. 1A), confirming
findings from the mesenteric vascular bed (Earley & Walker, 2002;Naik & Walker,
2006). Consistent with this finding, VSM cells in arteries from CH rats were
hyperpolarized compared to controls at higher pressures (Fig. 1B) again confirming
earlier results (Earley & Walker, 2002;Earley et al., 2002;Earley et al., 2003). Blunted
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myogenic responsiveness and VSM cell hyperpolarization of CH arteries compared to
controls persisted in the presence of L-NNA and indomethacin (Fig. 1C/ 1D). Myogenic
responses and VSM Em in the presence of vehicles for L-NNA and indomethacin were
not different to those of untreated arteries (data not shown). Endothelial disruption
restored myogenic reactivity and Em of CH arteries to control levels (Fig. 1E/1F) (Earley
& Walker, 2002;Earley et al., 2002). Effectiveness of endothelial disruption was verified
by elimination of ACh-induced dilation. Lucifer yellow loading allowed visual
identification of the cell type from which Em recordings were obtained.
Effect of K+ channel inhibitors on myogenic responsiveness and VSM Em. The effects of
K+ channel inhibitors were assessed at a transmural pressure of 120 mmHg. CH arteries
demonstrated reduced myogenic responsiveness at this pressure compared to arteries
from controls, which persisted in the presence of L-NNA and indomethacin (Fig. 2A).
Luminal exposure to CBTX and apamin restored myogenic responsiveness of CH arteries
at 120 mmHg to control levels. However, specific inhibition of endothelial IKCa and SKCa
channels did not affect myogenic responsiveness in either group. In contrast, IBTX alone
also restored myogenic responsiveness in CH arteries to control levels without affecting
reactivity in the controls. This latter observation is supportive of an endothelial specific
effect of intraluminal IBTX. A similar pattern of K+ channel inhibitor effects were seen
on VSM Em. As discussed previously, VSM cells from CH arteries were hyperpolarized
compared to controls at 120 mmHg and this hyperpolarization persisted in the presence
of NOS and COX inhibitors, as well as in the presence of endothelial SKCa and IKCa
inhibition (Fig. 2B). However, IBTX restored VSM Em to control levels when
administered luminally (Fig. 2B). VSM cells in control vessels treated with IBTX were
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slightly depolarized compared .with untreated control arteries, although myogenic tone
was unaffected. Myogenic responses and VSM Em at 120 mmHg in the presence of
vehicles were not different to those of untreated arteries (data not shown). To contrast
luminal application of IBTX, a separate set of experiments employed IBTX applied to the
superfusate to specifically target VSM. In contrast to luminal application, superfusate
administration of IBTX resulted in a significant increase in spontaneous tone at 100
mmHg in control arteries (data not shown). These results suggest that luminal
administration of IBTX selectively targets endothelial BKCa channels with minimal direct
effect on the VSM.
Effect of K+ Channel Blockers on Basal Endothelial Em. Resting Em in dye-identified
ECs were hyperpolarized in arteries from CH rats compared with controls (Fig. 3). This
hyperpolarization persisted in the presence of L-NNA and indomethacin and after
inhibition of IKCa and SKCa channels (Fig. 3). In contrast, IBTX restored CH EC Em
values to control levels, but did not affect controls (Fig. 3). Em in the presence of vehicles
was not different to those of untreated arteries (data not shown)
Effect of K+ Channel Blockers on Endothelium-Dependent Vasodilatory
Responses to ACh.

ACh-induced vasodilation was observed following L-NNA and

indomethacin treatment in arteries from both groups demonstrating an EDHF-type
response. This response was abolished by combined intraluminal administration of SKCa
and IKCa blockers in control arteries, but unaffected by BKCa inhibition (Fig. 4A). In
contrast, ACh dilation was eliminated by BKCa blockade with IBTX in arteries from CH
rats (Fig. 4B). Figure 5 compares the effect of the various inhibitors on vasodilation, Em
and EC [Ca2+]i responses to 10 μM ACh.
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Vasodilatory responses were greater in

untreated arteries from CH rats compared to controls (Figure 5A). As shown in the
previous figure, arteries from both groups still demonstrated vasodilatory responses after
NOS and COX inhibition (Fig. 5A) although there was no longer a difference between
groups. The normalization of vasodilatory responses between groups by combined LNNA and indomethacin was the result of opposing tendencies between the two groups.
ACh responsiveness tended to be slightly reduced in arteries from CH rats by this
treatment, although this trend did not reach statistical significance.

Similarly,

vasodilation to ACh tended to increase with treatment. These data suggest that control
vessels may possess a COX-dependent vasoconstrictor pathway that elicits VSM
depolarization that is not present in arteries from CH rats. Following COX and NOS
blockade, dilation to ACh was abolished in arteries of both groups exposed luminally to
CBTX and apamin to inhibit endothelial SKCa, IKCa and BKCa (Fig. 5A). In contrast,
specific inhibition of endothelial SKCa and IKCa with TRAM 34 and apamin eliminated
ACh-induced vasodilation only in arteries from control rats. Additionally, although
treatment with the BKCa inhibitor IBTX alone had no effect on vasodilatory responses in
controls, this agent abolished vasodilation in arteries from CH rats. In all cases, the
effects of the blockers were similar at all concentrations of ACh studied. Endothelial
disruption abolished ACh-induced vasodilation in both groups. Changes in endothelial
cell Em (Fig. 5B) and EC [Ca2+]i (Fig. 5C) in response to ACh were also examined and
the K+ channel inhibitors elicited a profile similar to the vasodilatory responses.
Although, the change in Em in response to ACh in CH untreated arterial strips was not
different from controls, basal Em was hyperpolarized relative to controls (Fig. 3) and thus
the degree of hyperpolarization following ACh was greater in the CH group. ACh-
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induced hyperpolarization was not affected by combined L-NNA and indomethacin in
either group. Similar to the vasodilatory responses, combined treatment with TRAM 34
and apamin impaired hyperpolarization in response to ACh only in the controls, whereas
IBTX blunted ACh-induced EC hyperpolarization only in arteries from CH rats (Fig. 5B).
Endothelial cell [Ca2+]i responses to ACh closely mirrored the vasodilatory responses in
each treatment group (Fig. 5C).
Effect of K+ Channel Blockers on Isolated EC Transmembrane Currents . Whole cell
currents from freshly isolated ECs from CH and control animals were studied under
normoxic conditions to assess long term adaptations to hypoxia and not acute hypoxic
exposure effects. Whole cell currents in isolated ECs were greater over a wide range of
voltages in cells from CH rats compared to controls (Fig. 6A). Treatment with the K+
channel inhibitors TEA and 4-AP nearly abolished currents in both groups indicative of
K+ conductance. Outward K+ currents from the CH group and controls were significantly
reduced following TEA and 4-AP blockade (Fig. 6D). Residual current after TEA and 4AP treatment was not different between the groups. To selectively block EC BKCa
channels, current sensitivity to IBTX was tested. The difference in current between
control and CH groups was eliminated by IBTX, whereas IBTX was without effect in
control cells (Fig. 6C/7A/7C). In addition, the BKCa activator NS1619 elicited a further
increase in outward current in cells from CH rats, but was without effect in controls (Fig.
7B/ 7D). Administration of a nitric oxide (NO) donor increased EC BKCa currents at
depolarized potentials (Supplemental Fig. 5) but had no significant effect in controls.
Immunofluorescent localization of BKCa. Although these data suggest differential
expression

of

BKCa

channels

between
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groups,

we

observed

similar

BKCa

α immunofluorescence in isolated aortic endothelial cells from control and CH rats (Fig.
8A/8B) and in intact sections of gracilis resistance arteries (Fig. 8E/8F).

The β1

regulatory subunit for the BKCa channel was also observed in endothelial cells from both
groups (Fig. 8C/8D and 8G/8H). Endothelial localization was confirmed with the
endothelial specific marker PECAM-1 (Supplemental Data Figure 2). No staining for
either subunit was observed when only secondary antibody was applied (Supplemental
Data Figure 1). In addition, no staining was observed in rat T-cells that do not express
BKCa channels (Supplemental Data Figure 3).
Effect of Cholesterol Depletion on Isolated EC Transmembrane Currents. Endothelial
whole cell currents from control animals were significantly increased following
cholesterol depletion with MBCD (Fig. 9A), whereas currents from CH animals were
unaffected (Fig. 9B). The enhanced currents from controls were found to be sensitive to
IBTX treatment (Fig. 9C/D), supporting the immunofluorescence results that BKCa exist
in both controls and CH ECs and are not differentially expressed.
DISCUSSION
The present study examined the contribution of endothelial BKCa channels to altered
vasoreactivity following hypobaric CH. The major findings of this study are: 1) CH is
associated with endothelium-dependent VSM hyperpolarization and associated blunted
myogenic constriction and persistent VSM hyperpolarization; 2) endothelial cell Em is
also hyperpolarized after CH exposure and restored by BKCa channel inhibition, 3)
similarly, selective endothelial cell BKCa blockade restores myogenic reactivity and VSM
Em to control levels and blocks endothelium-dependent vasodilatory responses to ACh, 4)
endothelial cells isolated from CH rats demonstrate an IBTX-sensitive outward current
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not present in cells from control animals, and 5) the IBTX-sensitive outward current is
revealed in cells from control animals following cholesterol depletion. These results
suggest that endothelial BKCa activity is increased by CH and is responsible for altered
vasoreactivity.
The blunted myogenic reactivity and VSM hyperpolarization observed in gracilis
resistance arteries from CH rats are consistent with previous observations of diminished
vasoconstrictor reactivity in mesenteric arterioles (Gonzales & Walker, 2002;Naik &
Walker, 2006;Earley & Walker, 2002;Earley et al., 2002;Earley & Walker, 2003;Earley
et al., 2003), diaphragmatic arteries (Siegl et al., 2005) and aortic rings (Caudill et al.,
1998) after 48 hours of CH. Although the present study used a hypobaric model of CH,
similar attenuation of vasoconstrictor reactivity is observed with normobaric CH of
similar duration and PIO2 (Auer & Ward, 1998). Unlike the mesenteric circulation where
myogenic tone developed at lower pressures (Doyle & Walker, 1991), gracilis arteries
from control rats did not develop significant myogenic tone until pressures of 80 mmHg
were reached. Consequently differences between control and CH arterial myogenic tone
were not observed except at the higher end of the pressure-diameter relationship in
gracilis arteries whereas in the mesenteric arteries this difference is apparent over most of
the pressure-diameter relationship (Doyle & Walker, 1991). In further agreement with
earlier studies (Earley & Walker, 2002;Naik & Walker, 2006), blunted myogenic
reactivity and VSM hyperpolarization of CH arteries persisted in the presence of NOS
and COX inhibition, but was reversed by endothelial disruption. Endothelial disruption
could potentially have unintended direct effects on smooth muscle reactivity; however
there was no significant difference in myogenic tone between control vessels with an
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intact or disrupted endothelium. These results convincingly demonstrate a role of the
endothelium in attenuated myogenic responsiveness of small gracilis arteries after CH
that is not dependent upon release of NO or a COX product.
In addition to diminished myogenic reactivity, we observed that endothelial cell
Em in isolated gracilis arteries was relatively hyperpolarized following CH. We chose to
study gracilis resistance arteries based on recent observations that this bed does not
demonstrate myoendothelial gap junction communication (Sandow et al., 2002;Zygmunt
et al., 1995;Wigg et al., 2001). This characteristic allowed examination of endothelial
cell Em in a setting not influenced by responses conducted from the VSM. Consistent
with Sandow et al. (Sandow et al., 2002), we observed endothelial cell Em that was much
more depolarized than the VSM in this vascular bed, suggesting that myoendothelial
coupling is not present. The potentials measured were considerably more depolarized
than we have observed in endothelia from intact pulmonary arteries (Paffett et al., 2007)
and mesenteric arteries (-47 + 3 mV; unpublished observation) using identical techniques.
These observations coupled with the effectiveness of ACh to hyperpolarize the
endothelium (Fig. 5B) suggest that the relatively depolarized Em observed under
unstimulated conditions in this bed is not an artifact. Endothelial cell hyperpolarization
in CH arteries persisted following NOS and COX inhibition and in the presence of SKCa
and IKCa inhibitors. In contrast, although IBTX did not alter endothelial cell Em values in
arteries from control rats, it significantly depolarized CH endothelial cell Em to normoxic
control levels. These results suggest that there is tonic activity of endothelial BKCa
channels following CH exposure not seen in controls that results in EC hyperpolarization.
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To further investigate the role of endothelial BKCa channels in vascular control
following CH, we compared the effects of intraluminal administration of the various K+
channel inhibitors on vasodilatory, Em and endothelial cell calcium responses to the
endothelium-dependent dilator ACh between arteries from both groups. A hallmark of an
agonist-induced EDHF-type response is its abolition by the combination of apamin and
the nonselective K+-channel blocker CBTX (Hilgers et al., 2006;Crane et al.,
2003;Hinton & Langton, 2003). In the absence of myoendothelial gap junctions, VSM
hyperpolarization can still occur due to either release of a diffusible EDHF such as EETs
(Campbell et al., 1996) or by elevations in intercellular K+ levels (Edwards et al., 1998).
In the present study, combined apamin and CBTX completely inhibited vasodilation in
response to ACh in both groups. However, since CBTX may block both IKCa and BKCa
channels, we repeated these experiments with combined apamin plus the IKCa selective
inhibitor TRAM 34 (Wulff et al., 2000). Consistent with other reports (McSherry et al.,
2005;Hinton & Langton, 2003;Crane et al., 2003;Hilgers et al., 2006;Eichler et al.,
2003;Gluais et al., 2005), this treatment abolished ACh-induced dilation in arteries from
control rats suggesting a role of SKCa and IKCa channels in the EDHF-type response. In
contrast, this treatment did not significantly inhibit dilation in the CH group, whereas
BKCa channel inhibition with IBTX eliminated the response in this group. IBTX was
without effect in control arteries as previously shown by others (Parkington et al.,
2002;Crane et al., 2003;Hinton & Langton, 2003).

These data again support the

hypothesis that BKCa channels play an important role in endothelial cell physiology
following CH not observed under control conditions.
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In agreement with other studies (Sandow et al., 2002;McSherry et al., 2005), ACh
stimulation elicited hyperpolarization in endothelial cells of both groups. Although the
change in Em in response to ACh did not differ between groups, peak ACh-stimulated Em
was more hyperpolarized in CH endothelial cells due to the shift in basal Em in that
group. Although ACh induced hyperpolarization in both groups, the response was SKCa /
IKCa dependent in normoxic controls but BKCa dependent in arteries from CH rats. These
findings in control arteries are in agreement with others who demonstrated that
hyperpolarization in response to vasodilatory agonists is sensitive to SKCa (Siegl et al.,
2005;McSherry et al., 2005;Weston et al., 2005) and IKCa (Marrelli et al., 2003;Weston
et al., 2005) inhibitors but not BKCa blockers (Siegl et al., 2005). Thus, the reliance of
ACh-induced endothelial cell hyperpolarization on BKCa channels following CH
represents a switch from the normal involvement of IK/SK signaling in this response.
This shift to a reliance on BKCa channels following CH was also observed when we
examined the EC [Ca2+]i response to ACh. Elevation of endothelial cell [Ca2+]i following
treatment with ACh occurs through multiple pathways. Em may be a contributing
influence on Ca2+ influx by affecting the electrochemical driving force through nonselective entry pathways (Kamouchi et al., 1999). However, other studies suggest that
intracellular Ca2+ may be independent of changes in membrane potential, as EC
hyperpolarization in situ does not increase endothelial cell Ca2+ (Ungvari et al.,
2002;Ghisdal & Morel, 2001;Marrelli et al., 2003;Takano et al., 2004). Additionally,
increased calcium influx following muscarinic stimulation has been found to occur
independent of changes in membrane potential in freshly isolated endothelial cells
(Cohen & Jackson, 2005).
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Earlier studies showing that blunted myogenic responsiveness following CH is
reversed by either endothelial removal or administration of IBTX (Earley et al., 2003)
made no attempt to differentiate between the roles of endothelial vs. VSM BKCa
channels. In the present study, intraluminal administration of IBTX restored myogenic
vasoconstriction and VSM Em in arteries from CH rats to levels similar to controls. This
treatment was without effect on myogenic reactivity in control arteries, although VSM Em
was slightly depolarized at 120 mmHg by IBTX in this group. Nevertheless, these
experiments again suggest that endothelial hyperpolarization through BKCa channels is
functionally important in regulating vascular tone following CH.
In support of studies in whole arteries, patch clamp experiments demonstrated
greater outward current in cells freshly isolated from CH rats that was normalized by
IBTX. These results closely correlate with in situ assessment of endothelial cell Em in
intact arteries and suggest that the difference in basal Em following CH is due to enhanced
tonic activity of BKCa channels. Interestingly, the BKCa channel activator NS1619 caused
increased current only in cells from CH animals. This latter result could be evidence for
differential expression of BKCa channels between groups, however we observed similar
BKCa subunit immunofluorescence in endothelial cells from control and CH rats.
It has recently been documented that BKCa activity is negatively regulated by
caveolin-1 in cultured endothelial cells (Wang et al., 2005). Cholesterol depletion with
MBCD to disrupt caveolin function resulted in greater IBTX-sensitive outward currents
in cultured human umbilical vein endothelial cells (HUVECs) (Wang et al., 2005). We
hypothesized that CH exposure results in diminished caveolin-1 function thereby
activating BKCa. Thus we treated ECs from control animals with the cholesterol depletion
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agent MBCD possibly release EC BKCa channels from caveolin inhibition and mimic CH.
We chose the concentration of 100 μM MBCD to affect caveolin function but not to
eliminate caveolar structure. Previous studies using higher concentrations of MBCD in
uterine myocytes ablated caveolar structure and additionally significantly decreased BKCa
function (Shmygol et al., 2007). Electron microscopy analysis of 100 μM MBCD treated
cells revealed no significant changes in caveolar structure compared to untreated controls
(Supplemental Figure 4) and CH (not shown). Interestingly, treatment with MBCD
revealed an IBTX-sensitive outward current in ECs from control animals, thus supporting
earlier evidence in cultured cells of negative regulation of endothelial BKCa by caveolin.
This treatment did not further enhance currents in cells from CH rats. These data also
support our observation of similar channel immunofluorescence in cells from control and
CH rats. Thus, CH exposure may elicit channel activity through dissociation from
caveolin-1. This is an interesting possibility since endothelial heme oxygenase-1 (HO-1)
activity is similarly regulated by caveolin-1 (Kim et al., 2004) and we have previously
shown that HO inhibition restores reactivity in an IBTX-sensitive fashion in CH arteries
(Naik & Walker, 2006;Naik & Walker, 2003). Thus, HO-derived CO may play a role in
tonic activation of endothelial BKCa channels following CH. Future studies will focus on
interactions between HO and caveolin-1 with endothelial BKCa channels as well as
examination of the effects of CH on channel mRNA expression.
In summary, we have demonstrated a novel role of endothelial BKCa channels in
vascular regulation following CH. Whereas these channels do not appear to be important
in vasoreactivity in control arteries, CH exposure results in enhanced activity of
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endothelial BKCa channels that may account for earlier observations of diminished
constrictor reactivity in this clinically relevant setting.
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Figure 1: Myogenic tone (A, C, and E) and vascular smooth muscle (VSM) membrane
potential (Em; B, D, and F) as a function of intraluminal pressure for endothelium-intact
(A and B), NG-nitro-l-arginine (l-NNA) and indomethacin (Indo)-treated (C and D), and
endothelium-disrupted (E and F) gracilis arteries isolated from normoxic control and
chronic hypoxia (CH) rats.
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Figure 2: Myogenic tone (top) and VSM Em (bottom) in endothelium-intact gracilis
arteries isolated from normoxic control and CH rats at 120 mmHg from untreated, l-NNA
and Indo-treated arteries, and arteries exposed to different combinations of intraluminal
K+ channel inhibitors.
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Figure 3: Endothelial cell (EC) Em in gracilis artery strips isolated from normoxic control
and CH rats. EC Em was assessed in untreated, l-NNA and Indo-treated arterial strips, and
arterial strips exposed to different combinations of K+ channel inhibitors. Values are
means ± SE; n, no. of rats. *P < 0.05, normoxic control vs. CH. #P < 0.05 for CH
untreated vs. CH IBTX-treated strips.
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Figure 4: Concentration-response curves [% reversal of phenylephrine (PE)
vasoconstriction] to acetylcholine (ACh) for control (A) and CH (B) gracilis arteries after
treatment with l-NNA + Indo (n = 7 both groups), l-NNA + Indo + TRAM-34 + Ap (n =
4 control, n = 7 CH), or l-NNA + Indo + IBTX (n = 6 control, n = 5 CH). Values are
means ± SE; n, no. of rats. *Differs from l-NNA + Indo for each group, P < 0.05.
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Figure 5: ACh-induced responses in gracilis arteries isolated from normoxic control and
CH rats. Vasodilation responses (A), changes in Em (B), and EC intracellular Ca2+
concentration ([Ca2+]i; C) are shown in response to 10 μM ACh from untreated, l-NNA
and Indo-treated arteries, and arteries exposed to different combinations of K+ channel
inhibitors. Values are means ± SE; n, no. of rats. *P < 0.05, normoxic control vs. CH. #P
< 0.05, untreated vs. treated strips within groups.
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Figure 6: Whole cell K+ currents from gracilis and aortic ECs from normoxic control
(aortic: n = 10, gracilis: n = 9 cells) and CH rats (aortic: n = 9, gracilis: n = 5 cells). A:
whole cell K+ currents in both gracilis (*) and aortic (#) ECs from control rats were
significantly less than CH at all voltage steps. B: currents at a physiologically relevant
potential of 0 mV (*different from gracilis control; #different from aortic control).
Currents were not different between aortic or gracilis ECs within groups (A and B).
Values are means ± SE. C: gracilis EC voltage step traces from control and CH
treatments.
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Figure 7: Administration of K+ channel inhibitors tetraethylammonium (TEA; 10 mM)
and 4-aminopyridine (4-AP; 10 mM) reduced total whole cell K+ currents (n = 5 cells,
controls and CH). A: current subtraction data showing that TEA/4-AP-sensitive
transmembrane currents were greater in the CH group compared with control at all
voltage steps. B: data at the test potential of 0 mV, where currents were normalized by
TEA/4-AP between groups. Values are means ± SE. *P < 0.05, CH vs. normoxic control.
#P < 0.05, control TEA/4-AP vs. control untreated. ψP < 0.05, CH TEA/4-AP vs. CH
untreated. C: voltage step traces from control and CH groups with vehicle or TEA/4-AP.
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Figure 8: Effects of large-conductance, calcium-activated potassium (BKCa) channel
inhibition in aortic ECs. IBTX (100 nM) diminished whole cell K+ current in CH (n = 9)
cells to control levels, but had no effect on control (n = 8) cells. A: IBTX-sensitive
current over the entire range of voltage steps derived by current subtraction. B: data at the
test potential of 0 mV. Values are means ± SE. *P < 0.05, CH vs. normoxic control. C:
traces from voltage steps with vehicle and IBTX treatments.
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Figure 9: A: the BKCa activator NS1619 was without effect in control cells (n = 3), but
increased outward current in cells from CH rats (n = 4). B: comparisons between groups
were conducted at the testing potential of 0 mV. Values are means ± SE. *P < 0.05, CH
vs. normoxic control. #P < 0.05, different from untreated CH. C: traces in the presence of
vehicle or NS1619.
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Figure 10: Positive immunofluorescence for BKCa α-subunit (BK α) and β1-subunit (BK
β1) in freshly dispersed ECs and gracilis cross sections from control (left) and CH (right)
rats. A–D: positive staining for BK α (A and B) and BK β1 (C and D) in aortic ECs from
control and CH rats, respectively. E–H: positive staining for BK α (E and F) and BK-β1
(G and H) in gracilis cross sections from control and CH rats, respectively.
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Figure 11: Cholesterol depletion with methyl β-cyclodextrin (MBCD) increased K+
currents in ECs from control animals (A) with no effect on cells from CH rats (B). Values
are means ± SE. C: traces from control cells before and after treatment with MBCD. D:
traces from CH animal ECs before and after treatment with MBCD. *P < 0.05, MBCD
vs. control.
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Figure 12: A: the increased current in MBCD-treated control ECs was sensitive to IBTX
(100 nM) and demonstrated similar magnitude to IBTX-sensitive current observed in CH
ECs. B: normalization of outward current by IBTX in MBCD-treated control cells at a
physiologically relevant potential of 0 mV. Values are means ± SE. *P < 0.05, MBCD vs.
control. #P < 0.05, MBCD IBTX vs. MBCD. C: traces from MBCD-treated cells in
vehicle or IBTX.
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SUPPLEMENT: Novel Role of Endothelial BKCa Channels In Altered
Vasoreactivity Following Hypoxia

Supplemental Methods
T cell isolation and staining: Negative immunofluorescence controls were performed on
cells that do not express BKCa channels. Whole blood was fixed in 16% formaldehyde
and centrifuged. The supernatant was removed and the sample was re-suspended in 50%
MeOH in PBS. Small aliquots of the sample were then dried on slides, permeabilized,
and blocked in donkey serum. Samples were then treated with anti-CD3 (1:100); a T-cell
marker, BK α (1:100) or BK β1 (1:100). Primary antibodies were detected with
fluorescently labeled secondary antibodies and nuclei were labeled with Hoechst 33342.
All images were collected with a confocal microscope using a 63x oil immersion
objective.
Electron microscopy of rat aortic endothelial cells: To validate that the methyl-βcycodextrin (MBCD) concentration (100 μM) chosen to mildly deplete membrane
cholesterol did not drastically impact caveolar structure, electron microscopic images
were obtained in control tissue and tissue subjected to cholesterol chelation. Aortic
sections were fixed for 2 hours at room temperature in 2% formaldehyde + 3%
glutaraldehyde in 0.1 M Na cacodylate, pH 7.4. Tissues were washed in 0.1 M cacodylate
and treated for 1 hour at room temperature in 1% osmium-potassium ferrocyanide in 0.1
M cacodylate, followed by washes in 0.1M cacodylate and then in Barnstead H2O.
Tissues were then treated en bloc with 1% uranyl acetate (aq), for 1 hour at room
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temperature and washed with Barnstead H2O, dehydrated through a graded series of
ethanol to 100%, infiltrated and embedded in Epon-Araldite resin (cured at 65ºC).
Sections were cut 70-90 nm thick, mounted on Cu grids, stained with uranyl acetate and
lead citrate, and examined on a Hitachi H7500 TEM at 80kV. Digital images were taken
on a CCD camera (AMT XR60).
Effect of Nitric Oxide on BKCa Channel Activity in Isolated Endothelial Cells. As further
confirmation of the activity of endothelial BKCa channels following CH, whole cell patch
clamp experiments were performed in the presence and absence of a donor of nitric oxide
(NO), a known activator of the channel (Bolotina et al., 1994). After cell dialysis,
recordings were taken before and after 5 min of superfusion with the NO donor S-nitrosoN-acetyl-D,L-penicillamine (SNAP) (100 μM) in aortic endothelial cells from control and
CH rats.
Supplemental Results
Validation of Specificity of BKCa Channel Immunofluorescence. Additional experiments
validated the specificity of immunofluorescence for BK α and BK β1. Supplemental
Figure 1A shows the lack of staining in the presence of only the secondary (no primary)
antibody in gracilis arterioles. Furthermore, blocking peptides for each primary antibody
prevented staining (Supplemental Figure 1 B, C).

In addition, the endothelial cell

localization of BK α was confirmed in sections of gracilis arterioles stained for both BK
α and the endothelial cell specific marker PECAM-1 (Supplemental Figure 2) as
described in the Methods section of the paper. As a final determination of specificity of
the BK α and BK β1 primary antibodies, we examined staining in isolated rat T-cells
that do not express the channel. Supplemental Figure 3 shows the lack of BK α or BK β1
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immunofluorescence in these cells, whereas they stain positive for the T-cell marker
CD3. The same secondary antibody was used for all images.
Lack of Effect of MBCD on Gross Structure of Caveolae. A dose of MBCD (100 μM)
was chosen that unmasked endothelial BKCa channels activity in control cells, but was
much lower than the 10 mM concentration used by others in vascular preparations
(Linder et al., 2007;Linder et al., 2005). Following administration of this lower dose of
MBCD, no apparent differences were detectable in caveolae number or structure from
untreated controls. CH treatment additionally did not result in an apparent reduction in
caveolae number or structure. However, a 10mM concentration of MBCD eliminated EC
caveolae (Supplemental Figure 4).
Effect of Nitric Oxide on BKCa Channel Activity in Isolated Endothelial Cells.
Administration of the NO donor SNAP elicited a further increase in outward current in
aortic endothelial cells from CH but not control rats (Supplemental Figure 5). NO has
been identified as an activator of BKCa channels (Bolotina et al., 1994) and thus this
observation confirms their presence in endothelial cells from CH rats. Our other data
showing that MBCD treatment unmasks channel activity in cells from control animals
suggests that the channels are normally inhibited by likely association with caveolin-1
(Wang et al., 2005) that is inhibition is removed following CH, thus permitting activation
by NO.
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A

B

C

Supplemental Figure 1: Gracilis arteriole cross sections were treated with secondary
antibodies and no primary antibodies to confirm lack of staining in the absence of
primary antibody. (panel A). Additional cross sections were treated with BK α (panel B)
or BK β1 (panel C) primary antibodies plus respective blocking peptides to confirm
primary antibody specificity.

Supplemental Figure 2:

BK α and PECAM-1 primary antibodies demonstrated

endothelium specific staining. Cross sections were stained for BK α (green) and the
endothelial marker PECAM-1 (1:100) (red). PECAM-1 staining appeared only in
endothelial cells (middle and right panels), while BK α staining appeared in vascular
smooth muscle cells and endothelial cells in the cross sections (left and right panels).
Nuclei are blue.
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Supplemental Figure 3: Isolated leukocytes (T cells) from control rats were treated
with primary antibodies to BK α as a negative control, since these cells do not express
BK channels. Slides were stained for BK α (middle panel) or BKβ1 1:100 (right panel),
the T-cell marker CD3 (red), and a nuclear stain (blue). No BK α or BK β1 staining
appeared in leukocytes, in contrast to positive staining in vascular smooth muscle cells
and endothelial cells in figure 8 and supplemental figure 2. Scale bar = 10 μm.

115

Supplemental Figure 4: Electron microscopy
images of endothelial cells from control gracilis
arterioles treated with vehicle, 100 μM or
10mM

methyl

β-cylcodextrin

(MBCD).

Caveolae per 500nm of
EC Plasma Membrane

5

Control (n=3)
CH (n=3)

4
3
2
1
0

Treatment with MBCD did not eliminate caveolar structures at the 100 μM concentration
(top panel), however the 10mM MBCD concentration eliminated caveolae. CH treatment
did not alter caveolar presence or apparent structure compared to normoxic controls
(bottom panel). The 100μM MBCD treatments elicited increased outward K+ currents
from control ECs (Fig. 11a) with no significant effect on outward currents in ECs from
CH animals (Fig. 11b). Interestingly, putative reduction in cellular cholesterol by MBCD
treatment without ablation of caveolae enabled EC BKCa channel activity in controls to a
level similar to that found in CH animals (Figure 12A: IBTX-sensitive currents) Scale bar
= 500 nM, images at 15000x.
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Supplemental Figure 5: Exogenous nitric oxide (NO) increased outward K+ currents in
ECs from CH animals (n=6 cells) but had no effect on currents in controls (n=4 cells)
(top panel). Current density at -40mV was significantly larger from ECs from CH
animals (bottom panel) and exogenous NO from the NO donor S-nitroso-N-acetyl-D,Lpenicillamine (SNAP) 100µM increased outward current only in ECs from CH animals.
*p<0.05 CH vs. control vehicle, #p<0.05 CH SNAP vs. CH vehicle (+70mV through
+150mV).
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ADDENDUM AIM 1: Determining the Expression and Activity of Endothelial
BKCa Channels Following Chronic Hypoxia

Experiments detailed in “The Novel Role of Endothelial BKCa Channels in Altered
Vasoreactivity Following Hypoxia” were designed to address objectives in Aim 1 of this
project. Additional experiments that specifically address Specific Aims 1.1, 1.2, and 1.4
that were not included in the publication are detailed below.

Specific Aim 1.1: Investigate EC BKCa activity following CH through whole cell patch
clamp.
Initial experiments in freshly dispersed ECs measured significantly greater
outward K+ currents in cells from CH animals versus controls. To identify the source of
the increased currents, we treated ECs with TEA and 4-aminopyridine to block all KCa
and KV activity, respectively. Blockade of KCa currents significantly decreased outward
currents and brought the two groups together, demonstrating the importance of KCa
channels in total EC currents. Three KCa channels have been identified in the vascular
endothelium; small (SKCa), intermediate (IKCa), and large calcium-activated potassium
channels (BKCa). Due to the importance of SKCa and IKCa in ECs, which has suggested
small and intermediate conductance calcium-activated potassium channels have a
predominant role regulating EC Em (Ledoux et al., 2008) we examined total currents in
the presence of the SKCa inhibitor, apamin and the IKCa inhibitor, TRAM-34 in freshly
dispersed ECs from controls and CH animals.
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Interestingly, administration of TRAM-34 and apamin did not normalize outward
currents in CH ECs to levels of controls, (Addendum Figure 1) in contrast in TEA
administration. These results led us to investigate if blockade of BKCa activity in CH ECs
would normalize currents. It was determined that outward K+ currents in freshly isolated
ECs only from CH animals demonstrated sensitivity to IBTX, the BKCa specific inhibitor,
which normalized currents. IBTX subtraction currents demonstrated non-ohmic increases
in conductance, suggesting voltage sensitivity of the channel and further supporting our
claim of the IBTX sensitive currents in ECs to be derived from BKCa. Another important
validation of BKCa currents is investigation of the currents sensitivity to intracellular
calcium. Conditions utilized in whole cell patch clamp contained 1µM free Ca2+, an
amount of calcium that is significantly higher than reported endogenous levels (Hu &
Ziegelstein, 2000;Wickham et al., 1998), that have been demonstrated to maximally
activate BKCa channels. To determine if endogenous calcium levels were sufficient
enough to activate EC BKCa channels we performed perforated patch clamp experiments
in the freshly isolated rat aortic endothelial cells from normoxic and hypoxic animals and
compared IBTX sensitive currents to studies conducted in whole cell patch clamp
(Addendum Figure 2). To further characterize calcium sensitivity in EC BKCa channels,
we designed patch clamp experiments with the xeno-estrogen derivative Tamoxifen,
which increases BKCa activity with the presence of active β subunits, or decreases
currents when only α subunits of the channel are functional (Dick et al., 2001;Liu et al.,
2003;Duncan, 2005) (Addendum Figure 3) Calcium sensitivity in smooth muscle cells
is largely dependent upon accessory β subunits, and their role in ECs has not been
determined.
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Patch Clamp Studies on Isolated Endothelial Cells: Endothelial cells were dispersed for
electrophysiological study from control and CH rat aortae as previously described
(Hughes et al., 2010). For experiments utilizing conventional whole cell patch clamp
configuration, biophysical criteria: (seal resistance > 1GΩ, series resistance <25MΩ) was
checked following membrane rupture and monitored throughout the course of the
experiment. Cells were held at -60mV and were dialyzed for 5 min with an intracellular
solution (ICS: 140 mmol/l KCl, 0.5 mmol/l MgCl2, 5 mmol/l Mg2ATP, 10 mmol/l
HEPES, 1 mmol/l EGTA and adjusted to pH 7.2 with KOH). CaCl2 was added to yield a
free-Ca2+ concentration of 1 μM, as calculated using WinMAXC chelator software.
For experiments utilizing the perforated patch technique, 4-6 MΩ patch electrodes were
backfilled with amphotericin B. After gigaseals were obtained, the series resistance fell
over a 10- to 15-min period to 15–20 M and remained stable for up to 1 h. ECs with
stable series resistances under 25 MΩ were used for experiments.
Determination of the Contribution of SKCa and IKCa to EC Outward Currents
Currents in freshly dispersed ECs from control and CH animals were dialyzed for 5
minutes to wash out intracellular contents and total outward were measured in the
presence of the vehicle, after 5 minutes of treatment with apamin, and lastly after 5
minutes with TRAM-34 and apamin. Total outward currents were compared for each
group following treatments with KCa inhibitors.
Activity of EC BKCa in the Presence of Endogenous Intracellular Calcium or 1µM Free
Calcium: Freshly dispersed ECs were dialyzed for 5 minutes to wash out intracellular
contents and total outward currents were measured in the presence of vehicle, and after a
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5 minute treatment with IBTX. ECs in perforated patch clamp mode currents were
measured in vehicle conditions and following 5 minute treatment with IBTX. Outward
currents were compared in each group between vehicle and IBTX treatments.
Determining the Role of β Subunits in EC BKCa: Currents in freshly dispersed ECs
currents were measured following treatment with tamoxifen (1 µM) for 10 minutes. The
effect of tamoxifen treatment in ECs was additionally compared to the actions of the drug
in freshly isolated VSMCs, which have been demonstrated to have active β subunits.

Results:
SKCa and IKCa Currents Contribute Largely to Total Outward Currents in ECs;
Difference in CH vs. Control Currents Persists Following SKCa and IKCa Blockade:
Blockade of SKCa and IKCa channels in ECs significantly decreased outward currents
(Addendum Figure 1), however the residual current after SK/IK blockade was still
significantly higher in CH than controls. Administration of IBTX to block EC BKCa had
no effect in controls, but normalized currents to levels of controls in CH ECs. These
results support a role for all KCa channels in EC function following CH, and a role only
for SK/IK channels in normoxic conditions.

Channel Activity in the Presence of Endogenous Intracellular Calcium: Experiments in
whole cell patch clamp and perforated patch clamp modes were not different in the
magnitude of IBTX sensitive currents. Suggesting that endogenous levels of calcium are
sufficient to drive channel activity in the absence of supra-physiologic calcium.
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The Effect of Tamoxifen on ECs: Tamoxifen treatment decreased outward currents in CH
ECs whilst increasing outward currents in VSMCs. These results suggest that β subunits,
if present are not active in ECs. Immunofluorescence experiments localized the subunits
to the endothelium, however these results demonstrate they are not important in calcium
sensitivity in ECs in contrast to their important role in VSMCs.
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Addendum Figure 1: Administration of the IKCa inhibitor TRAM-34 (100µM)
decreased currents in control ECs (Panel A) and CH ECs (Panel B). Results with the
SKCa inhibitor, apamin had similar effects in both groups and subtraction currents from
SKCa and IKCa were not different amongst groups (Panel C). Blockade of SKCa and IKCa
almost eliminated outward currents in controls (Panel D). TRAM-34 and apamin
(100nM) did not normalize current differences between CH and controls, however
following the addition of IBTX to block BKCa to the cocktail of inhibitors currents were
normalized (Panel D). These results demonstrate that SK/IKCa channels play a role in EC
outward currents, with BKCa emerging following CH.
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CHAPTER 2 ADDENDUM: SPECIFIC AIM 1.1 – FIGURE 2

Addendum Figure 2: K+ currents in ECs dialyzed with 1 μM [Ca2+]i or studied in
perforated patch mode. BK inhibition with IBTX significantly reduced outward currents
in both preparations. Data ± SEM. * p < 0.05 vs. untreated (all test potentials) n = 10-15
cells
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CHAPTER 2 ADDENDUM: SPECIFIC AIM 1.1 – FIGURE 3

Addendum Figure 3: Whole cell K+ current responses to tamoxifen (β1 agonist / BK α
inhibitor) in VSMCs and ECs . Data ± SEM. * p < 0.05 vs. vehicle. (n = 5-7 cells)
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Specific Aim 1.2: Characterize EC BKCa channels through single channel records.
Whole cell current experiments detailed above strongly support the presence and
activity of EC KCa channels. To further support whole cell patch clamp data we
performed experiments to determine unitary conductance for SK/IK/ EC BKCa. Channel
frequency in isolated patches was measured for each channel in whole-cell cell attached
and inside-out configurations. For BKCa, unitary conductance and channel opening (NPo)
in the presence of varying levels of intracellular calcium and voltage were measured and
contrasted to VSM BKCa. Changes in NPo following treatment withthe channel inhibitor,
IBTX, were additionally conducted.
Single Channel Recordings. For single channel experiments, cell attached and inside-out
patch clamp configurations were used. Patch pipettes had resistances ranging from 6 to 8
MΩ. Extracellular solutions (ECS) contained: 130 NaCl, 5 KCl, 1.2 MgCl2, 10 HEPES,
10 Glucose, 1.2 CaCl2 (pH 7.30 with NaOH). Intracellular solutions (ICS) contained (in
mM): 130KCl, 2 Na2ATP, 3 MgCl2, 10 HEPES, 1 EGTA, (pH 7.30 with KOH). For
inside-out patch experiments ECS contained: 140 KCl, 10 HEPES, 1 CaCl2, 1 MgCl2 (pH
7.3 with KOH). For experiments investigating the effect of calcium concentration on
single channel opening probability (Npo) on inside out patches EGTA and free Ca2+
(CaCl2 ) were varied to provide 10 nM, 50 nM, 100 nM, 1 μM, and 10 μM solutions.
Patches were held at -60, 0, and 40 mV test potentials

for voltage sensitivity

experiments. Single channel unitary conductance was determined from the slope of
currents measured in response to voltage steps applied from -100 mV to 150 mV in 10
mV increments from a holding potential of -60 mV. EC KCa unitary conductance in
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symmetrical K+ and assymetrical K+ were determined. All data were filtered at 5 kHz (3dB) and digitized at 10 kHz.
Whole cell currents were measured in response to voltage steps applied from -60
mV to +150 mV in 10 mV increments from a holding potential of -60 mV. Cell
capacitance was monitored and transmembrane currents were expressed in terms of
current density (pA/pF).
Single Channel Recordings from VSM Cells. For single channel experiments on freshly
isolated smooth muscle cells, aortae were digested as stated above. Following gentle
trituration freshly isolated VSMCs were placed on Sylgard coated cover slips. VSMCs
were identified by spindle shape and an absence of DiI-Ac-LDL labeling. All
experimental conditions were identical to EC recordings (methods stated above) and
calcium sensitivity of VSM BKCa channels compared to that in EC BKCa channels.

Measurement of KCa channel unitary conductances: Whole cell-cell attached in
assymetrical K+ solutions or inside-out patches in symmetrical K+ solutions were taken
through a series of voltage steps from -100 to 150 mV in 10 mV increments and channel
unitary conductance was calculated from the slope of the current to voltage curve. To
avoid contamination of patches with other KCa channels, experiments determining SKCa
unitary conductance contained TRAM-34 and IBTX, while experiments characterizing
IKCa had apamin and IBTX, and BKCa with apamin and TRAM-34.
Results
Unitary conductances of four KCa channels in ECs: Four distinct KCa channels were
identified in vascular endothelial cells, which CH ECs contained all four channels (two
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SKCa, IKCa, and BKCa) and ECs from controls contained patches with two SKCa channels,
and IKCa (Addendum Figure 4). Without the use of inhibitors, channel frequency in
isolated patches were determined (Addendum Figure 5). Patches from control animals
did not contain BKCa channels but contained similar frequencies of SK to IKCa channels
in whole cell-cell attached (WC) configuration. CH patches contained significantly more
BKCa channels and had similar frequency of SK to IKCa channels in WC configuration. In
I/O configuration however there was a shift to having more SKCa channels in both CH
and control ECs.

Comparison of EC BKCa and VSMC BKCa Unitary Conductances: Unitary conductances
were not found to be different amongst EC and VSM BKCa channels (Addendum Figure
5).
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Unitary Conductance (pS)
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Addendum Figure 4: Unitary conductances of two distinct SKCa channels and IKCa in
ECs . Data ± SEM. * p < 0.05 vs. vehicle. (n = 5-7 cells)
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Addendum Figure 5: Calculation of channel frequency in patches without inhibitors in
vehicle conditions in inside-out (I/O) and whole cell - cell attached configurations (WC).
Isolated patches on ECs from control animals did not demonstrate the presence of a large
conductance channel. In control WC, 14 patches contained IKCa channels and 13 patches
contained SKCa channels out of a total 27 patches studied for channel frequency in cells;
while in CH WC 11 patches contained BKCa channels with only 4 patches identifying
either SKCa or IKCa out of a total of 19 cells examined. For control I/O, 22 patches
contained SKCa channels and 11 patches contained IKCa out of 33 studied patches; while
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in CH I/O 9 patches contained BKCa channels with 6 patches identifying SKCa and 3 with
IKCa out of the 18 patches studied.

CHAPTER 2 ADDENDUM: SPECIFIC AIM 1.2 – FIGURE 6

Addendum Figure 6: Unitary conductances of BKCa in VSMCs and ECs . Data ± SEM.
* p < 0.05 vs. vehicle. (n = 5-7 cells)
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ABSTRACT

A novel vasodilatory influence of endothelial cell (EC) large conductance calcium
activated potassium channels (BKCa) is present following in vivo exposure to chronic
hypoxia (CH) and may exist in other pathological states. However, the mechanism of
channel activation that results in altered vasoreactivity is unknown.

We tested the

hypothesis that CH removes an inhibitory effect of the scaffolding domain of caveolin-1
on EC BKCa channels to permit activation thereby affecting vasoreactivity. Experiments
were performed on gracilis resistance arteries and ECs from control and CH (PB = 380
mmHg for 48 hr) exposed rats. EC membrane potential was hyperpolarized in arteries
from CH rats or arteries treated with the cholesterol depleting agent methyl-βcyclodextrin (MBCD) compared to controls. Hyperpolarization was reversed by the
BKCa antagonist iberiotoxin (IBTX) or by a scaffolding domain peptide of caveolin-1
(AP-CAV). Patch clamp documented an IBTX-sensitive current in ECs from CH rats
and in MBCD treated cells not present in controls. This current was enhanced by the
BKCa activator NS1619 and blocked by either AP-CAV or cholesterol supplementation.
EC BKCa displayed similar unitary conductance but greater calcium sensitivity than BKCa
from vascular smooth muscle.

Immunofluorescence imaging demonstrated greater

association of BKCa α subunits with caveolin-1 in control arteries than CH. Finally, APCAV restored both myogenic and phenylephrine-induced constriction in arteries from CH
rats without affecting controls. We conclude that CH unmasks EC BKCa activity by
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removal of an inhibitory action of the caveolin-1 scaffolding domain that may depend
upon cellular cholesterol levels.

Key words: hyperpolarization; large conductance calcium activated potassium channel;
scaffolding domain
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INTRODUCTION
Large conductance calcium activated potassium channels (BKCa) are important
regulators of arterial tone via their hyperpolarizing influence on vascular smooth muscle
(VSM). VSM BKCa channels are regulated by localized increases in calcium due to
sparks from ryanodine-sensitive stores (Jaggar et al., 2000). Although most studies
concerning the role of BK channels in vascular control focus on the VSM, there is
increasing evidence that endothelial cells (EC) also express these channels although both
their expression and physiological significance in native cells have been questioned
(Gauthier et al., 2002). It has been suggested that although these channels may be
quiescent in some vascular beds, their activity is unmasked in various pathological
conditions or in cell culture (Sandow & Grayson, 2009). We have recently demonstrated
that endothelial BKCa channels are active following in vivo exposure to chronic hypoxia
(CH) and that they participate in regulation of vasoreactivity (Hughes et al., 2010x).
Systemic hypoxemia occurs in pathological conditions that impair pulmonary gas
exchange or as a result of residence at high altitude. Patients subjected to CH demonstrate
systemic vasodilation (Casiglia et al., 1998) and blunted reflex vasoconstriction to lower
body negative pressure challenges (Heistad et al., 1972). Diminished vasoconstrictor
reactivity is not reversed by restoration of normoxia in these patients (Casiglia et al.,
1998) or in experimental animals subjected to prolonged hypoxia (Auer & Ward,
1998;Doyle & Walker, 1991) suggesting that CH elicits long term adaptations in vascular
function.
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CH causes a generalized reduction in vasoconstrictor reactivity evidenced by
similar blunting of both myogenic and agonist-induced reactivity (Earley & Walker,
2002;Earley et al., 2002;Jernigan et al., 2001;O'Donaughy & Walker, 2000).

This

impairment of vasoconstriction is endothelium-dependent and is associated with VSM
hyperpolarization (Earley et al., 2002;Hughes et al., 2010w). Inhibition of either heme
oxygenase (HO) (Earley et al., 2002;Naik & Walker, 2003) or BKCa channels (Naik &
Walker, 2003;Hughes et al., 2010v) normalizes membrane potential and restores
vasoreactivity in arterioles from CH rats. Interestingly, although HO-mediated VSM
hyperpolarization and relaxation is BKCa-dependent in these arteries, it is unaffected by
inhibition of pathways linked to VSM BKCa channels such as ryanodine receptors and
soluble guanylate cyclase activity (Naik & Walker, 2003), supporting a role for
endothelial BKCa channels.

This possibility was recently confirmed in studies

specifically targeting endothelial BKCa channels with luminal administration of the
specific inhibitor iberiotoxin (IBTX) in arteries from CH rats that restored
vasoconstrictor responsiveness and normalized EC and VSM membrane potential to
control levels (Hughes et al., 2010u). Whole cell patch clamp experiments demonstrated
an IBTX-sensitive current in ECs from CH rats that was not observed in controls.
Interestingly, BKCa channels were detected by immunofluorescence in ECs from both
control and CH rats and BKCa current could be elicited in control cells with mild
cholesterol depletion (Hughes et al., 2010t). These results suggest that although
endothelial BKCa channels are expressed in both groups, their activity is normally
inhibited in a cholesterol-dependent fashion and that CH exposure allows their activation.
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Caveolae are cholesterol rich plasmalemmal microdomains characterized by their
flask-like structure and by the presence of the scaffolding protein caveolin-1 (Cav-1).
Cav-1 has a high affinity for cholesterol and possesses an intracellular binding domain
that regulates the activity of various signaling molecules. Importantly, Cav-1 inhibits
BKCa activity in cultured ECs (Wang et al., 2005) through its scaffolding domain (amino
acids 82-101: DGIWKASFTTFTVTKYWFYR), however the role of Cav-1 on BKCa
channel function in native ECs has not been examined and Cav-1 regulates BKCa
channels differently in other cell types. Cav-1 knockout mice (cav-1 -/-) develop cardiac
hypertrophy, pulmonary hypertension, and systemic hypotension (Murata et al., 2007).
Additionally cav-1-/- mice demonstrate augmented endothelium-dependent relaxation
(Drab et al., 2001a;Yu et al., 2006) and decreased myogenic (Adebiyi et al., 2007) and
agonist-induced vasoconstriction (Drab et al., 2001b) that parallel observations in CH
rats (Earley & Walker, 2002;Earley et al., 2003;Hughes et al., 2010s). Thus, it is
possible that altered vascular control in settings such as CH may be related to dysfunction
of endothelial Cav-1.
The goal of the present study was to test the hypothesis that CH enhances EC
BKCa channel activity and alters vasoreactivity via loss of an inhibitory effect of Cav-1.
To examine this hypothesis in the most physiologically relevant manner possible,
experiments were performed on intact arteries or on cells freshly dispersed from rats
exposed to either CH or control conditions.
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METHODS
Detailed descriptions of the methods employed are presented in an accompanying
online supplement.
Animals. Experiments were performed on male Sprague-Dawley rats (Harlan Industries).
All procedures were approved by the Institutional Animals Care and Use Committee of
the University of New Mexico Health Sciences Center.
Hypoxic Exposure. CH rats were exposed to hypobaric hypoxia at a barometric pressure
of 380 mmHg for 48 hours, whereas normoxic control rats were housed in identical cages
at ambient pressure (barometric pressure, ~630 mmHg). In previous studies, we have
determined that 48 hour CH exposure results in vasoconstrictor hyporeactivity
indistinguishable from more prolonged (4 week) exposure and that the effects of CH do
not reverse for at least 96 hours post-hypoxia (Jernigan et al., 2001;O'Donaughy &
Walker, 2000).
Endothelial Membrane Potential in Intact Arteries. Rats were anesthetized with sodium
pentobarbital (50 mg ip) and hindlimbs removed and placed in ice-cold HEPES buffered
physiological saline solution (HBSS): mmol/l 150 NaCl, 6 mmol/l KCl, 1 mmol/l MgCl2,
1.5 mmol/l CaCl2, 10 mmol/l HEPES, and 10 mmol/l glucose and adjusted to pH 7.4 with
NaOH. Gracilis artery branches (passive inner diameter at 100 mmHg, 150-200 µm) were
carefully dissected, cut into vascular strips, and superfused (10 ml/min) with warmed
(37°C) HBSS. All experiments were performed under normoxic conditions to examine
sustained alterations in vascular control rather than acute responses to hypoxia. Vessel
strip endothelial cell membrane potential (Em) was measured by impalement with sharp
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electrodes backfilled with Lucifer yellow for subsequent confirmation of endothelial
identity (Earley et al., 2004;Naik et al., 2005;Hughes et al., 2010r).
Patch Clamp Studies on Isolated Endothelial Cells: Endothelial cells were dispersed for
electrophysiological study from control and CH rat aortae as previously described
(Hughes et al., 2010q). Previous studies demonstrated that endothelial cells from aorta
display the same characteristics as cells from gracilis arteries in terms of their response to
CH (Hughes et al., 2010p). One to two drops of the resulting cell suspension were
seeded on a glass cover slip mounted on an inverted fluorescence microscope (Olympus
IX71) for 30 min prior to superfusion. Single endothelial cells were identified by the
selective uptake of the fluorescently labeled acylated low density lipoprotein Ac-LDL-Dil
with a rhodamine filter (Paffett et al., 2007) prior to each electrophysiological
experiment. Freshly dispersed endothelial cells were superfused under constant flow (2
ml/min) at room temperature (22-23°C) in an extracellular solution (ECS: 141 mmol/l
NaCl, 4.0 mM KCl, 1 mmol/l MgCl2, 1 mmol/l CaCl2, 10 mmol/l HEPES, 10 mmol/l
glucose and buffered to pH 7.4 with NaOH).

Whole cell current data were generated

using an Axopatch 200B amplifier (Axon Instruments). For experiments utilizing
conventional whole cell patch clamp configuration, biophysical criteria: (Seal resistance
> 1GΩ, series resistance <25MΩ) was checked following membrane rupture and
monitored throughout the course of the experiment. Cells were held at -60mV and were
dialyzed for 5 min with an intracellular solution (ICS: 140 mmol/l KCl, 0.5 mmol/l
MgCl2, 5 mmol/l Mg2ATP, 10 mmol/l HEPES, 1 mmol/l EGTA and adjusted to pH 7.2
with KOH). CaCl2 was added to yield a free-Ca2+ concentration of 1 μM, as calculated
using WinMAXC chelator software. For experiments utilizing the perforated patch
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technique, 4-6 MΩ patch electrodes were backfilled with amphotericin B. After gigaseals
were obtained, the series resistance fell over a 10- to 15-min period to 15–20 M and
remained stable for up to 1 h. ECs with stable series resistances under 25 MΩ were used
for experiments.
Single Channel Recordings. For single channel experiments, cell attached and inside-out
patch clamp configurations were used. Patch pipettes had resistances ranging from 6 to 8
MΩ. Extracellular solutions (ECS) contained: 130 NaCl, 5 KCl, 1.2 MgCl2, 10 HEPES,
10 Glucose, 1.2 CaCl2 (pH 7.30 with NaOH). Intracellular solutions (ICS) contained (in
mM): 130KCl, 2 Na2ATP, 3 MgCl2, 10 HEPES, 1 EGTA, (pH 7.30 with KOH). For
inside-out patch experiments ECS contained: 140 KCl, 10 HEPES, 1 CaCl2, 1 MgCl2 (pH
7.3 with KOH). For experiments investigating the effect of calcium concentration on
single channel opening probability (Npo) on inside out patches EGTA and free calcium
(CaCl2 ) were varied to provide 10 nM, 50 nM, 100 nM, 1 μM, and 10 μM free calcium
solutions. Patches were held at -60, 0, and 40 mV test potentials to for voltage sensitivity
experiments. Single channel unitary conductance was determined from the slope of
currents measured in response to voltage steps applied from -100 mV to 150 mV in 10
mV increments from a holding potential of -60 mV. EC BKCa unitary conductance in
symmetrical K+ and assymetrical K+ were determined. All data were filtered at 5 kHz (3dB) and digitized at 10 kHz.
Whole cell currents were measured in response to voltage steps applied from -60
mV to +150 mV in 10 mV increments from a holding potential of -60 mV. Cell
capacitance was monitored and transmembrane currents were expressed in terms of
current density (pA/pF).
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Single Channel Recordings from VSM Cells. For single channel experiments on freshly
isolated smooth muscle cells, aortae were digested as stated above. Following gentle
trituration freshly isolated VSMCs were placed on Sylgard coated cover slips. VSMCs
were identified by spindle shape and an absence of DiI-Ac-LDL labeling. All
experimental conditions were identical to EC recordings (methods stated above) and
calcium sensitivity of VSM BKCa channels were compared to EC BKCa channels.
Immunofluorescence in Sectioned Arteries: Gracilis arteries from control and CH rats
were collected following transcardial perfusion with PSS containing 10 mg papaverin.
The gracilis muscle was removed and frozen in OCT compound in liquid N2 and
isopentane. 10 µm sections were adhered to superfrost slides (Fisher) and fixed in ice
cold methanol (100%) for 10 min. After fixation cross sections were blocked in 4%
donkey serum in PBS for 1 hr at room temperature. Cross sections were incubated with
primary antibodies for BKα (Alamone 1:100) and Cav-1 (BD Biosciences 1:50). Primary
antibodies for BKα were detected with Cy5-conjugated donkey, anti-rabbit secondary
antibodies. Cav-1 was detected with a Cy3-conjugated donkey, anti-mouse secondary
antibody (all secondaries 1:500 dilution; Jackson Labs).

The nuclear stain, Sytox

(1:10,000 dilution; Molecular Probes) was then applied. Confocal microscope images
were obtained using a 63x oil immersion DIC objective (NA =1.4) at a resolution of 524
X 524 and an optical slice of 0.7 µm. For co-localization analysis, z stacks (10 sections, 1
µm) were analyzed for fluorescence overlap of BKCa α and Cav-1. Images underwent
nearest-neighbor deconvolution and individual channels were thresholded to normalize
intensity between channels.

Thresholded channels were then made into masks.

Endothelial cells were then traced within the lumen of arteriolar cross sections made into
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a mask for analysis. Individual channel masks and the EC mask were combined to
examine endothelial specific co-localization as defined by Mander’s correlation
coefficient values (Manders et al., 1992). Values range from 0 to 1, with values close to 0
indicating non-overlapping images and values close to 1 reflecting co-localization.
Study of Isolated Resistance Arteries. Hindlimbs from control or CH animals were
removed and placed in ice-cold physiological saline solution [PSS: 119 mmol/l NaCl, 4.7
mmol/l KCl, 25 mmol/l NaHCO3, 1.18 mmol/l KH2PO4, 1.17 mmol/l MgSO4, 0.026
mmol/l K2-EDTA, 5.5 mmol/l glucose and 2.5 mmol/l CaCl2]. Gracilis arterioles (passive
inner diameter at 60 mmHg, 140-200 µm) were dissected free, cannulated on glass
pipettes and mounted in an arteriograph (Living Systems, CH-1). The proximal end of the
artery was cannulated with a tapered glass pipette, secured in place with a single strand of
silk ligature and gently flushed to remove blood from the lumen. The distal end of the
artery was then cannulated and the vessel stretched longitudinally to approximate its in
situ length. Arteries were slowly pressurized to 60 mmHg with PSS using a servocontrolled peristaltic pump (Living Systems) and superfused (10 ml/min) with warmed
(37°C) PSS aerated with a normoxic gas mixture (21% O2-6% CO2-73% N2). Arteries
were required to hold a steady pressure upon switching off the servo-control function to
confirm the absence of a leak. Any vessels with apparent leaks were discarded. The
vessel chamber was then transferred to the stage of a Nikon Eclipse TS100 microscope
and the preparation superfused with PSS. Bright-field images of vessels were obtained
with an IonOptix CCD100M camera and dimensional analysis performed by IonOptix
Sarclen software to measure inner diameter as described in previous studies from our
laboratory (Earley & Walker, 2002). All experiments were performed under normoxic
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conditions to examine sustained alterations in vascular control rather than acute
vasodilatory responses to hypoxia. Arteriole exposure to normoxic conditions for 2.5-3
hours throughout the course of the experiment do not reverse sustained alterations elicited
by CH exposure
Measurement of Vascular Smooth Muscle Cell Calcium. Pressurized arteries were loaded
abluminally with the cell-permeant, ratiometric, Ca2+-sensitive fluorescent indicator fura2 AM (Molecular Probes) as detailed previously (Earley & Walker, 2002). Immediately
prior to loading, fura-2 AM (1 mM in anhydrous DMSO) was mixed 2:1 with a 20%
solution of pluronic acid in DMSO, and this mixture diluted in PSS to yield a final
concentration of 2

M fura-2 AM and 0.05% pluronic acid. Arteries were incubated in

this solution for 45 min at room temperature in the dark. The diluted fura-2 AM solution
was equilibrated with the 21% O2 gas mixture during this loading period. Vessels were
rinsed for 20 min with aerated PSS (37 °C) following the loading period to wash out
excess dye and to allow for hydrolysis of AM groups by intracellular esterases. Fura-2loaded vessels were alternately excited at 340 and 380 nm at a frequency of 1 Hz with an
IonOptix Hyperswitch dual excitation light source and the respective 510 nm emissions
collected with a photomultiplier tube. Background-subtracted 340/380 emission ratios
were calculated with IonOptix Ion Wizard software and recorded continuously
throughout the experiment, with simultaneous measurement of i.d. from red wavelength
bright-field images as described above. VSM [Ca2+]i is expressed as the mean F340/F380
ratio from the background-subtracted 510 nm signal.
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Experimental Protocols:
Due to the sustained nature of the effect of CH exposure, all experiments on tissue from
CH and control rats were performed under normoxic conditions.
Effect of CH or Cholesterol Depletion on Basal Endothelial Em. Endothelial cell Em was
measured using sharp electrodes in gracilis arteries from control and CH rats. To test
whether CH-induced changes in Em could be mimicked by caveolar disruption, some
arteries from control animals were treated with 100 µmol/L of the cholesterol depleting
agent methyl-β-cyclodextrin (MBCD; Sigma). This concentration of MBCD is 100 fold
less than that commonly used in vascular preparations and we have previously shown that
it does not affect caveolae structure or number in this preparation (Hughes et al., 2010o).
Iberiotoxin (IBTX) Sensitivity of Em.

To examine the role of BKCa channels on

endothelial Em, sharp electrode measurements were made in control, CH and MBCDtreated gracilis arteries in the presence 100 nmol/L of the BKCa specific inhibitor IBTX
(Sigma) or its vehicle.
Effect of Caveolin-1 Scaffolding Domain Peptide on Basal Endothelial Em. Endothelial
cell Em was measured in arteries from control and CH rats and control arteries treated
with MBCD in the presence of 10 µmol/L of the Cav-1 scaffolding domain peptide (APCAV; Twentyfirst Century Biochemicals) or a scrambled control peptide.
Effect of CH or Cholesterol Depletion on Isolated Endothelial Cell Transmembrane
Currents. Currents were measured in aortic ECs freshly dispersed from control and CH
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rats.

Previous

studies

demonstrated

that

ECs

from

aorta

display

identical

electrophysiological characteristics as cells from gracilis arteries in terms of their
response to CH and to cholesterol depletion (Hughes et al., 2010n). In perforated patch
clamp mode, whole cell currents were measured in response to a series of voltage steps.
After initial recording, one group of cells from control rats was superfused with MBCD
for 15 minutes before voltage steps were applied and currents re-examined.
Effect of BKCa Channel Inhibition and Activation on Isolated Endothelial Cell
Transmembrane Currents.

In perforated patch clamp mode, recordings were taken

before and 5 min after superfusion with IBTX (100 nmol/L), or the BKCa activator
NS1619 (1,3 dihydro-1-[2-hydroxy-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-2Hbenzimidazol-2-one) (Sigma) (10 μmol/L) in cells from control and CH rats. Additional
measurements were taken in a group of control cells after treatment with 100 µmol/L
MBCD.
Effect of Cholesterol Repletion on Endothelial Cell BKCa Currents. Whole cell currents
were first measured in cells from control rats in perforated patch clamp mode following
incubation with vehicle. Following the initial recording, cells were superfused with
MBCD for 15 minutes before voltage steps were applied and currents recorded, whereas
cells from CH animals remained in vehicle conditions for 15 minutes. A mixture of
MBCD and cholesterol (MBCD + ChL 8:1) shown to replete membrane cholesterol and
restore caveolar function (Levitan et al., 2000;Romanenko et al., 2004) was then
administered to each group and transmembrane currents were re-examined.
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Effect of AP-CAV on Whole Cell Currents. Currents were assessed using conventional
whole cell patch clamp mode in aortic ECs from control and CH rats. One group of
control cells was also treated with MBCD as above. Measurements were first made
following cellular rupture in vehicle conditions. Next, AP-CAV or the scrambled control
peptide were backfilled into patch pipettes and dialyzed into the clamped cells for 5
minutes. Voltage steps were again applied and currents recorded following dialysis of
AP-CAV or scrambled peptide.
Determination of Unitary Conductance of EC BKCa Channels. Unitary conductance was
determined in symmetrical K+ in inside-out patches of aortic ECs from CH animals and
control ECs pre-treated with MBCD. Assessments were also made in whole cell-cell
attached mode to determine conductance in asymmetrical K+ relevant to the in situ
environment.
Determination of EC BKCa Channel Calcium and Voltage Sensitivity. Inside-out patches
from CH rats were held at varying test potentials and intracellular calcium levels to
investigate channel opening probability (NPo). Parallel experiments were performed on
freshly isolated VSM to compare calcium sensitivity of BKCa channels between the two
cell types.
Sensitivity of EC BKCa Channels to Iberiotoxin (IBTX). Inside-out patches from CH aortic
ECs were held at varying test potentials in 1µmol/L free Ca2+_ solution. NPo was assessed
in the presence or absence of intrapipette IBTX.
Myogenic Responses. Experiments were performed on cannulated, pressurized gracilis
arterioles.

Active and passive (Ca2+-free) pressure–diameter relationships were
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determined, as described previously (Hughes et al., 2010m;Earley & Walker, 2002) over
intraluminal pressure steps between 20 and 160 mmHg. Vessel inner diameter was
monitored using video microscopy and edge-detection software (IonOptix Sarclen). VSM
was selectively loaded with the ratiometric calcium indicator fura 2-AM and [Ca2+]i
monitored as previously described (Earley & Walker, 2002;Earley et al., 2002).
Endothelial integrity was assessed by dilation with 10 µmol/L acetylcholine (ACh) prior
to Ca2+-free superfusion. Pressure-induced vasoconstrictor and calcium responses were
determined in the presence of AP-CAV or scrambled control peptide (Scrambled). APCAV or Scrambled were administered intraluminally in an effort to specifically target the
endothelium.
Vasoconstrictive Reactivity to Phenylephrine (PE). Arteriole inner diameter and VSM
[Ca2+]i were assessed in response to increasing PE concentrations (10-9 µmol/L to 10-5
µmol/L) in the presence of intraluminal AP-CAV or scrambled control peptide. Reversal
of constriction with 10 µM ACh at the termination of the PE concentration-response
curve was used to verify endothelial integrity.
Calculations and Statistics. Data are expressed as means ± SE. Values of n refer to the
number of animals in each group except for patch clamp studies where n represents the
number of cells studied. Data were analyzed by repeated measures analysis of variance
(RMANOVA) and by a Bonferroni modified unpaired Student's t-test for multiple
comparisons when differences were indicated. Unpaired t-tests were used for single
comparisons between groups. P < 0.05 was accepted as indicating a statistically
significant difference.
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RESULTS
Effect of CH or Cholesterol Depletion on Basal Endothelial Em. Consistent with our
earlier report (Hughes et al., 2010l), endothelial cell Em was hyperpolarized in gracilis
arteries from CH rats compared to controls (Figure 1A). Mild cholesterol depletion with
100 µmol/L MBCD elicited a similar degree of hyperpolarization (Figure 1A). As
observed earlier (Sandow et al., 2002;Hughes et al., 2010k), resting Em was more
depolarized in these arteries than in some other beds, likely due to the lack of
myoendothelial gap junctions (Sandow et al., 2002). We have observed significantly
more polarized Em in other beds using techniques identical to those used in the present
study (Paffett et al., 2007).
Iberiotoxin (IBTX) Sensitivity of Em. IBTX significantly depolarized membrane potential
to baseline vehicle treated control level in EC cells from CH rats and in MBCD treated
arteries, but was without effect in controls (Figure 1B). These results support the
hypothesis that BKCa channel activity causes endothelial hyperpolarization following
MBCD and CH treatments.
Effect of Caveolin-1 Scaffolding Domain Peptide on Basal Endothelial Em.

The Cav-1

scaffolding domain peptide AP-CAV had no effect on endothelial Em in arteries from
control rats compared to arteries receiving the scrambled peptide (Figure 1C).

In

contrast, AP-CAV depolarized the endothelium of CH arteries and arteries treated with
MBCD to control (scrambled) levels (Figure 1C).
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These results suggest that the

depolarizing influences of CH and cholesterol depletion are caused by loss of an
inhibitory effect of the Cav-1 scaffolding domain on basal BKCa channel activity.
Effect of CH or Cholesterol Depletion on Endothelial Cell Transmembrane Currents.
Whole cell outward currents were greater in ECs from CH rats and MBCD treated cells
compared to untreated controls at each test potential from -50 mV to +150 mV (Figure
1D). Cholesterol depletion and CH resulted in similar outward currents that were not
different (Figure 1D/E).
Measurement of EC BKCa Unitary Conductance and Channel Sensitivity to Voltage and
Ca2+. EC BKCa unitary conductance in patches from CH rats (Figure 2A) was 221 ± 12
pS in symmetrical K+. Conductance measured in asymmetrical K+ in cell attached whole
cell mode was 145 ±9 pS. Unitary conductances did not vary between cells from CH rats
and control cells treated with MBCD (Figure 2A).

EC BKCa channels displayed

enhanced calcium sensitivity compared to VSM channels (Figure 2B) consistent with our
evidence for tonic activity of these channels at basal [Ca2+]i in EC from CH rats. EC
channels assessed from CH cells also displayed voltage sensitivity (Figure 2C).
Effect of BKCa Channel Inhibition and Activation on Endothelial Cell Transmembrane
Currents. IBTX significantly reduced whole cell currents from CH ECs (at test potentials
from -50 to +150 mV; Figure 3B and D), but had no effect in controls (Figure 3A and D)
as previously described in conventional whole cell studies with much higher [Ca2+]i
(Hughes et al., 2010j) than in the present perforated patch experiments. Similarly, IBTX
normalized outward current in cholesterol depleted cells to levels of controls (at test
potentials from -40 to +150 mV; Figure 3C and D), demonstrating active BKCa channels
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following caveolar disruption with MBCD. Consistent with these whole cell
measurements, IBTX applied via the pipette to inside-out patches effectively inhibited
channel opening (Figure 3E).
The BKCa activator NS1619 had no effect in cells from control rats (Figure 4A
and D), but further increased outward currents in CH cells at test potentials between -40
and +150 mV (Figure 4B and D).

NS1619 also effectively enhanced current in

cholesterol depleted cells (from -30 to +150 mV) (Figure 4C and D).
Effect of Cholesterol Repletion on Whole Cell Currents. Administration of MBCD-ChL
to restore Cav-1 function significantly reduced outward currents in cells from CH rats
(Figure 5B and D) and cells treated with MBCD (Figure 5B and D), but had no effect in
controls (Figure 5A and D). These results demonstrate the dynamic regulation of EC
BKCa by cellular cholesterol and presumably Cav-1.
Effect of AP-CAV on Whole Cell Currents. AP-CAV potently inhibited BKCa-dependent
current in ECs from CH rats (Figure 6B and D) and MBCD treated ECs from control rats
(Figure 6C and D), demonstrating an inhibitory effect of the Cav-1 scaffolding domain on
channel activity in these settings. AP-CAV treatment had no effect on current in
untreated controls (Figure 6A and D). Currents observed with the scrambled peptide did
not differ from vehicle in any of the groups (data not shown).
Co-localization of Cav-1 and BKCa α Subunit in Gracilis Arterioles. Staining for BKCa α
(Alamone, 1:100, shown in green) was positive in VSM and ECs (Figures 7A) in both
control and CH groups. Cav-1 (BD Transduction 1:50, shown in red) was also found in
VSM and EC (Figure 7A) in control and CH groups. However, overlap of Cav-1 and
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BKCaα was significantly less in arteries from CH rats compared to controls as assessed by
Manders correlation coefficient (Figure 7B).
Effect of AP-CAV on Myogenic- and PE-induced Tone in Gracilis Arteries from Control
and CH Rats. In gracilis arteries receiving scrambled peptide, myogenic-induced tone
and VSM [Ca2+]i responses were less in arteries from CH rats compared to controls
(Figure 8A/B) consistent with earlier reports from untreated vessels (Hughes et al.,
2010i). Luminal application of AP-CAV to target and inhibit EC BKCa restored myogenic
tone and VSM [Ca2+]i in CH arteries similar to luminal IBTX or endothelial disruption
in earlier studies (Earley & Walker, 2002;Earley et al., 2002;Hughes et al., 2010h), but
was without effect in controls. AP-CAV similarly restored PE-induced vasoconstrictor
and [Ca2+]i responses in arteries from CH rats to levels of scrambled controls without
affecting arteries from normoxic rats (Figure 8 C/D).

DISCUSSION
The major findings of the present study are 1) CH or cholesterol depletion removes
Cav-1 inhibition of BKCa channels leading to persistent channel activity and
hyperpolarization of ECs; 2) cholesterol repletion or introduction of the scaffolding
domain of Cav-1 potently inhibits EC BKCa activity and normalizes outward K+ currents
to levels of controls; 3) unitary conductance of EC BKCa channels are similar to those
seen in VSM, but exhibit greater Ca2+ sensitivity; 4) co-localization of endothelial BKCa
and Cav-1 is reduced following CH exposure; and 5) diminished myogenic and agonist
induced tone following CH exposure can be restored by endothelial introduction of the
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scaffolding domain of Cav-1. These results provide evidence for a novel mode of
vascular control elicited by CH involving loss of an inhibitory effect of Cav-1 on EC
BKCa channels.
Consistent with an earlier report (Hughes et al., 2010g), we observed EC
hyperpolarization in arteries from CH rats compared to controls. Interestingly, mild
cholesterol depletion with MBCD elicited a similar degree of hyperpolarization in control
arteries. Neither treatment results in discernable alteration in gross structure or number
of endothelial caveolae (Hughes et al., 2010f), suggesting that modest interference of
Cav-1 function or impaired cholesterol homeostasis have functional consequences on EC
membrane potential. Hyperpolarization of the endothelium can lead to hyperpolarization
of the underlying VSM through several postulated mechanisms to promote vasodilation.
VSM hyperpolarization can occur by conduction of charge through low resistance
myoendothelial gap junctions (Griffith, 2004), however the femoral circulation does not
appear to have these structures (Sandow et al., 2002). This is evident from the relatively
depolarized EC Em that we and others observe in this bed that contrasts with the
mesenteric circulation that possesses direct myoendothelial communication (Sandow et
al., 2002;Hughes et al., 2010e). Another possible mechanism of VSM hyperpolarization
is through elevated extracellular [K+] due to activation of EC K+ channels that in turn
activate VSM inwardly rectifying K+ channels (Kir) and Na+/K+/ATPase (Jackson, 2005).
Regardless of the initiating event, VSM hyperpolarization results in inhibition of voltage
gated Ca2+ channels and hence dilation. Persistent hyperpolarization of the vascular wall
as seen with CH (Hughes et al., 2010d;Earley & Walker, 2002;Earley et al., 2002)
opposes vasoconstriction and thus dampens vasoconstrictor reactivity.
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Interestingly, EC hyperpolarization following CH or MBCD treatment appears to be
due to tonic activity of EC BKCa channels not seen in controls. We have previously
shown that this basal hyperpolarization leads to more profound hyperpolarization
responses to agonists like acetylcholine (ACh), thereby amplifying endotheliumdependent vasodilation (Hughes et al., 2010c). However, BKCa channels in VSM require
high local [Ca2+] from sparks to elicit activity (Jaggar et al., 2000), which led us to
hypothesize that EC channels may exhibit enhanced Ca2+ sensitivity.

Previous

experiments from our laboratory examined IBTX sensitive currents in conventional
whole cell configuration with intracellular Ca2+ levels maintained at 1 µmol/L (Hughes et
al., 2010b). This [Ca2+] maximally activates the channel and thus provides little insight
into channel activity at endogenous [Ca2+]i . In the present study, we employed perforated
patch clamp configuration to maintain more physiological [Ca2+]i and still observed BKCa
currents in cells from CH rats and cells treated with MBCD.

Although EC BKCa

channels exhibited unitary conductances consistent with those from VSM, the Ca2+
sensitivity of EC channels was enhanced as evidenced by significantly greater channel
opening at 10 and 100 nmol/L [Ca2+] than seen in VSM patches. Thus, within the
endothelium, basal Ca2+ levels seem sufficient to maintain BKCa channel activity. This
enhanced Ca2+ sensitivity does not appear to be related to activity of the β1 accessory
subunit of the BKCa channel, since the β1 activator tamoxifen (Dick et al., 2001) inhibited
rather than enhanced outward current in EC from CH rats, whereas tamoxifen predictably
stimulated current in VSM (data not shown).
Previous studies on cultured ECs suggest that the scaffolding domain of Cav-1
exerts an inhibitory effect on BKCa channels that can be eliminated by cholesterol
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depletion (Wang et al., 2005). Our data support this inhibitory role of Cav-1 and for the
first time demonstrate that an in vivo stimulus can tonically activate endothelial BKCa by
affecting this mode of regulation. In addition, consistent with cultured cell studies,
cholesterol depletion with MBCD unmasked BKCa currents in ECs from control animals.
The presence of BKCa in EC from both control and CH rats was confirmed by
immunofluorescence (Figure 7), however the apparent association between channels and
Cav-1 was less in arteries from CH rats compared to controls as assessed by pixel overlap
analysis. The importance of the scaffolding domain of Cav-1 in regulating BKCa channel
activity was demonstrated by the effectiveness of AP-CAV to inhibit BKCa currents in
cells from CH rats and cholesterol-depleted control ECs and it effect to reverse EC
hyperpolarization in intact arteries from these groups. Importantly, both myogenic and
PE-induced vasoconstrictor responsiveness were also restored by luminal AP-CAV
without affecting control arteries, in a pattern identical to the effects of intraluminal
IBTX or endothelial disruption (Earley & Walker, 2002;Earley et al., 2002;Hughes et al.,
2010a). VSM calcium responses to both pressure and PE were also restored by AP-CAV
consistent with earlier studies documenting a similar effect of endothelial removal
(Earley & Walker, 2002;Earley et al., 2002) and consistent with reversal of VSM
hyperpolarization and restoration of calcium influx through voltage-gated calcium
channels. These results clearly demonstrate the central role of altered EC Cav-1 function
in altered vascular control following CH; however these alterations could reflect
differences in cholesterol homeostasis between groups rather than demonstrable
differences in Cav-1 expression or number of EC caveolae.
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In the present studies, cholesterol supplementation inhibited BKCa currents both in
cells from CH rats and MBCD treated ECs, suggesting a key role of cholesterol in
channel regulation. Cholesterol directly binds to Cav-1 both in vitro (Murata et al., 1995)
and in vivo (Thiele et al., 2000). Cav-1 localization at the plasma membrane is closely
associated with the presence of free cholesterol (Pol et al., 2005), where decreases in
cellular cholesterol levels significantly reduce Cav-1 transport and membrane association.
Interestingly, CH exposure reduces de novo cholesterol synthesis by inhibiting HMGCoA-reductase activity in cultured cells (Nguyen et al., 2007). HMG-CoA-reductase is
the rate limiting enzyme in de novo synthesized cellular cholesterol, thus CH exposure
could limit cholesterol production in the present model. It is noteworthy that cultured rat
aortic ECs exposed to hypoxia demonstrate reduced cellular cholesterol and cholesterol
esters (Arai et al., 1996). In addition, inhibition of de novo cholesterol with cerivastatin
enhances EC BKCa activity and results in significant membrane hyperpolarization in
human umbilical vein ECs (Kuhlmann et al., 2004b). These actions of the HMG-CoAreductase inhibitor on EC BKCa activity were rapidly reversed by the addition of
mevalonate, suggesting that endothelial BKCa channel activity is regulated by this agent
and other non-steriodal isoprenoids (Kuhlmann et al., 2004a).

Isoprenoids such as

geranyl pyrophosphate and farnesyl pyrophosphate are required for membrane insertion,
caveolar targeting and localization of multiple proteins (Gelosa et al., 2007). Thus,
changes in EC free cholesterol following hypoxemia could possibly underlie the changes
in vascular function seen in the CH model and have functional implication to other
pathologies associated with altered EC cholesterol homeostasis.
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In conclusion, the present experiments describe a novel mode of regulation of
vascular tone associated with Cav-1 regulation of EC BKCa channels. Although these
studies center on a model of hypoxemic disorders, i.e. CH, the establishment of the
central role of cholesterol in regulating this pathway suggests that these observations may
be relevant in a variety of pathophysiological and therapeutic settings.
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with MBCD (M); Panel B: effect of IBTX to reverse hyperpolarization in CH and
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Figure 7. Co-localization of BKα (green) and caveolin-1 (red) in the endothelium (EC)
and vascular smooth muscle (VSM) of gracilis resistance arterioles from control (C) and
CH rats (Panel A).

Nuclei are stained white in all sections. Overlap of BKα and

caveolin-1 was significantly less in CH ECs compared to control as determined by
Manders correlation coefficient (Panel B).
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Figure 8. AP-CAV restores vasoconstrictor reactivity in arteries from CH rats to levels
of scrambled controls.

Panels A and B show the pressure-induced (myogenic)

constrictor responses in arteries treated with AP-CAV or scrambled peptide and the
parallel smooth muscle [Ca2+]i responses.
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phenylephrine (PE). * p < 0.05 vs. control scrambled. Starting vessel diameters were
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experimental groups.
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SUPPLEMENT: Role of Caveolin-1 in Endothelial BKCa Regulation of
Vasoreactivity
Supplemental Methods:
Culture of rat aortic endothelial cells: Frozen rat aortic endothelial cells (Cell
Appllications) were thawed and seeded as directed by the manufacturer. Cells were
grown on attachment factor coated plates in rat endothelial cell growth medium (Cell
Applications) at 37°C at 5% CO2 in a humidified incubator to confluency for western blot
and co-immunoprecipitation experiments.
Western blot of cultured rat aortic endothelial cells: ECs passages 6-7 were washed
twice in PBS then lysed in radio-immunoprecipitation assay buffer (RIPA) (Thermo
Scientific) containing protease and phosphatase inhibitors (Thermo Scientific). Lysates
were collected, centrifuged at 10,000 x g at 4°C for 5 minutes, and analyzed for protein
content (Thermo - Scientific Pierce BCA Protein kit). Cell lysates (10 μg) were separated
in 10% sodium dodecyl sulfate polyacrylamide gels by electrophoresis and transferred to
a nitrocellulose membrane. Blots were blocked in odyssey blocking buffer (LI-COR) 1 h
at room temperature then incubated with primary antibodies for Cav-1 (1:500) or BKCa
(1:250) in 0.01% Tween PBS overnight at 4°C (BKCa: Alamone, Cav-1: Santa Cruz).
After washing (3× 10 min in 0.01% Tween PBS), blots were incubated 1 h at room
temperature with dye conjugated secondary antibodies (LI-COR). Images were collected
on an infrared imaging system (LI-COR).
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Co-immunoprecipitation of BKCa and Cav-1 in rat aortic endothelial cells: Rat aortic
endothelial cells (RAECs) passages 6-7 were collected and lysed as described above. Coimmunoprecipitation (co-IP) was completed using Thermo Scientific Pierce co-IP kit as
directed by the manufacturer. Briefly, the BKCa or Cav-1 antibodies were immobilized to
the AminoLink Plus coupling resin or to control non-amine reactive resin for 4 hours at
4°C. Columns containing either the antibody linked resins or control non-amine reactive
resins were washed and incubated overnight at 4°C with arterial lysates. The next day
columns were washed and protein eluted using the kit’s provided elution buffer. Using
the Thermo Scientific Pierce Micro BCA Protein Assay kit, washes were tested for
protein content to verify successful washing before elution. Eluted samples were
analyzed by Western blotting using antibodies for BKCa or Cav-1 with infrared dyeconjugated secondary antibodies (LI-COR).
Supplemental Results
Western Blot detection of BKCa in cultured rat aortic ECs. Western blot experiments
(Figure 1A) demonstrate the presence of BKCa channels and Cav-1 (Figure 1B) in
cutltured rat aortic endothelial cells, supporting our findings in native tissue.
Co-Immunoprecipitation of BKCa and Cav-1 in cultured rat aortic ECs.

A BKCa

antibody was able to co-immunoprecipitate BKCa and Cav-1 and a Cav-1 antibody was
able to co-immunoprecipitate Cav-1 and BKCa (Figure 1C). These results support our
previous findings in native tissues with Cav-1 and BKCa association through
immunofluorescence.
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Supplemental Figure 1. Western blots for BKCa and Cav-1 in cultured rat aortic
endothelial cells. Blots probed for BKCa displayed a single band around 120 kD (Panel
A). Blots probed for Cav-1 had dense staining at 22kD (Panel B). CoImmunoprecipitation experiments for BKCa and Cav-1. BKCa co-immunoprecipitated
with Cav-1 and BKCa (Panel C) Cav-1 co-immunoprecipitated with BKCa (Panel C).
174

Addendum Chapter 3
Chapter 3 Addendum Methods:
Immunofluorescence in gracilis arterioles: Gracilis arteries from control and CH rats
were collected following transcardial perfusion with PSS containing 10 mg papaverin.
The gracilis muscle was removed and frozen in OCT compound in liquid N2 and
isopentane. 10 µm sections were adhered to superfrost slides (Fisher) and fixed in ice
cold methanol (100%) for 10 min. After fixation sections were blocked in 4% donkey
serum in PBS for 1 hr at room temperature. Sections were incubated with primary
antibodies for Cav-1 (BD Biosciences 1:50). Primary antibodies for Cav-1 was detected
with a Cy3-conjugated donkey, anti-mouse secondary antibody (1:500 dilution; Jackson
Labs). The nuclear stain, Sytox (1:10,000 dilution; Molecular Probes) was then applied.
Confocal microscope images were obtained using a 63x oil immersion DIC objective
(NA =1.4). The individual channel (Cy3 for Cav-1) was thresholded and then made into a
mask. A second mask was then created by tracing the endothelial cells within the lumen
of arteriolar cross sections. Only Cav-1 staining within the EC mask was used for study.
Relative fluorescence for Cav-1 in CH and control animals was determined and
normalized to fluorescent standards for Cy3.
Immunofluorescence in RAECs: RAECs passages 4-6 were grown to confluency on
attachment factor coated glass bottom dishes for imaging. Cells were fixed in 4%
paraformaldehyde PBS for 10 min, permeabilized in 0.01% Triton-X PBS, and blocked
in 4% donkey serum in PBS for 1 hr at room temperature. Cells were then incubated with
primary antibodies for BKCa α (Alamone 1:100). Primary antibodies for BKCa α were
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detected with Cy5-conjugated donkey, anti-rabbit secondary antibodies (secondary 1:500
dilution; Jackson Labs).
Patch Clamp Studies on Isolated Endothelial Cells: Endothelial cells were dispersed for
electrophysiological study from control and CH rat aortae as previously described (16).
One to two drops of the resulting cell suspension were seeded on a glass cover slip
mounted on an inverted fluorescence microscope (Olympus IX71) for 30 min prior to
superfusion.

Single endothelial cells were identified by the selective uptake of the

fluorescently labeled acylated low density lipoprotein Ac-LDL-Dil with a rhodamine
filter (29) prior to each electrophysiological experiment. Freshly dispersed endothelial
cells were superfused under constant flow (2 ml/min) at room temperature (22-23°C) in
an extracellular solution (ECS: 141 mmol/l NaCl, 4.0 mM KCl, 1 mmol/l MgCl2, 1
mmol/l CaCl2, 10 mmol/l HEPES, 10 mmol/l glucose and buffered to pH 7.4 with
NaOH).

Whole cell current data were generated using an Axopatch 200B amplifier

(Axon Instruments). In conventional whole cell patch clamp configuration, biophysical
criteria: (Seal resistance > 1GΩ, series resistance <25MΩ) was checked following
membrane rupture and monitored throughout the course of the experiment. Cells were
held at -60mV and were dialyzed for 5 min with an intracellular solution (ICS: 140
mmol/l KCl, 0.5 mmol/l MgCl2, 5 mmol/l Mg2ATP, 10 mmol/l HEPES, 1 mmol/l EGTA
and adjusted to pH 7.2 with KOH). CaCl2 was added to yield a free-Ca2+ concentration of
1 μM, as calculated using WinMAXC chelator software.
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Experimental Protocols:
Effect of Cholesterol Saturation of AP-CAV on Endothelial Cell BKCa Currents. AP-CAV
(10µM) or scrambled was mixed into MBCD + Cholesterol (MBCD + ChL 8:1) and
administered via patch pipette to control ECs. In whole cell patch clamp mode, currents
were measured. Following dialyzation with AP-CAV or scrambled (MBCD + ChL),
voltage steps were applied and currents were recorded. Cells were then superfused with
MBCD for 15 minutes; voltage steps were applied and currents were then recorded and
compared to the dialyzed cells in vehicle.
Results:
Relative Expression of Cav-1 in Gracilis Arteriole Cross Sections: Relative expression of
EC Cav-1 was determined to not be different amongst control and CH animals within
gracilis arterioles (Chapter 3 Addendum Figure 1). These results suggest there is no
apparent change in Cav-1 expression following CH.
Immunolocalization of BKCa in RAECs: RAECs passages 4-6 stained positive for BKCa
(Chapter 3 Addendum Figure 2). These results support our immunolocalization studies
previously conducted in native ECs from rat aorta (Hughes et al., 2010) and gracilis
(Figure 7). These results are also in accordance with western blot studies conducted in
these same cells (Supplement Figure 1).
Effect of Cholesterol Supplementation of AP-CAV on Endothelial Cell BKCa Currents: To
further demonstrate that the effects of AP-CAV were independent of effects of
cholesterol, control cells were subjected to AP-CAV/ MBCD + ChL intracellular
solutions and treated with MBCD. AP-CAV / MBCD + ChL inhibited MBCD elicited
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outward currents (Chapter 3 Addendum Figure 3), while treatment with scrambled /
MBCD + ChL did not. Treatment with MBCD did not release AP-CAV/ MBCD + ChL
inhibition, however in scrambled/ MBCD + ChL currents did increase following
cholesterol depletion. Thus, AP-CAV and the actions of Cav-1 through its’ scaffolding
domain can inhibit EC BKCa independently of cholesterol.
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Addendum Chapter 4 Figure 1: Gracilis arteriole cross sections from control and CH
rats did not demonstrate changes in relative Cav-1 fluorescence. n = 12 images from 4
animals in each group.
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Addendum Chapter 4 Figure 2: RAECs stained positive for BKCa α (pseudo-colored
green) (1:100 Alamone).
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Addendum Chapter 4 Figure 3: Outward currents from freshly isolated ECs dialyzed
with scrambled / MBCD + ChL following cholesterol depletion with MBCD (100µM)
were increased. In contrast, AP-CAV/ MBCD + ChL treated cells did not demonstrate
increases to MBCD. Scrambled + MBCD/ChL vehicle is shown following MBCD
treatments for comparison of scrambled / MBCD + ChL treatments. (n=4).
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CHAPTER 5: Regulation of Endothelial BKCa Channels by Heme
Oxygenase-Derived Carbon Monoxide and Caveolin-1
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ABSTRACT

A novel vasodilatory influence of endothelial cell (EC) large conductance calcium
activated potassium channels (BK) is present following in vivo exposure to chronic
hypoxia (CH) and may exist in other pathological states. However, the mechanism of
channel activation that results in altered vasoreactivity is unknown.

Previously we

demonstrated that inhibition of either BK channels or heme oxygenase (HO) restores
vasoconstrictor reactivity following CH. Additionally, administration of the scaffolding
domain of caveolin-1 (cav-1) inhibits EC BK activity and restores vasoconstrictor
reactivity in this setting. These results led us to hypothesize that CH exposure results in a
loss in cav-1 inhibition of EC BK channels, resulting in their activation by HO-derived
carbon monoxide (CO). Experiments were conducted on freshly dispersed rat aortic ECs
from control and CH (PB = 380 mmHg for 48 hr) exposed rats and on cultured rat aortic
endothelial cells (RAECs). In electrophysiology experiments, outward currents were
greater in cells from CH rats as well as from cells from control rats and cultured cells
treated with the cholesterol depleting agent methyl-β-cyclodextrin (MBCD).

These

enhanced currents were reduced to control by HO inhibition. Channel activity could be
restored by the CO donor CORM-2 during HO inhibition.

Administration of the

scaffolding domain eliminated BK currents in cells from CH rats and current was not
restored by addition of CORM-2. Co-localization experiments in freshly dispersed ECs
from control and CH rats demonstrated association between HO-2, Cav-1 and BK.
Additionally, co-immunoprecipitation experiments in RAECs corroborated the presence
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of HO-2/BK complexes associated with cav-1. We conclude that CH unmasks EC HOdependent BK activity by removal of an inhibitory action of cav-1 on the channel.

Key words: electrophysiology, methyl-β cyclodextrin, scaffolding domain
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INTRODUCTION
Chronic hypoxia (CH) results from pathological conditions or prolonged residence at
high altitude that impair oxygenation. Patients with hypoxemia resulting from obstructive
lung diseases have lower calf vascular resistance (Casiglia et al., 1998) and blunted
reflex vasoconstriction in response to a challenge of lower body negative pressure
(Heistad et al., 1972). In experimental models of chronic hypoxemia, systemic
vasoconstrictor responsiveness is attenuated following prolonged exposure to both
normobaric or hypobaric hypoxia (Auer & Ward, 1998;Doyle & Walker, 1991). In
addition, CH reduces total peripheral resistance responses to vasoconstrictor agonists
(Doyle & Walker, 1991) and diminishes vasoconstrictor reactivity within several
systemic vascular beds (Caudill et al., 1998;Jernigan et al., 2001;O'Donaughy & Walker,
2000). Upon return to normoxic conditions the blunted vasoconstrictor reactivity persists
(Doyle & Walker, 1991) and remains for up to 96 hours (Jernigan et al., 2001). This
response is associated with vascular smooth muscle (VSM) and endothelial cell (EC)
membrane potential hyperpolarization that involves activation of endothelial large
conductance calcium-activated K+ channels (BK) (Earley et al., 2000;Hughes JM et al.,
2010;Naik & Walker, 2003).

Consistent with these observations, removal of the

endothelium restores agonist-induced and myogenic vasoconstrictor reactivity within the
mesenteric and gracilis circulations following CH (Earley et al., 2002;Earley & Walker,
2002;Hughes JM et al., 2010).
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Activity of endothelial BK channels is inhibited by the scaffolding domain of
caveolin-1 (cav-1) (Hughes JM et al., 2010;Wang et al., 2005) ( Riddle et. al., 2011) and
may be enhanced by a variety of endothelial vasoactive substances. Indeed, nitric oxide
(NO),

carbon

monoxide

(CO),

and

the

cytochrome

P450

product

11,12

epoxyeicosatrienoic acid (EET) all activate BK channels (Baron et al., 1997;Bolotina et
al., 1994;Burnette & White, 2006;Dong et al., 2007;Jackson, 2005;Xi et al., 2004).
Previous work from our laboratory has demonstrated a role of heme oxygenase (HO)
(Gonzales & Walker, 2002) as a hyperpolarizing influence following CH that diminishes
agonist-induced vasoconstrictor reactivity (Gonzales & Walker, 2002). Additionally, HO
inhibition or administration of the BK channel blocker iberiotoxin similarly restores
VSM membrane potential (Hughes JM et al., 2010;Naik & Walker, 2003) in arteries from
CH rats. There is also evidence in other cell types of association between HO and BK
channels (Kooli et al., 2008;Williams et al., 2004;Yi et al., 2010) and the HO product CO
activates

VSM BK channels (Jaggar et al., 2002;Wang et al., 1997;Wang et al.,

1997;Wang, 1998;Wang & Wu, 1997). Since EC BK channels appear to be tonically
active following CH, we hypothesized that HO-derived CO serves as an endogenous
stimulus under conditions in which cav-1 inhibition of the channel is impaired. This
novel mode of endothelium-dependent vascular regulation would explain the HO- and
BK-dependency of diminished vasoconstrictor reactivity in this setting.
METHODS
Animals: Experiments were performed on male Sprague-Dawley rats (Harlan). All
procedures were approved by the Institutional Animals Care and Use Committee of the
University of New Mexico Health Sciences Center.
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Hypoxic Exposure: CH rats were exposed to hypobaric hypoxia at a barometric pressure
of 380 mmHg for 48 hours. Normoxic control rats were housed in identical cages at
ambient pressure (~630 mmHg).
Isolation of Endothelial Cells: Freshly dispersed aortic endothelial cells (ECs) were
used for patch clamp and immunofluorescence imaging experiments. The aorta was
chosen as the source of cells based on earlier results showing parallel endotheliumdependent attenuation of vasoconstrictor reactivity following CH in aortic rings and
resistance vessels that is similarly reversed by heme oxygenase (HO) inhibition (Caudill
et al., 1998;Gonzales & Walker, 2002).

Further, cells from the aorta and gracilis

resistance arteries demonstrate identical effects of CH to unmask functional BK channels
(Hughes JM et al., 2010). Aortae were removed and placed in ice-cold HEPES buffered
physiological saline solution (HBSS): mmol/l 150 NaCl, 6 mmol/l KCl, 1 mmol/l MgCl2,
1.5 mmol/l CaCl2, 10 mmol/l HEPES, and 10 mmol/l glucose and adjusted to pH 7.4 with
NaOH. Thoracic aortae were cut longitudinally and subsequently incubated for 2 hours
in basal endothelial growth medium with 4% bovine serum albumin and 10 μg/ml of the
endothelial

specific

probe,

1,1’-dioctadecyl-3,3,3’,3’-tetramethyl-indocarbocyanine

percholorate (Ac-LDL-Dil) at 37°C. Immediately following the endothelial labeling
procedure previously described (Hogg et al., 2002;Hughes JM et al., 2010;Paffett et al.,
2007) aortae were cut into 2 mm strips and exposed to mild digestion solution containing
0.2 mg/ml dithiothreitol and 0.2 mg/ml papain in HBSS for 45 min at 37°C.

Vessel

strips were removed from the digestion solution and placed in 1 ml of HBSS containing 2
mg/ml BSA. Single endothelial cells were released by gentle trituration with a small bore
Pasteur pipette and were stored at 4°C between experiments for up 5 hrs. One to two
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drops of the cell suspension were seeded on a glass coverslip mounted on an inverted
fluorescence microscope (Olympus IX71) for 30 min prior to superfusion.

Single

endothelial cells were identified by the selective uptake of the fluorescently labeled
acylated low density lipoprotein Ac-LDL-Dil with a rhodamine filter prior to each
electrophysiological experiment.
Culture of Rat Aortic Endothelial Cells (RAECs): Due to limitations in the number of
freshly dispersed cells attainable from the aortae, western blot co-immunoprecipitation
studies were performed on commercially available cutured RAECs (Cell Appllications).
Cells were seeded on plates coated with attachment factor solution and grown in rat
endothelial cell growth medium (Cell Applications) at 37°C at 5% CO2 in a humidified
incubator. Cells were grown to confluency on attachment factor coated plates for western
blot and co-immunoprecipitation experiments. In addition, patch clamp experiments
were performed on these cells to demonstrate functional presence of BK channels.
Patch Clamp Studies:

Freshly dispersed endothelial cells were superfused under

constant flow (2 ml/min) at room temperature (22-23°C) in an extracellular solution
(ECS: 141 mmol/l NaCl, 4.0 mM KCl, 1 mmol/l MgCl2, 1 mmol/l CaCl2, 10 mmol/l
HEPES, 10 mmol/l glucose and buffered to pH 7.4 with NaOH). Whole cell current data
were generated with an Axopatch 200B amplifier (Axon Instruments) following a 5 min
dialysis period using 4-6 MΩ patch electrodes filled with an intracellular solution (ICS:
140 mmol/l KCl, 0.5 mmol/l MgCl2, 5 mmol/l Mg2ATP, 10 mmol/l HEPES, 1 mmol/l
EGTA and adjusted to pH 7.2 with KOH].

CaCl2 added to yield a free-Ca2+

concentration of 1 μM, as calculated using WinMAXC chelator software. Whole cell
currents were measured in response to voltage steps applied from -60 mV to +150 mV
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in 10 mV increments from a holding potential of -60 mV. For experiments utilizing
conventional whole cell patch clamp configuration, biophysical criteria: (Seal resistance
> 1GΩ, series resistance <25MΩ) was checked following membrane rupture and
monitored throughout the course of the experiment.
Cultured RAECs were grown to confluency before trypsinizing and plating on
glass bottom dishes for study. Cultured cells were tested for the ability to uptake AcLDL-Dil for endothelial verification prior to experimentation.
Protocols:
Role of HO-Derived CO in EC BK Activity: Experiments were performed on freshly
dispersed ECs from control and CH rats. Whole cell macroscopic currents were recorded
before and after superfusion with the HO inhibitors zinc protoporphryin (ZnPPIX; 500
nM) or chromium mesoporphyrin

(CrMP; 100 µM).

Additional experiments were

conducted testing the effect of the HO substrate hemin (100 µM) on transmembrane
currents as well as the effect of the CO donor CORM-2 (100 µM). The presence of BK
currents was confirmed in some studies by use of the specific inhibitor iberiotoxin
(IBTX; 100 nM) or the BK activator NS-1619 (100 µM).
Another series of experiments were performed in whole cell mode on RAECs to
confirm the existence of BK currents. Macroscopic currents were observed with vehicle
treatment and in the presence of CrMP or CrMP plus IBTX.
Role of Caveolin-1 and Cholesterol in EC BK Activity: Experiments were performed on
freshly dispersed cells from control and CH rats. Cells from control animals were
superfused with the cholesterol depleting agent methyl-β-cyclodextrin (MBCD; 100 µM)
to disrupt cav-1 microdomains and unmask BK currents as we have previously reported
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(Hughes JM et. al., 2010; Riddle et. al., 2011). Following this treatment, cells were
superfused with ZnPPIX to assess the role of HO on channel activity. Cells from CH rats
were first dialyzed with the cell permeant cav-1 scaffolding domain peptide (AP-CAV;
10 mM) to inhibit channel activity as previously reported (Riddle et. al., 2011) and then
superfused with the CO donor CORM-2 as above to test if exogenous CO restores
current.
Immunofluorescence of Isolated Endothelial Cells: Endothelial cells were freshly
dispersed from the aorta (see detailed methods above) and used for immunofluorescent
detection of BK α, HO-1, HO-2, and cav-1. One to two drops of the cell suspension were
seeded on a glass coverslip for 30 min prior to fixation in 4% formaldehyde PBS at room
temperature for 15 min. After fixation cells were permeabilized in 0.01% Triton-X PBS
for 10 min and blocked in 4% donkey serum in PBS for 1 hr. Cells were incubated with
primary antibodies for HO-1 (Stressgen) or HO-2 (Stressgen), and cav-1 (BD
Biosciences) for association of HO and cav-1. Other sections were treated with primary
antibodies for BKα, (Alamone) and HO-1 or HO-2. All primary antibodies were detected
with secondary antibodies conjugated to fluorescent dyes. Isolated cells were visualized
with a confocal laser microscopy (LSM 510 Zeiss; 63x oil immersion lens). Colocalization of HO-1 and BK or HO-2 and BK was analyzed by calculating the Manders
correlation coefficient. Co-localization (pixel overlap between channels) was defined by
Manders correlation coefficient values (Manders et al., 1992) ranging from 0 to 1, with
values close to 0 indicating non-overlapping images and values close to 1 reflecting colocalization. Similar analysis was performed to assess the association of cav-1 with HO1 and HO-.2.
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Western blot of cultured rat aortic endothelial cells: ECs passages 6-7 were washed
twice in PBS then lysed in radio-immunoprecipitation assay buffer (RIPA) (Thermo
Scientific) containing protease and phosphatase inhibitors (Thermo Scientific). Lysates
were collected, centrifuged at 10,000 x g at 4°C for 5 minutes, and analyzed for protein
content (Thermo - Scientific Pierce BCA Protein kit). Cell lysates (10 μg) were separated
in 10% sodium dodecyl sulfate polyacrylamide gels by electrophoresis and transferred to
a nitrocellulose membrane. Blots were blocked in odyssey blocking buffer (LI-COR) 1 h
at room temperature then incubated with primary antibodies for HO-1 (1:500) or HO-2
(1:200) in 0.01% Tween PBS overnight at 4°C (HO-1: Stressgen, HO-2: Stressgen). After
washing (3× 10 min in 0.01% Tween PBS), blots were incubated 1 h at room temperature
with dye conjugated secondary antibodies (LI-COR). Images were collected on an
infrared imaging system (LI-COR).
Co-immunoprecipitation of BKCa, Cav-1, HO-1, and HO-2 in rat aortic endothelial
cells: Rat aortic endothelial cells, passages 6-7, were collected and lysed as described
above. Co-immunoprecipitation (co-IP) was completed using Thermo Scientific Pierce
co-IP kit as directed by the manufacturer. Briefly, the BK (Alamone 1:250), caveolin-1
(Santa Cruz 1:500), HO-1, or HO-2 antibodies were immobilized to the AminoLink Plus
coupling resin or to control non-amine reactive resin for 4 hours at 4°C. Columns
containing either the antibody linked resins or control non-amine reactive resins were
washed and incubated overnight at 4°C with arterial lysates. The next day columns were
washed and protein eluted using the kit’s provided elution buffer. Using the Thermo
Scientific Pierce Micro BCA Protein Assay kit, washes were tested for protein content to
verify successful washing before elution. Eluted samples were analyzed by Western
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blotting using antibodies for BK, cav-1, HO-1, or HO-2 with infrared dye-conjugated
secondary antibodies (LI-COR).

RESULTS
Role of HO-Derived CO in EC BK Activity. Endothelial transmembrane currents in cells
from CH rats were significantly larger than controls as previously reported (Hughes JM
et. al., 2010). This enhanced current in cells from CH rats has been previously shown to
be blocked by IBTX (Hughes JM et. al., 2010), as seen in the present studies (Figure 1C).
Interestingly, blockade of HO activity in ECs from CH animals also normalized currents
to controls similar to IBTX (Figure 1B and C), without effect in control cells (Figure 1A).
Inhibition of BK activity by HO blockade was reversed by the BK channel opener NS1619 (Fig. 1D/ 1E). We have previously shown that NS-1619 is without effect in control
cells (Hughes JM et. al., 2010). Thus, tonic BK channel activity is dependent upon an
HO product following CH, however functional channels are still present in these cells and
can be activated by other stimuli.
We also observed that addition of excess substrate for the HO enzyme caused
further enhancement of outward current only in cells from CH rats. Figure 2 shows this
differential effect of hemin in cells from the two groups of animals, however this
augmentation was only observed at very positive potentials and may not be relevant at
physiological membrane potentials. Nevertheless, these data suggest that HO activity
may be mildly substrate limited in this preparation and that further stimulation of HO is
associated with greater channel activity.
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Role of CO in BK Channel Activation. CO is a product of HO and has been shown to
activate VSM BK channels (Jaggar et. al., 2002). We performed experiments to test
whether administration of a CO donor could reverse the effects of HO inhibition. Figure
3A and B show the effect of CrMP to inhibit outward current and the efficacy of the CO
donor CORM-2 to reverse this effect in cells from CH rats. Although CORM-2 reversed
the effects of CrMP, it was without further effect in the absence of HO blockade in cells
from either control or CH rats (Figure 3 C-E).

These data support the hypothesis that

HO-derived CO is responsible for tonic activation of EC BK channels in cells from CH
animals.
HO-Dependence of BK Currents in Cholesterol Depleted EC.

We have previously

demonstrated that cholesterol depletion with MBCD (100 μM) unmasks BK currents in
ECs from control animals due to a loss in cav-1 inhibition of the channel (Hughes JM et.
al., 2010, Riddle et. al., 2011). Thus we hypothesized that disruption of cav-1 inhibition
of BK channels by cholesterol depletion would elicit a HO-dependent activation of the
channel similar to results observed in cells from CH animals. Consistent with this
hypothesis, MBCD treatment of control ECs elicited HO-dependent currents (Fig 4A/B).
Thus, like in CH cells, tonic BK channel activity is dependent upon HO when caveolar
domains are disrupted. These results suggest a tight coupling of HO with BK channels in
these cells within lipid-rich microdomains.
Role of the Scaffolding Domain of Caveolin-1 on HO-dependent BK Currents. Similar to
our previous results (Hughes JM et. al., 2010; Riddle et. al., 2011), AP-CAV treatment
significantly decreased outward currents from CH ECs (Figure 5 A and B). In contrast to
the HO inhibition experiments above however, exogenous CO had no effect in the
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presence of AP-CAV. These results support the hypothesis that cav-1 inhibits BK activity
rendering the channels insensitive to activators such as NS-1619 and CO.
Co-localization of HO-1, HO-2, with Cav-1; BK α with HO-2.. Immunofluorescence
imaging of freshly dispersed ECs demonstrated co-localization of HO-2 with BK α in
aortic ECs from CH and control rats. However, the Mander’s correlation coefficient
representative of pixel overlap between fluorescence channels was not different between
CH and controls (Figure 6A). In contrast to HO-2, HO-1 demonstrated little colocalization with BK in cells from either group of rats.
Caveolin-1 demonstrated similar co-localization with both HO-1 and HO-2 in
cells from each group (Figure 6B). Thus, both isoforms of HO appear to be present in
caveolin-containing domains, but only HO-2 might be associated with the BK channel
(Kim et al., 2004).
HO-dependent BKCa currents in RAECs.

Due to limitations in collecting sufficient

endothelial cell specific samples from native tissue, cultured RAECs were used for this
and subsequent western blot protocols. As a validation for use of these cells, a limited
number of patch clamp experiments were performed to confirm the presence of BK
currents and their regulation by HO in RAECs. We found that blockade of HO activity
with CrMP significantly decreased outward currents in RAECs (Figure 7). The
combination of IBTX and the HO inhibitor CrMP had no further inhibitory effect. These
results demonstrate that HO-dependent BK complexes are likely present in cultured
RAECs.
Western Blot detection of HO-1, and HO-2 in RAECs. Single bands for HO-1 or HO-2
appeared at 32 kD and 36kD respectively, (Figure 8) within the reported molecular
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weights for each isoform. Previous studies had identified BK and cav-1 in RAECs
(Riddle et. al., 2011).
HO-2 and BK α immunoprecipitated in RAECs. Caveolin-1 immunoprecipitated with
HO-1 and HO-2 (Figure 8B), and with BK α (Figure 9C) supporting previous work
demonstrating association between BK and cav-1 (Riddle et. al., 2011; Wang et al.,
2005) in cultured ECs; and cav-1 and HO-1 / cav-1 and HO-2 in pulmonary artery
endothelial cells (Kim et al., 2004). BK α immunoprecipitated with cav-1 and HO-2 (Fig.
9A); whereas HO-2 immunoprecipitated with BK α and cav-1 (Figure 9B). HO-1
immunoprecipitated with cav-1 only. These results support the co-localization data in
freshly dispersed ECs and suggest that HO-2 / BK complexes exist in ECs in association
with cav-1.

DISCUSSION
The major findings from this study are: 1) endothelial BK channels exhibit tonic HOdependent activation following in vivo exposure to CH or ex vivo cholesterol depletion;
2) cultured RAECs demonstrate similar HO-dependent BK channel activity ; 3) BK
channel activity can be restored following HO inhibition in cells from CH rats by the HO
product CO or by NS-1619; 4) association of BK channels with the scaffolding domain of
cav-1 prevents activation by HO or the HO product CO; and 5) EC BK channels are
associated with the HO-2 isoform, but not HO-1 in caveolin enriched domains. These
findings suggest that BK channels and HO-2 form a functional unit within caveolae that
is regulated by the scaffolding domain of cav-1.
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Our findings of a functional association between HO-2 and BK channels in
endothelial cells are consistent with prior observations in other cell types. Recent coimmunoprecipitation experiments in HEK293 and glomus type I cells (Williams et al.,
2004) found that BK and HO-2 form oxygen sensitive complexes. Interestingly,
knockdown of HO-2 significantly decreased channel activity (Williams et al., 2004). The
authors hypothesized that acute hypoxia inhibits HO production of CO and thus limits
channel activity, suggesting that HO-2 is the “oxygen sensor” that regulates glomus cell
membrane potential and hence neurotransmitter release in the carotid body. BK channels
are hemoproteins, and upon binding of heme are potently inhibited. In conditions in
which free heme can be degraded by HO, the channel remains active and can be
stimulated by the HO product CO (Yi et al., 2010). However, experiments characterizing
the heme binding domain (HBD) of BK channels found that decreased oxygen and a
reduced state of the HBD significantly increased the channel’s affinity for heme and
resulted in potent inhibition (Yi et al., 2010). In contrast, under normoxic conditions
channel affinity was much higher for CO than heme and permitted channel activity (Yi et
al., 2010). Thus, HO function and heme/CO binding appear to be very important
regulators of BK activity and associate with the channel to form “oxygen sensitive”
complexes. In the present studies, all experiments were performed under normoxic
conditions to eliminate any complicating effects of acute hypoxia. Thus, in vivo during
CH, the regulation of EC BK channels could be affected by the influence of acute
hypoxia on HO activity. However, the degree of hypoxia used ex vivo to inhibit HO
activity is likely much more severe than that observed in the intact vessel wall during CH.
The level of hypoxia reported to decrease HO activity is below 10 torr (Carraway et al.,
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1998) (Carraway et al., 2000), whereas the partial pressure of O2 (PaO2) measured in in
vivo blood gases in rats under CH conditions is around 41 torr (Doyle & Walker, 1991).
Furthermore, we have observed that the HO-dependent attenuation of vasoconstriction in
intact animals is largely unaffected by acute restoration of normoxia (Doyle & Walker,
1991).
The present study also confirms the important regulatory role of cav-1 on EC BK
function. Under control conditions, cav-1 potently inhibits HO-dependent activation of
BK channels as evidenced by the lack of BK current under control conditions and the
inability to activate channel activity with NS-1619 or CORM-2. However, CH exposure
decreases association between cav-1 and BK channels (Riddle et. al., 2011) enabling the
channel activation by endogenous gaseotransmitters such as CO, and NO (Hughes JM et
al., 2010). Recent studies in vascular ECs demonstrate that HO isoforms 1 and 2 colocalize and are inhibited by association with cav-1 (Kim et al., 2004). Thus a
derangement in cav-1 function following CH exposure may enable not only accessibility
of the channel to activators and permit channel opening, but could possibly increase
endogenous HO activity. Although previous studies found enhanced vascular HO-1
expression following CH (Jernigan et. al., 2001), both immunofluorescence on native
cells and immunoprecipitation experiments on RAEC suggest that BK channels associate
with HO-2 in endothelial cells and this enzyme isoform is likely responsible for channel
activation.

Interestingly, co-localization experiments demonstrated no decreases in

association of either HO isoform with cav-1 in native cells following CH. These results
suggest that the BK, cav-1, and HO-2 complex is intact in control conditions, but only
becomes active following CH or cholesterol depletion due to decreased cav-1 inhibition
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of the channel. Although HO-1 appears to also be associated with cav-1, it is not part of
the BK signaling entity.
With sufficient levels of HO activity following CH to activate EC BK channels,
the next question that arises is how HO activity is driving BK activity. In human BK
channels, the breakdown of heme by heme oxygenase enables enhanced channel activity
from production of CO, presumably through CO binding of a redox sensitive domain
with the C-terminus (Christou et al., 2000;Yi et al., 2010). Our results confirm the ability
of CO to activate EC BK channels and are consistent with earlier reports in human
umbilical vein endothelial cells (Wang et. al., 1997). Our results also indicate that
channel activity is near maximum tonically in a HO-dependent fashion. This later result
may be related to the greater calcium sensitivity that we have observed in EC BK
channels compared to similar channels in VSM (Riddle et. al., 2011) where localized
calcium events (sparks) are required for full activation.

In addition, the apparent

enhanced calcium sensitivity of EC BK channels could be due to an effect of CO itself as
previously suggested (Jaggar et. al., 2002). We propose that HO-BK complexes are
inhibited in control conditions due to channel association with cav-1 and its scaffolding
domain. The rapid emergence of HO-dependent BK currents in cells from control
animals treated with MBCD illustrates how cav-1 function either permits or inhibits this
unique complex.
To conclude, CH exposure results in a loss of cav-1 inhibition of EC BK
channels, that are dependent for activation by HO-derived CO. Activation of these
normally dormant EC BK channels results in EC hyperpolarization (Hughes JM et al.,
2010) (Riddle et. al., 2011) and subsequent vascular wall hyperpolarization and
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diminished vasoconstrictor reactivity as previously demonstrated (Caudill et al.,
1998;Earley & Walker, 2002;Hughes JM et al., 2010;Naik & Walker, 2006).
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Figure 1. Heme oxygenase inhibition with ZnPPIX decreased outward currents only in
ECs from CH rats (Panel B), while having no effect in controls (Panel A). The inhibitory
effect of ZnPPIX in CH cells was not different from the effect of the BK specific
inhibitor IBTX (Panel C). Panels D and E show the effect of the BK activator NS-1619
to restore outward current to CH vehicle levels following HO inhibition. NS-1619 is
without effect in control cells (Hughes JM et. al 2010). * p < 0.05 vs. vehicle treated CH.
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Figure 2. Addition of the HO substrate hemin increased outward currents in the CH
group (Panel B) but was without effect in control cells (Panel A).
summary data at +40 mV. * p < 0.05 vs. vehicle treated Controls.
# p < 0.05 vs. vehicle treated CH.
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Panel C shows the

Figure 3. Similar to with ZnPPIX, outward currents were diminished in cells from CH
rats by the HO inhibitor CrMP, however current was restored by the CO donor CORM-2
(Panel A). These data are summarized in Panel B. In contrast, CORM-2 was without
effect on transmembrane currents in the absence of HO inhibition in either group (Panels
C and D). * p < 0.05 vs. vehicle treated controls. # p < 0.05 vs. vehicle treated CH
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Figure 4. Cholesterol depletion in control ECs to disrupt cellular caveolin-1 function
resulted in outward currents that were significantly larger than non cholesterol depleted
control ECs (Panel B). The enhanced outward currents were additionally sensitive to HO
blockade (Panels A/B). * p < 0.05 vs. MBCD treatment . δ p < 0.05 vs. vehicle treated
controls
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Figure 5. EC HO-dependent BK currents from CH rats were significantly reduced
following treatment with a cell permeant peptide of the scaffolding domain of caveolin-1
(AP-CAV). Unlike following HO inhibition (Figure 3), current was not restored by
exogenous CO (Panels A and B). # p < 0.05 vs. vehicle treated CH
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Figure 6. Freshly dispersed rat aortic ECs stained positive for BK α , HO-1, HO-2, and
Cav-1. Co-localization between HO-2 and BK α did not differ between CH and control
groups (Panel A). Cav-1 co-localized with both HO-1 and HO-2 in native tissue. No
differences between HO-1/ Cav-1 or HO-2/Cav-1 association were detected in either
group (Panel B).n = 4-5 animals, 5-8 images were obtained from each n.
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Figure 7. Cultured rat aortic endothelial cells (RAECs) demonstrated an outward current
that was reduced by the HO inhibitor CrMP. Current was not further diminished by
IBTX demonstrating that the HO-sensitive component was due to tonic BK activation.
* p < 0.05 vs. vehicle treated RAECs
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Figure 8. Western blots in RAECs (passage 6) detected HO-1 and HO-2 (Panel A). HO1 and HO-2 co-immunoprecipitated with cav-1 (Panel B). Western blots and coimmunoprecipitation experiments were repeated three times for demonstration of
reproducibility.
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Figure 9. HO-2 but not HO-1 co-immunoprecipitated with BK α (Panel A) in RAECs.. In
addition, cav-1 and BK α co-immunoprecipitated with HO-2 (Panel B). Caveolin-1 coimmunoprecipitated with HO-1, HO-2, and BK α (Panel C). co-immunoprecipitation
experiments were repeated three times for demonstration of reproducibility.
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CHAPTER 6: DISCUSSION
Aim 1: Investigation of the expression and activity of EC BKCa following CH
The general goal of this dissertation was to identify and characterize the
physiological role of endothelial BKCa channels following chronic hypoxia. In the first
aim we determined the localization and activity of EC BKCa channels following CH and
tested the hypothesis that the loss of vasoconstrictor reactivity following CH exposure
results from increased EC BKCa channel activity and resultant membrane
hyperpolarization through whole cell patch clamp and single channel electrophysiology
and immunofluorescence localization studies. The rationale behind these studies emerged
from vascular reactivity and sharp electrode studies that determined that the endothelium
and BKCa channels were responsible for decreased constrictor responses and
hyperpolarization of the vascular wall. The controversy over the expression and
physiological function of endothelial BKCa channels has been extensively debated the
past two decades (Sandow & Grayson, 2009). It has been long accepted that endothelial
BKCa were present in cultured cell lines such as human umbilical vein endothelial cells
(HUVECs) (Sandow & Grayson, 2009;Jow & Numann, 1999;Wang et al., 2005). In
freshly isolated tissues however, the presence and/or function of the channel has been
found to be absent in bovine coronary (Gauthier et al., 2002), mouse aortic (Ledoux et
al., 2008), and rat aortic endothelial cells (Marchenko & Sage, 1996). The results from
the aforementioned studies attempted to characterize EC BKCa through patch clamp. In
agreement with the cell culture studies conducted in HUVECs, we identified EC BKCa
currents in ECs from CH rats. In control animals, aortic and gracilis ECs did not
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demonstrate outward currents that were sensitive to BKCa channel inhibitors or activators,
supporting the previous findings in freshly isolated tissue. The inability to detect BKCa
activity in controls may result from channel inhibition from Cav-1, as later discussed, or
may be an artifact of experimental conditions. Endothelial BKCa channels are
hypothesized to be localized to EC caveolae (Wang et al., 2005) and are possibly
sensitive to changes in vascular flow (Sun et al., 2001), thus removal of endothelial cells
from their native environment may result in decreased or absent activity of the channels.
We have not conducted studies thus far in varied flow conditions in isolated or cultured
ECs, nor have we investigated flow-induced dilation in arterioles from control and CH
rats. Segmental differences in activity of endothelial BKCa channels may also occur as
freshly isolated ECs from 120 µm mesenteric arterioles from normoxic control rats
exhibit IBTX-sensitive currents (data not published). Thus, future studies addressing
segmental differences and flow dependent dilation and the role of endothelial BKCa are
warranted.
The emergence of active EC BKCa following CH may not be the only disease state
where these channels become active, as the activity and expression of endothelial BKCa
following disease has been documented in human mesenteric arteries from cancer
patients (Kohler et al., 2001). Changes in vascular flow over time from disease, such as
in CH may permanently alter the membrane domain through changes to Cav-1 and/or
cellular cholesterol and lead to chronic activation of endothelial BKCa channels.
Investigations into other diseases that alter Cav-1 expression and intracellular
cholesterol/lipids, such as intermittent hypoxia and obesity, may additionally provide
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insight into how these channels function endogenously in disease and in normal
conditions.
Characterization of endothelial KCa channels:
The present results demonstrate that EC BKCa have tonic activation following CH
and contribute to resting membrane potential of ECs (Figure 3: Chapter 2). In addition
to contributing to the membrane potential, ACh induced dilation following CH becomes
dependent upon endothelial BKCa channels whereas the contribution of other calciumactivated K+ channels is significantly decreased (Figure 4: Chapter 2). This switch of
KCa channels in endothelium-derived hyperpolarizing factor (EDHF) dilation is a novel
finding, suggesting BKCa channels following hypoxemic diseases may become
responsible for hyperpolarizing the endothelium and leading to the release of vasodilators
to regulate vascular tone. Several studies have recently demonstrated that endothelial
BKCa channels function in mediating the release of NO upon channel stimulation and
membrane hyperpolarization with NS-1619 (Calderone et al., 2005;Calderone et al.,
2007). Thus it is possible that BKCa activity following CH may lead to the release of
other important endothelial derived vasodilators, such as CO, NO, or EETs.
Electrophysiological characterization of EC KCa Channels:
Our initial observation of increased total EC transmembrane currents and the
emergence of BKCa following CH exposure, was the first published documentation of
enhanced BKCa currents in endothelial cells in a model of chronic hypoxemia.
Interestingly, the aorta and gracilis displayed significantly larger transmembrane currents
than controls (Figures 6A-C: Chapter 2), suggesting that CH treatment may enable EC
BKCa activity throughout the systemic vasculature and not just in individual beds.
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Experiments that characterized the role of all KCa channels in vascular EC outward
currents displayed the importance of SK/IKCa currents in both control and CH groups
(Figures 1A-D: Chapter 2 Addendum). Our results support previous experiments
conducted in murine endothelial cells (Ledoux et al., 2008) that demonstrated a vital role
for SK/IKCa in endothelial membrane potential and outward currents in control nondiseased animals. Interestingly, following SK/IKCa blockade, CH ECs maintained
significant residual currents. These currents were blocked by the BKCa specific blocker,
IBTX. Application of the BKCa-specific activator, NS-1619 selectively enhanced currents
in ECs from CH rats and was without effect in controls (Figures 9A-C: Chapter 2),
providing more evidence for the presence of BKCa in ECs following CH.
Although ECs clearly express BKCa channels, a number of observations suggest
that they are regulated differently from those in VSM. Previous experiments in our
laboratory had demonstrated BKCa dependent responses to endogenous CO produced by
HO that were independent of soluble guanylate cyclase (sGC) and activity of ryanodine
receptors (Naik & Walker, 2003). The blockade of ryanodine receptors significantly
decreases VSM BKCa activity which is dependent upon RyR derived calcium sparks
acting on calcium sensitive β subunits for activation. Thus if EC BKCa are responsible
for the previous observations, then calcium sensitivity in EC BKCa may be significantly
different from VSM. To determine if BKCa activity in endothelial cells also utilized β
subunits, which enhance channel opening by increasing calcium sensitivity, we studied
outward currents in the presence of the β subunit activator tamoxifen, and found no
apparent role for the accessory subunit in vascular endothelial cells (Figure 3:
Addendum Chapter 2). These results are in agreement with previous studies conducted
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in cultured ECs which have not found a physiological role for β1 subunits (McManus et
al., 2011;Eichhorn & Dobrev, 2007). Without a role for beta subunits, or RyR activity,
activity of EC BKCa activity must be maintained through endogenous intracellular
calcium and possess higher calcium sensitivity than VSMC BKCa.
EC BKCa channels have significantly greater calcium sensitivity than VSM BKCa :
To examine this possibility, we identified endothelial BKCa channels through
single channel electrophysiology and determined their unitary conductance, voltage and
calcium sensitivity, and inhibition by the channel specific inhibitor, iberiotoxin (IBTX)
(Figures 2A-C: Chapter 3). EC BKCa unitary conductance was determined and
contrasted to VSM BKCa unitary conductance to verify channel identity in whole cell-cell
attached and inside-out patch clamp single channel recordings. No differences between
cell types were found (Figure 6: Addendum Chapter 2). Calcium and voltage
sensitivity of EC BKCa were performed in inside-out patches and contrasted to VSM
BKCa calcium and voltage sensitivity and determined that EC BKCa exhibited enhanced
calcium sensitivity (Figure 2B: Chapter 3). These results are in contrast to previous
findings in cultured ECs which have shown lower calcium sensitivity of EC BKCa and
activation at higher voltages (Nimigean & Magleby, 1999;Papassotiriou et al.,
2000;Eichhorn & Dobrev, 2007). The effects of culturing may significantly affect
endothelial BKCa channel function compared to those in native tissue. With scant
literature characterizing endothelial BKCa it will continue to be important to characterize
channel sensitivity to voltage and calcium in each model presented to provide insight into
the mechanisms responsible for driving EC BKCa activity, as it is apparent EC BKCa
channel regulation differs from regulation in VSM.
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CH ECs demonstrated EC BKCa activity at the single channel level in whole-cell
cell attached or inside-out patches. These results provide evidence that the mechanism
responsible for enabling BKCa activity following CH permits channel activity in a
membrane-delimited fashion. However, studies using a variety of electrophysiological
methods including perforated patch, whole cell patch clamp, and single channel studies
never isolated BKCa activity in control ECs from rat gracilis and aortae. These studies
support previous observations of no electrophysiological evidence for these channels
within ECs from control animals (Ledoux et al., 2008). Though a powerful technique for
identifying and characterizing the role of ion channels in cells, electrophysiological
experiments are not able to discriminate between a lack of expression, or the presence of
functional endogenous channel inhibitors. Indeed experiments within control animals
suggested no functional role for EC BKCa, thus additional methods to characterize and
identify EC BKCa were employed to either prove or disprove the lack of physiological
function of BKCa in control ECs.
Control and CH animals have EC BKCa channels:
Endothelial expression of BKCa α and β1 subunits was confirmed in sectioned resistance
arteries

and

in

freshly

isolated

aortic

endothelial

cells

using

confocal

immunoflourescence microscopy (Figures 10A-H & Supplemental Figure 2: Chapter
2). These results were in contrast to our aforementioned data that only demonstrated the
functional presence of BKCa in CH ECs through electrophysiological characterization.
The presence of β subunits in the localization experiments is interesting as they do not
appear to be functionally coupled to the channel (Figures 10C-D: Chapter 2). The
localization of β subunits in isolated cells does not match localization of the α subunit and
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appears to be restricted to cytosolic domains. However, without the use of membrane
specific markers, we cannot discount plasma membrane β subunit localization.
Nevertheless, their lack of functional coupling to the α subunit and irregular staining may
suggest endosomal compartmentalization. Currently their function in the vascular
endothelium is unknown and warrants further investigation.
RAECs express BKCa:
Immunofluorescence localization experiments provided evidence for channel
expression in control ECs, but did not discriminate changes in channel expression. These
results led us to investigate how EC BKCa channels were regulated and if BKCa
expression could be maintained in culture. Due to the limitations of sample purity and
quantity from freshly dispersed ECs, we utilized a cultured EC line from rat aorta
(RAECs) to characterizethe presence of BKCa in RAECs through immunofluorescence
and western blot.

RAEC expression of BKCa α was confirmed using confocal

immunoflourescence microscopy (Figure 1: Addendum Chapter 3). Western blot
detection also confirmed

BKCa α expression in RAECs (Supplemental Figure 1:

Chapter 3). The use of cultured cells does not address changes in expression that may
exist following CH in native cells. The use of cultured cells, however does enable the use
of molecular methods that are not feasible in native tissue. Results from these studies
support previous studies also identifying BKCa in cultured ECs (Wang et al., 2005;Dong
et al., 2007;Sandow & Grayson, 2009) and warrant their use as a tool for investigations
of cellular mechanism responsible for BKCa regulation in native ECs.
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Aim2 : Assess the role of the Cav-1 scaffolding domain in regulating EC BKCa
channels following CH.
The second aim of this dissertation project assessed the role of the Cav-1
scaffolding domain in regulating EC BKCa channels following CH by testing the
hypothesis that CH exposure results in a loss of Caveolin-1 inhibition of EC BKCa
enabling increased channel activity and a loss in vasoconstrictor reactivity. Following
immunofluorescent localization of BKCa channels within ECs from control rats, we
sought to find an inhibitory mechanism which may be responsible for the lack of activity
found in controls. BKCa in cultured ECs are hypothesized to be localized within caveolae
and inhibited by the scaffolding domain of caveolin-1 (Wang et al., 2005). Loss of
caveolar structure, caveolin presence, or the ability of Cav-1 to directly regulate the
channel through its scaffolding domain following CH would result in increased channel
activity and subsequent diminished vasoconstrictor reactivity. Experiments in this aim
addressed alterations to caveolae, Cav-1, and channel inhibition by Cav-1 following CH
exposure. Patch clamp electrophysiology, membrane potential recordings, and isolated
arterioles were utilized for functional experiments determining the role of Cav-1 and its
scaffolding domain on BKCa activity; and immunofluorescent localization and coimmunoprecipitation experiments were conducted to investigate association between
Cav-1 and BKCa. EC BKCa channels (in HUVECs) are inhibited by association with
caveolin-1 and its scaffolding domain (Wang et al., 2005) and are tightly regulated by
lipid content of cellular membranes (Thompson & Begenisich, 2006;Weaver et al.,
2007). Two consensus caveolin-1 binding sites exist on BKCa, with previous studies
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demonstrating that caveolin-1 siRNA acts similarly to cholesterol depletion (Lu et al.,
2006).
Caveolin-1 and cholesterol regulation of EC BKCa :
To determine the role of caveolin-1 in regulation of EC BKCa channels,, we
examined the effect of cholesterol depletion, cholesterol repletion, and the administration
of a cell permeant peptide of the scaffolding domain of Cav-1 on BKCa currents in freshly
dispersed cells from control and CH rats. For cholesterol depletion experiments, the agent
methyl-β-cylcodextrin (MBCD) was administered. MBCD treatment resulted in
significantly larger currents in control ECs in (Figures 11A-D: Chapter 2 / Figure 1D:
Chapter 3) that were inhibited by IBTX (Figures 12A-C: Chapter 2 / Figures 3C/D:
Chapter 3) and augmented by NS-1619 (Figures 4C/D: Chapter 3). These results are in
agreement with previous studies that determined that depletion of cellular cholesterol
with MBCD enhanced BKCa currents in HUVECs (Wang et al., 2005f) and in other
volume sensitive cell types, such as acinar cells (Tajima et al., 2011;Thompson &
Begenisich, 2006b). Interestingly in myometrial myocytes cholesterol depletion may
cause significant decreases or increases in BKCa currents. In freshly isolated myocytes
from non-pregnant and pregnant female human donors, Brainard demonstrated increases
in BKCa activity (Brainard et al., 2005), however these results are in sharp contrast to
observations in freshly isolated rat myometrial myocytes (Shmygol et al., 2007) which
demonstrated decreased BKCa function. The relationship between BKCa and Cav-1 and
cholesterol rich domains was further explored in studies with cholesterol repletion, in
which we found the addition of cholesterol significantly decreased currents in CH ECs to
the level of controls (Figures 5A-D : Chapter 3). Co-immunoprecipitation experiments
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conducted by our group and others (Brainard et al., 2005;Shmygol et al., 2007;Wang et
al., 2005) have provided evidence for possible direct association between Cav-1 and
BKCa, however it is unclear if cholesterol limits Cav-1 association with the channel, as
free cholesterol is necessary for its plasma membrane localization (Pol et al., 2005) or if
cholesterol itself may bind and inhibit the channel (Bukiya et al., 2011).
It has been demonstrated that either large scale depletion or repletion of cellular
cholesterol content, or changes in the contents of the lipid bilayer result in decreased
BKCa channel activity (Romanenko et al., 2009;Yuan et al., 2007). Cholesterol
“manipulation” affects membrane fluidity and may possibly result in the activation of
multiple signaling cascades, not just those localized and dependent on caveolae. It is
possible that MBCD treatment increases the production of endogenous channel
activators, such as NO derived from eNOS, or CO derived from heme oxygenase. It is
also possible that the removal of cholesterol, may directly alter in channel activity. BKCa
channels are sensitive to changes in lipid environments and are hypothesized to have
direct sterol-channel interactions (Bukiya et al., 2011), thus manipulation of cholesterol
content with cyclodextrins likely affects channel activity through Cav-1 dependent and
independent mechanisms.
The use of the scaffolding domain is thought to be a more direct approach tostudy
the effect of Cav-1 function. Several studies have demonstrated the scaffolding domain
of Cav-1 acts similarly to overexpression or rescue of Cav-1 (Bucci et al., 2000;Couet et
al., 1997;Oka et al., 1997) suggesting that AP-CAV affects Cav-1 function more directly
than cyclodextrins.

Other studies have supported the specificity of the scaffolding

domain peptide on Cav-1 function by utilizing the peptide as an inhibitor of caveolin-1
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function. In these studies, the administration of AP-CAV acted similarly to cholesterol
depletion with both treatments resulting in hindering of Cav-1 function but through very
different mechanisms (Sathish et al., 2011; Adebiyi et al., 2010). The scaffolding domain
peptide in these studies overloaded binding of endogenous Cav-1 to target proteins,
resulting in a decrease in Cav-1 dependent signaling. In the present studies, AP-CAV
administration significantly inhibited BKCa currents. This is in agreement with previous
studies in which the scaffolding domain of Cav-1 inhibited BKCa channels (Lu et al.,
2006), however the nature of this inhibition is unclear. Currently, we believe that Cav-1
may inhibit BKCa channels in endothelial cells through its scaffolding domain. Future
studies addressing whether the scaffolding domain of Cav-1 alters Cav-1 aggregation
and targeting of BKCa channels or cellular cholesterol levels are warranted and would
provide clarification between the observed effects of cholesterol manipulation and APCAV on BKCa channel function.
Endothelial hyperpolarization following CH is restored through inhibition of EC BKCa:
Following characterization of endothelial BKCa inhibition by Cav-1, we next
investigated if manipulation of Cav-1 activity would translate to alterations in vascular
function. We found that endothelial cell Em in gracilis arteries from MBCD treated
controls was hyperpolarized compared to controls, similar to findings in the CH model.
The MBCD induced hyperpolarization was inhibited by IBTX (Figure 3: Chapter 2 /
Figure 1B: Chapter 3) and by AP-CAV (Figure 1C: Chapter 3). Thus, caveolar
disruption with MBCD also resulted in hyperpolarization of the endothelium. These
results support a role for EC BKCa in mediating the vascular wall hyperpolarization
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following CH due to a loss in Cav-1 inhibition of the channel through its scaffolding
domain.

Diminished vasoconstrictor reactivity following CH is restored through the Cav-1
scaffolding domain :
Previous studies demonstrated that vasoconstrictor responsiveness of the systemic
circulation is attenuated following prolonged exposure to hypoxia (Auer & Ward,
1998a;Toporsian & Ward, 1997;Hu et al., 1996;Doyle & Walker, 1991). Diminished
vasoconstrictor reactivity following CH is observed both systemically and in several
individual vascular beds (O'Donaughy & Walker, 2000;Jernigan et al., 2001;Auer &
Ward, 1998;Caudill et al., 1998) as

reduced vascular resistance response to

vasoconstrictor agonists (Doyle & Walker, 1991). The role of Cav-1 in vascular reactivity
has not been defined in this setting. Due to expression of Cav-1 in both VSM and the
endothelium, we designed our studies to focus on the effects of endothelial Cav-1 in
vascular reactivity by employing intraluminal administration of agents affecting caveolar
function. Myogenic and PE responses of isolated gracilis arteries displayed decreased
vasoconstrictor reactivity in CH and MBCD treated controls. Luminal administration of
the scaffolding domain peptide AP-CAV restored myogenic tone and vasoconstriction to
PE to levels of controls. These results support a role for Cav-1 and its scaffolding domain
in maintaining vascular reactivity. Whether Cav-1, the scaffolding domain peptide, or
both are acting directly upon EC BKCa channels or through indirect mechanisms is
unclear from these results. Interestingly, these results are in sharp contrast to much of the
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literature describing the role of Cav-1 and MBCD treatment on VSM and vasoconstrictor
reactivity (Potocnik et al., 2011).
Caveolar structure and relative number does not change with CH:
The concentration of MBCD utilized by Potocnik is 100 fold greater than the
concentration of MBCD that we used in our studies to mimic the effects of CH. The
concentration of 10 mM of MBCD has been previously demonstrated to ablate caveolae,
and following structural studies conducted in rat aorta we additionally found the
concentration was sufficient to eliminate cellular caveolae. The 100 µM concentration
that we utilized did not alter the structure or number of cellular caveolae. Neither did CH
treatment (Supplemental Figure 4: Chapter 2). These results suggest that CH exposure
is not resulting in a dramatic change in plasma membrane caveolae, but rather BKCa
activity is enabled by more subtle alterations in caveolar function.
Decreased Cav-1 and BKCa association following CH:
Drastic changes in localization or relative fluorescence between Cav-1 or BKCa α
were not documented in immunofluorescence studies following CH. However,
determination of BKCa/Cav-1 co-localization in arteriole cross sections did demonstrate a
significant decrease in association (Figure 7 bottom panel: Chapter 3). These results
suggest that CH exposure results in decreased association between the channel and Cav-1
and not through changes in expression per-se. This could be through decreased plasma
membrane targeting of EC BKCa associated with diminished cellular cholesterol, which is
required for Cav-1 localization at the plasma membrane (Pol et al., 2005). Increased Cav1 phosphorylation or decreased post-translation modifications such as palmitoylation,
have also been demonstrated to be important for Cav-1 inhibition of its various signaling
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partners (Cohen et al., 2004;Parat et al., 2002), and could also explain the decrease in
association between the channel and Cav-1. However, although immunofluorescent
localization provided basic assessment of Cav-1/BKCa association in ECs, it has
limitations by not discriminating possible small but significant changes in localization
and targeting at the plasma membrane. Further exploration into the effect of hypoxia on
Cav-1 post-translational modifications, phosphorylation, and targeting of BKCa through
direct association with the channel in cultured cell systems may provide further insight
into the direct mechanism responsible for the decreased association amongst BKCa and
Cav-1.

Caveolin-1 and BKCa co-immunoprecipitate in RAECs:
We further determined association of BKCa and Cav-1 through coimmunoprecipitations of cultured RAECs, and found that BKCa and Cav-1
immunoprecipitate (Supplemental Figure 2: Chapter 3). These results suggest that
BKCa and Cav-1 are structurally associated in ECs. The use of cultured cell systems has
limitations as characteristics of cultured cell lines may be drastically different from native
cells. Characterization of Cav-1/BKCa association in native endothelium would be ideal,
but due to sample size and purity limitations we chose to use RAECs to conduct these
studies. We chose to only conduct experiments in normoxic conditions as we have not
characterized the effects of hypoxia in these cells. Current investigations using RAECs
demonstrated expression of BKCa. However, unlike results obtained in native tissues,
cholesterol depletion was not required to unmask BKCa activity (Figure 7: Chapter 4).
Thus, although BKCa channels are associated with caveolin-1 in these cells, channel
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function is not inhibited. However, it must be pointed out that even in native cells from
CH rats, there is a level of maintained association between these proteins. Therefore, the
disinhibition of BKCa channels in CH or in cultured cells does not require complete
dissociation from Cav-1.

Aim 3: Investigate caveolin-1 regulation of heme oxygenase and HO-dependent
BKCa activity following CH.

In the third aim of the project we directed our attention on the relationship
between BKCa and HO, and their regulation by Cav-1. Previous data have linked HO
activity and BKCa activity resulting in hyperpolarization of the vascular wall and
decreased vasoconstrictor reactivity (Jernigan et al., 2001;Naik & Walker, 2003;Naik &
Walker, 2006;Wang et al., 2005). We tested the hypothesis that CH treatment results in a
loss of Cav-1 inhibition of HO dependent BKCa activity resulting in EC hyperpolarization
and

diminished

vasoconstriction

through

electrophysiology,

immunofluorescent

colocalization, and co-immunoprecipitation experiments.
HO dependent activation of EC BKCa:
The HO product, CO can activate VSM BKCa channels (Jaggar et al., 2002) and
HO-dependent activation of BKCa channels has been additionally found in carotid body
glomus cells where it acts as an oxygen sensor (Williams et al., 2004). Patch clamp
experiments in freshly isolated ECs found HO-dependent activation of EC BKCa channels
(Figure 1: Chapter 4). It was further determined that the HO product responsible for
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activating EC BKCa was likely CO, as the effects of enzyme blockade could be restored
by exogenous CO treatment (Figure 3: Chapter 4). These results are in agreement with
previous studies demonstrating HO derived CO directly activates BKCa channels in
functional oxygen sensing units (Williams et al., 2004;Kooli et al., 2008). Following
cholesterol depletion to unmask BKCa channel activity, currents from control ECs were
similarly sensitive to HO blockade (Figure 4: Chapter 4). Thus, a loss in Cav-1
regulation unmasks HO-dependent BKCa currents in ECs. Subsequent experiments
determined that the scaffolding domain of Cav-1 inhibits HO-dependent BKCa currents
that were not restored by exogenous CO (Figures 5A/B: Chapter 4). Furthermore the
use of a channel activator could stimulate channel activity following blockade of HO,
providing evidence that blockade of the enzyme does not affect the ability of the channel
to be activated by channel openers or CO. However, the scaffolding peptide AP-CAV
does not enable subsequent channel activity. To corroborate findings in freshly dispersed
cells, we additionally performed experiments examining HO-dependent BKCa activity in
cultured RAECs and also observed HO-dependent BKCa currents (Figure 7: Chapter 4).
The HO-dependent BKCa currents were present without the need for cholesterol
depletion, suggesting culturing of these cells alters Cav-1 and membrane properties as
discussed above. As reviewed by Sandow and Grayson, the effects of culturing may
significantly alter phenotypic properties of endothelial cells enabling the activity of BKCa
in cells that have quiescent channels in vivo or in ex vivo (freshly dissociated) conditions
(Sandow & Grayson, 2009). Thus, RAECs cultured in normoxic conditions do not
display identical properties to freshly isolated ECs from normoxic rat aorta; however both
models do contain functional HO-BKCa units.
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Co-immunoprecipitation experiments demonstrate association amongst HO-2 and BKCa
in RAECs:
Without the capacity to perform co-immunoprecipitations and western blots on
freshly isolated ECs without contamination from VSMCs, we utilized RAECs and found
HO-2 and BKCa, and Cav-1 and both HO isoforms co-immunoprecipitated (Figures 8
and 9: Chapter 4). These results are in agreement with previous studies which
demonstrated HO and Cav-1 association in pulmonary vascular endothelial cells (Kim et
al., 2004b) and HO-2 and BKCa in cerebral microvascular ECs and carotid body glomus
cells (Kooli et al., 2008;Roth et al., 2009;Williams et al., 2004). Supporting these
findings, imunnofluorescence co-localization experiments in freshly dispersed ECs for
CH found association between HO-1 and Cav-1, HO-2 and Cav-1, and BKCa and HO-2.
Co-localization was quantitated and no differences were observed in the degree of
association following CH (Figure 6 : Chapter 4) in contrast to previous results in which
BKCa and Cav-1 association decreased with CH..
These studies are the first investigation of the role of HO on BKCa activity in
native endothelial cells, although others have provided evidence for this pathway in
cultured HUVECs (Wang. et al., 2005). However, the role of Cav-1 in this signaling
pathway was not been examined. The limitations of the study include: the inability to
determine changes in BKCa/ HO/ and Cav-1 association through co-immunoprecipitation
in native tissues; and a lack of discrimination of direct / indirect actions of Cav-1 on
BKCa function. The strengths of this study include: establishment of EC BKCa regulation
by Cav-1 and HO in native tissues and cultured RAECs enabling a variety of models to
study detailed mechanisms of this novel regulatory unit in ECs. These observations were
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also translated into in vivo experiments where we observed that long term and short term
administration of the scaffolding domain peptide restored vascular reactivity following
CH (these data were not in the scope of the dissertation and are not included). Coupled
with the observation that acute luminal cholesterol depletion of arterioles mimicked the
effects previously described in CH, our data suggest an important role for Cav-1 and
cellular cholesterol in mediating HO-dependent BKCa activity in the vasculature.
The question of whether Cav-1 function is decreased initially and cholesterol
decrease, or if cholesterol levels decrease leading to derangements in Cav-1 activity may
be a difficult task to delineate. Unpublished observations from our laboratory
demonstrate that in a 4 wk model of CH, pulmonary ECs have significantly less
cholesterol than controls. Previous studies have demonstrated that enzymes responsible
for cholesterol synthesis are hypoxia sensitive and alter cholesterol synthesis and
metabolism in vascular tissues (Arai et al., 1996;Nguyen et al., 2007). In addition,
hypoxia has been demonstrated to increase HO expression and activity (Jernigan et al.,
2001;Lee et al., 1997;Motterlini et al., 2000). Interestingly, recent studies have also
provided evidence for HO expression and activity driving cholesterol synthesis and efflux
in cultured astroglia (Hascalovici et al., 2009). In addition, Cav-1 negatively regulates
HO activity (Kim et al., 2004).
Adding to the complexity of the scenario, oxidative stress which is elevated with
CH, can increase HO expression and activity (Abraham & Kappas, 2008) and have affect
Cav-1 function. Oxidative stress has been shown to increase Cav-1 expression in
fibroblasts (Bartholomew & Ganetzky, 2010), while in vascular smooth muscle cells
Cav-1 expression in unchanged. However there is an increase Cav-1 phosphorylation
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which regulates Cav-1 trafficking and localization (Basset et al., 2009). Interestingly,
different types of ROS may also contribute to either increases or decreases in Cav-1
expression. In human lung carcinoma cells, superoxide anions and hydrogen peroxide
down-regulated Cav-1 expression, while hydroxyl radicals upregulated Cav-1 expression
(Luanpitpong et al., 2010). Thus depending upon which type of ROS is present and
which particular cell is exposed, differences in Cav-1 expression and/ or activity may
occur. The effect of hypoxemia and ROS on Cav-1 in systemic endothelial cells has not
been characterized and warrants further investigation. Recent data from our laboratory
have demonstrated roles for both HO and ROS contributing to impaired vasoconstriction
following CH (Sweazea & Walker, 2009). The blockade of both ROS and HO increased
CH vascular reactivity similarly to our present findings with AP-CAV treatment.
However, we did not examine the role of ROS in the
current studies and it is a potential future direction of this research.

LIMITATIONS OF STUDIES
Non-specific actions of AP-CAV:
The experiments and studies conducted within the scope of this project are not
without limitations. As previously discussed, the actions of AP-CAV on BKCa channel
activity do not permit channel activation by exogenous CO or channel openers, however
these experiments have not demonstrated physical association between the peptide and
BKCa. Additionally, AP-CAV may target other Cav-1 regulated kinases and
phosphatases. It is possible that kinase or phosphatase activity may result in posttranslational modification of BKCa and cause the decreased channel activity. Thus, from
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our results it is unclear if AP-CAV is decreasing BKCa activity through indirect or direct
mechanisms. Investigations into possible post-translational modifications of EC BKCa
channels may provide greater insight into channel regulation following treatments with
the scaffolding peptide.

Limitations on the resolution of BKCa and Cav-1 association:
We have hypothesized that EC BKCa are localized to caveolae and are directly
associated with Cav-1. Immunofluorescence data support this claim by demonstrating a
reduced BKCa / Cav-1 overlap following CH. Immunofluorescence studies are limited by
the size and bulk of fluorescent proteins which determine “association” between labeled
proteins. The overlap of large fluorescent proteins attached to secondary antibodies
determines co-localization, which may not be indicative of physical interactions between
two proteins in vivo. Additionally, confocal microscopy does not have the resolution to
view cellular structures such as caveolae. Thus, without determining association between
Cav-1 and BKCa in caveolae or the plasma membrane we cannot definitively claim BKCa
and Cav-1 directly interact in EC caveolae.

Limitations on the study of isolated arterioles in no flow conditions:
Current studies investigated the role of Cav-1 and BKCa on vasoconstrictor
reactivity following CH in isolated arterioles. By removing the arteriole from native
conditions in the animal we are removing blood flow and studying the arteries under
static conditions. We hypothesize that EC BKCa channels are localized to cellular
caveolae and regulated by Cav-1 in the plasma membrane. Therefore, changes in flow
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may result in significant changes in membrane fluidity, Cav-1 association with the
channel, and ultimately BKCa activity.

Limitations of the model used for these studies:
We chose to study the model in the Sprague Dawley rat, which has been
previously used to determine HO-dependent hyperpolarization and losses in
vasoconstrictor reactivity following CH. The use of knockout animals for HO, Cav-1, or
BKCa would have strengthened these studies by allowing investigation of each protein in
the regulation of vascular tone in conscious animal, isolated arteriole, and isolated cell
experiments. Whether HO-BKCa dependent regulation of vascular tone occurs in humans
is unclear. Our studies assessed physiological adaptations in rats following CH exposure,
which may not reflect physiological adaptations to hypoxia or COPD in humans.
Additionally, by studying how Cav-1 and HO-BKCa complexes are regulating vascular
tone within isolated cell systems our interpretation on whether these complexes are
important in an intact animal or human is limited.
SUMMARY
To summarize, vascular endothelial cells contain BKCa channels which are
inhibited by Cav-1 and cellular cholesterol and are activated endogenously by CO
derived from HO. These functional oxygen sensing units become active following CH
with the removal of Cav-1 inhibition and causing endothelial and vascular wall
hyperpolarization leading to diminished vasoconstrictor reactivity. The role of BKCa
channels in regulating vascular tone following hypoxia and a possible contribution to
vascular tone in normoxia appears to depend upon the vascular bed and size of the
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arteriole, and on whether the arteries are studied under constant flow or constant pressure
conditions. Activation of these functional units may additionally contribute to increased
release of EDHFs as ACh-induced dilations following CH become dependent upon the
activity of EC BKCa. Thus HO-dependent activation of EC BKCa channels may function
in flow-induced vasodilation and regulation of vascular tone through modulation of
endothelial membrane potential and the release of EDHFs.
The removal of Cav-1 inhibition may be due to a loss in cellular cholesterol
synthesis and Cav-1 targeting of the ion channel to the plasma membrane. Enhanced HO
activity, as previously characterized (Jernigan et al., 2001), may additionally contribute
to Cav-1 dysfunction through reductions in cholesterol synthesis; as could increases in
ROS as both have been recently implicated in dampening vasoconstrictor reactivity
following CH.
Further elucidation into how HO-BKCa is unmasked in vascular ECs will be of
importance in models of increased vasoconstriction such as systemic hypertension and
obesity. For example, in a model of diet-induced obesity, increased ROS and decreased
HO expression contributed to endothelial dysfunction and impaired vasodilation (Roberts
et al., 2006). The ability to activate and target EC HO-dependent BKCa to oppose
vasoconstriction may restore vasodilation and endothelial function in this model. In
contrast, in settings with enhanced vasodilation in the systemic circulation as in animal
models of cirrhosis, where enhanced production of CO and increased BKCa activity have
been documented (Bolognesi et al., 2007) , inhibition of HO-dependent BKCa activity
within the endothelium could prove beneficial.
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To conclude, the delicate balance of vasoconstriction and vasodilation has long
been connected with BKCa function in the vascular smooth muscle. However, our current
studies clearly establish a prominent role for the regulation of vascular tone by
endothelial BKCa. This represents a truly novel mode of vascular regulation of potential
significance in a variety of physiological and pathophysiological conditions.
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